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Patients' perceptions of their rheumatic condition: why does it matter and how can 
healthcare professionals influence or deal with these  perceptions? 
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1. What are illness perceptions?  
Illness perceptions are as old as mankind. Long before the term was formulated by researchers, people 
have tried to interpret symptoms and illnesses that they and those close to them encountered and 
thus give meaning to their experiences [1]. ‘Illness perceptions’ is a term used to refer to the mental 
representations and personal ideas that people have about an illness, which is a dynamic process and 
can fluctuate over time [2]. These personal ideas about illness can be seen in the broader context of 
the self and the sociocultural system. This means that they are not merely states of the individual, 
experienced and interpreted at the physical and psychological levels but that they are also shaped by 
the pre-illness self, the surrounding culture, institutions, and social networks [3].  
Currently, illness perceptions are seen as frameworks or mental models that individuals 
construct to make sense of their symptoms and medical conditions [4]. These illness models are 
implicit and can be very specific to the individual. Also, patients with the same condition can have 
different perceptions regarding their illness [5,6]. Nevertheless, consistent patterns can be identified 
in the way individuals generate illness perceptions. These perceptions are an important key to 
understanding individuals’ illness behavior, no less important than the classical so-called objective 
indicators of the disease. The concept of illness perceptions has been introduced in the early 1980s by 
Howard Leventhal and colleagues [7,8] in the Common-Sense Model of Self-Regulation in health and 
illness. The work performed and discussed in this PhD thesis is based on this model.   
 
2. The Common-Sense Model of Self-Regulation in Health and Illness 
The origin of the Common-Sense Model 
The origin of the Common-Sense Model of Self-Regulation in health and illness (CSM) lies in the health 
communication research that was booming in the 1960s. The goal of this research was to examine if 
threatening communication about diseases elicited fear that led to attitudes and actions, for 
preventing the threat [9]. The findings of this research were that fear and the effects of fear were 
transient. Years later, Leventhal (1970) [10] developed the parallel processing model which posits that 
processing ‘danger control’ (i.e., disease threat) occurs parallel and independent from processing ‘fear 
control’. The parallel actions were undertaken and appraised to reduce the negative emotions evoked 
by health threats (fear control) and reducing the threats themselves (danger control) [11]. In this model 
a belief about a threat led to an action. Previous research had shown that this belief was not fear 
because it was known that fear faded away within 24-48 hours. It was the cognitive representation of 
the disease threat that was the source of motivation for activating plans of action but the content of 
this cognitive representation was unclear. The first step for the creation of the CSM was undertaken.  
10 |CHAPTER 1  
 
Leventhal and colleagues first described the CSM in 1980 [7] and fine-tuned the model 
afterwards [8,9,12]. The CSM presents how internal stimuli (e.g. symptom experience such as pain) 
and external stimuli (e.g. disease-related information from family or healthcare professionals) 
generate cognitive and emotional representations which guide the selection of coping procedures in 
order to eliminate and control potential or ongoing illness threats. Hereafter, an appraisal of these 
coping efforts occurs and an evaluation of their success in regulating outcomes (see Figure 1). For 
example, an individual with a rheumatic disease may view his illness as long lasting but controllable 
through medication intake, and therefore a change in the medication regimen might be viewed 
effective to cope with the disease progression. An individual who believes the same disease is 
uncontrollable and finds it a source of emotional distress may adopt a denial coping response. If the 
patient appraises a particular coping procedure as being ineffective then this might result in the 
selection of an alternative coping strategy or even a change in the representation of the illness [9]. So, 
illness perceptions occur at a two-level stage and are part of a dynamic process.  
 
Figure 1: Common-Sense model of Self-regulation in Health and Illness. Adapted from Leventhal et al. 
(1997)  
 
 
 
 
 
 
 
 
 
 
 
Within Leventhal’s CSM, cognitive representations are composed out of five main interrelated 
components that make up patients’ views of their illness: ‘Timeline’ which is the believed time 
trajectory of the illness; ‘Consequences’ which includes people’s overall evaluation of the seriousness 
of their conditions, as well as the extent to which these conditions affect specific domains of their lives-
physical, social, financial, occupational, etc.; ‘Causal attributions’ which describes the perceived causal 
mechanism of the illness; ‘Illness Identity’: the label a person uses to describe the illness which means 
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that symptoms are the starting point to label somatic experiences; and ‘Control/cure’ which measures 
whether something can be done to control the illness [13]. Researchers found an intercorrelation 
between the various illness perception dimensions and showed for a number of illnesses that the 
intercorrelations among the illness perception dimensions were strong and significant, but did not 
exhibit correlations of a magnitude that was indicative of conceptual overlap [14–16]. Hagger and 
Orbell (2003) [14] give as a remark in their meta-analysis that the intercorrelations among the 
dimensions were indicative of a systematic and logical pattern of relations which means that for 
instance the perception of more severe consequences is associated with a chronic and less controllable 
disease course.  
 
A closer inspection of the formation of illness perceptions 
The first step in establishing and shaping illness perceptions is the interpretation of different sources 
of information by an individual [15]. Leventhal describes in the CSM three basic sources of information 
[7,8]. The first source of information is the general pool of ‘lay’ information already assimilated by the 
individual from previous social communication and cultural knowledge of the illness. The second 
source considers information from the external social environment including perceived significant 
others or authoritative sources, such as family, healthcare professionals, peers. Finally, the individual 
completes her/his illness representation by taking into account their current experience with the 
disease. ‘Current experience’ refers to the somatic or symptomatic information based on current 
perceptions and previous experiences with the illness. Information from all these sources contributes 
to the formation of illness representations.  
Researchers have looked more in detail at these determinants or correlates of illness 
perceptions. Following correlates were found as influencing factors of illness perceptions: personality  
such as optimism and pessimism [15], neuroticism, i.e. negative affectivity, which means  experiencing 
negative emotions such as fear, anger, worry, frustration etc. more likely than average [17], type D 
personality, which is described as the tendency to experience a high joint occurrence of negative 
affectivity and social inhibition (i.e., not expressing these negative emotions because of fear of 
rejection by others) [18,19]; sociodemographic variables such as older age [20–22], female gender  
[20,22,23], culture [24–26] educational level [20] and high income [22]. Other correlates reported in 
literature are illness-related variables, the frequency of healthcare visits [15], anxiety, depression or 
depressive symptomatology [27–29]. Constant and colleagues (2005) [30] mention information from 
a physician and from the internet  as a correlate of illness perceptions.  
A clear overview of these correlates or determinants of illness perceptions and the focus on 
modifiable correlates is lacking. Modifiable correlates are changeable, meaning that they are amenable 
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for clinical interventions. Knowledge of modifiable correlates is an added value because in some 
situations it is much more convenient to tackle these correlates instead of the illness perceptions their 
selves.  
Another remark considers that the social environment is less studied in illness perception research, 
however, not less of importance. Leventhal and colleagues [11] described self-regulation as inherently 
dependent on the input and expertise of others. Hence, at any specific situation and throughout the 
individual’s development history, every component of the self-regulation system will be shaped and 
reshaped by the social environment. This means that the contacts throughout the care seeking and 
treatment process might determine one’s experiences with illness [11]. In this regard, it is interesting 
to know physicians’ perceptions concerning the illness of their patients.  The fact that illness 
perceptions of physicians and patients differ or do not differ is not extensively studied in the literature 
[1,5]. The literature that is available clearly states that healthcare professionals’ perceptions are 
shaped by experience and training and is different from patients’ illness perceptions [31].  
Furthermore, in clinical practice patients with chronic conditions do not only encounter their treating 
physicians but also physicians from other specialties who give them likewise advice and information 
about their condition. Documenting areas of major differences between patients and doctors in their 
views of an illness can avoid miscommunication and misunderstandings that exist in healthcare [5]. 
 
The importance of having knowledge of patients’  illness perceptions  
Illness perceptions are important because they motivate people to take specific behaviors directed at 
managing the condition and improve the outcome of their illness [8]. Studies in different patient 
populations state that illness perceptions are related to important health outcomes such as physical 
health, recovery, disability, survival/mortality [32], adherence, quality of life, etc. [5,6,14]. Illness 
perceptions explain, across a range of illnesses, between 25% and 30% of the variance in emotional 
health outcomes before any coping variables were considered [33]. A growing body of evidence in the 
past 20 years shows that more ‘negative’ views of illness held by patients, such as reporting more 
perceived symptoms, lower perceived controllability of their condition, a longer perceived disease 
duration and experiencing more serious consequences owing to their conditions, are associated with 
poorer outcomes, independently of disease-related characteristics or the medical severity of patients’ 
conditions [2,5,6,34]. This research is important because it helps inform clinical interventions and can 
also provide a basis for identifying patients at an early stage who are at risk of not coping well with 
their illness [5]. 
Based on the CSM, researchers assume that illness perceptions generate health outcomes. 
However, it is possible that these outcomes, in turn, can influence the formation of illness perceptions. 
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Which means that possibly some outcomes can also be correlates or influencing factors of illness 
perceptions. For instance, in the case of anxiety: do patients view their illness more negatively because 
they are anxious, or do they become anxious because they view their illness so seriously and feel they 
have no control over it? Most of the research conducted in illness perceptions is of cross-sectional 
nature which does not provide insight into this reciprocal process. The available longitudinal studies 
did not address this issue until now. Clarity is needed because in designing interventions to alter illness 
perceptions, clinicians need to know where to intervene [35]. 
 
3. Zooming into two severe diseases: systemic sclerosis and systemic lupus erythematosus 
In this PhD project we will investigate illness perceptions in patients with complex chronic diseases. As 
an appropriate example case of patients with complex chronic conditions, we have chosen for a patient 
population with systemic lupus erythematosus and systemic sclerosis. These two diseases are severe 
and incurable auto-immune diseases with multiple organ involvement, a heterogeneous occurrence 
and an unpredictable disease course.  
 
Systemic lupus erythematosus (SLE) is a chronic systemic disease of auto-immune origin with a 
broad range of clinical manifestations which are diverse and variable, ranging from relatively mild 
cutaneous and articular involvement through to severe organ damage such as end-stage renal disease 
and thrombosis [36]. The disease onset is between 18-45 years and it is more prevalent in women than 
men with a sex ratio of 9:1. The etiology is unknown but probably a combination of hormonal, genetic 
and environmental factors such as sunlight, drugs, occupational exposure, Epstein-Barr virus, etc. 
trigger the condition. The prevalence of SLE in Belgium is unknown; the reported values for the 
incidence and prevalence of SLE vary worldwide. The incidence is 0.3–31.5 cases per 100,000 
individuals per year and the prevalence is 3.2–517.5 cases per 100,000 individuals [37]. SLE is more 
prevalent and even more severe in persons with an African or Asian ancestry, explaining the large 
prevalence in specific countries or in specific ethnic groups as for instance Africans Americans. SLE 
patients are at risk for certain comorbidities such as cardiovascular disease or avascular necrosis of 
bone. Lupus nephritis and central nervous system disease -with possible neuropsychiatric 
manifestations- might cause serious life threatening complications but also treatment with 
glucocorticoids and immune suppressant drugs as cyclophosphamide is associated with serious 
complications [38]. Pregnant women with SLE have a greater risk for complications (miscarriage), 
disease flares (if active disease at conception) and even congenital lupus with heart block might occur 
[38]. SLE leads to physical and mental disability [39] characterized by fatigue [40], pain, depression 
[41], significant cognitive impairment, etc. This disease burden is often associated with poor quality of 
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life. The treatment options for patients with SLE remain limited compared to those for other rheumatic 
diseases, such as rheumatoid arthritis [37]. Follow-up is sometimes scattered over many medical 
specialties dependent of the organs involved. The number of effective treatments for SLE is growing, 
with the introduction of new (biological) therapies creating new hope [42]  . 
 
Systemic sclerosis (SSc) is a rare, auto-immune systemic disease characterized by excessive 
collagen production (i.e., fibrosis) in the skin and internal organs, vascular damage and inflammation 
as well autoimmunity [43]. The etiology of SSc is not yet understood although specific environmental 
triggers such as exposure to silica, solvents, benzene derivates, pesticides, viral triggers, etc. combined 
with a susceptible genetic background are at the basis of the disease process. Offspring of patients 
with SSc have a small but definitive risk; at the other part of the spectrum Choctaw American Indians 
have a high prevalence of SSc [44]. Race is related to a distinct phenotypic profile, with a less favorable 
outcome for African American patients [43]. It affects more women than men with an average sex ratio 
of 3:1 [45] and a peak of onset in the fifth decade of life [43]. The prevalence of SSc is <150 per million 
and the incidence is <10 per million per year in Northern Europe [46]. The mortality rate in SSc is much 
higher than for other rheumatic diseases [47,48]. 
Depending on the extent of skin fibrosis/sclerosis, the disease is typically classified in the limited 
cutaneous subtype (lcSSc) and the diffuse cutaneous subtype (lcSSc). In lcSSc patients, the skin 
involvement is distal to the elbows and knees with or without face involvement. In dcSSc, the skin 
thickening is proximal and distal to the elbows and knees with or without facial or truncal involvement 
[44,49]. Skin fibrosis is a hallmark feature of SSc with worsening skin thickness as a predictor of 
morbidity and mortality. Patients with dcSSc develop internal organ manifestations during this phase 
of skin thickening such as renal disease, interstitial fibrotic lung disease, pulmonary arterial 
hypertension, cardiac disease with cardiac failure and life threatening arrhythmias as well as 
gastrointestinal involvement (difficulties in swallowing, diarrhea …) and musculoskeletal problems  
(arthritis, joint rigidity,…) [49]. In addition to the organ impact, patients report also impairments in 
physical functioning in upper and lower extremities (caused by skin tightness, Raynaud’s phenomenon, 
contractures, etc.) [50–52] and pain (from digital ulcers) [53] which affects their ability to carry out 
household chores, work and leisure activities. This disease can have specific disfiguring end-stage 
consequences as amputation of fingers but also specific alterations in the face that might have severe 
impact on self-esteem. 
Treatment of SSc is a challenge because many controversies and uncertainties exist regarding 
treatment modalities and management lacking evidence based data [47]. Initiatives like the European 
Scleroderma Trials and Research group (EUSTAR) and Belgian Systemic Sclerosis Cohort (BSSC) try to 
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stimulate research initiatives in many domains at the European and Belgian level respectively. Patient 
organizations play an important role in promoting new research initiatives. 
 
Potential hurdles in the care for patients with SLE and SSc in daily practice 
In daily practice we are frequently confronted with SLE and SSc patients who report having received 
contradictory information about their condition or therapy. For instance in the case of pregnancy in 
SLE, the eventual consequences, risk of miscarriage, intake of drugs like antimalarials to control lupus 
and glucocorticoids are differently communicated depending of the expert and the organ specialty of 
the physician. When patients are recently diagnosed with SLE or SSc, most of them received very 
limited information or have no knowledge of their less prevalent condition. Literature in SSc describes 
that patients are sometimes dissatisfied because of the limited level of knowledge or understanding 
of the disease [54]. 
Not only for the patients who are faced with these devastating conditions, but also for the 
physicians who care for these conditions, it is not always easy to understand the impact or 
consequences of such diseases on the patient. When patients are asked about their physicians, they 
mention uncertainty or diverging advice, often even lack of prescription of an active treatment, and 
lack of regular follow-up by their treating physicians. This might be experienced by the patient as a lack 
of interest or even lack of professionality [54]. 
Because of the complexity and multi-organ involvement of both SLE and SSc, there is in clinical 
practice often not enough attention for all consequences for the patient and sometimes the focus is 
limited to a single organ. The uncertainty and lack of knowledge physicians might have can influence 
the care and management of the patient’s condition but also, according to our experience in daily  
practice, the illness perception of the patient. In our view, sometimes not only what is said or done by 
the treating physician but even more the way it is done - the non-verbal communication or intonation- 
can influence the perceptions of the patient. 
 
4. What is already known about illness perceptions in SLE and SSc and their relationship with health 
outcomes?  
Assessment of illness perceptions 
Before 1996, illness representations were mainly assessed by means of open ended interviews, and 
patients’ responses were coded into categories [55]. After the introduction of the Illness Perception 
Questionnaire (IPQ) in 1996 [16], illness perception research boomed. For the first time, the five 
dimensions of the CSM could be measured in a quantitative way and in large cohorts of patients [56]. 
Moss-Morris and colleagues created in 2002 a revised version of the IPQ, i.e., IPQ-R [57], including 
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emotional representations as an additional component because the CSM was proposed by Leventhal 
and colleagues (1980) [7] as a ‘parallel-processing’ model which means that people make simultaneous 
cognitive and emotional representations of their illness. The IPQ-R was also extended with other 
subscales such as illness coherence which is an overall comprehension of the illness, cyclical timeline 
perceptions which describes the recurrent pattern of the disease and the control/cure dimension was 
divided into personal control and treatment control. In 2006, a brief version of the IPQ-R, the brief-IPQ 
[58] was constructed featuring a single-item scale approach as a response to the long version that was 
developed before.  
Illness perceptions and outcomes in SLE and SSc 
A closer inspection of illness perceptions in SLE, shows that patients who perceived more severe 
consequences, an unpredictable disease course and less comprehension of their disease, reported high 
levels of depression [59]. The consequences subscale contributed to the greatest degree of variance 
in depression levels. This has been confirmed by the longitudinal study of Shortall and colleagues 
(1996) [60], which states that depression, anxiety and self-esteem are predicted by illness perceptions 
in SLE patients. In the latter study illness perceptions were assessed by a ‘problems with SLE’ 
questionnaire. Another SLE study [61] found that illness perceptions are strong predictors of sexual 
functioning in comparison with medical or socio-demographic characteristics. More specifically, a 
higher emotional impact of SLE predicted sexual functioning; illness coherence together with 
emotionality predicted best the subscale ‘attractiveness’ and personal control predicted best the 
subscale ‘body esteem’. Daleboudt and co-workers [62] found that strong emotional representations 
were associated with lower self-reported adherence levels. No other associations were found between 
the other illness perception dimensions and adherence measures. In a recent study of patients with 
discoid lupus erythematosus [63], which is the cutaneous form of lupus, patients with higher perceived 
personal control reported better quality of life, lower levels of depression, and better scores of disease 
activity and severity scores. More concern and emotionality about discoid lupus was associated with 
worse quality of life, higher depression scores and lower disease activity and severity scores. Kotsis 
and co-workers (2014) [64] found that the perception of more severe consequences and experiencing 
more SLE related symptoms were associated with decreased physical functioning.    
Concordant findings were found in studies describing illness perceptions in SSc. The most 
important contributor to good physical health was reporting less severe consequences and a lower 
score on illness identity, i.e. less SSc related symptoms. Reporting more SSc related symptoms and 
reacting in a more emotional way to SSc was correlated with worse mental health. Disease related 
characteristics such as disease activity, disease severity or disease duration explained less variance in  
physical and mental health in comparison with illness perceptions [65]. Richards et al. (2003) [66] 
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found that the perception of serious consequences by SSc patients was associated with pain and 
decreased physical functioning.  
 
5. The objectives and outline of the PhD dissertation 
Knowledge regarding illness perceptions is booming. There is an increasing evidence that illness 
perceptions are important within different aspects of the care and treatment of patients with 
multisystem diseases. However, there are still many gaps in the literature regarding the concept of 
illness perceptions, their correlates and impact on outcomes. Therefore, an overall objective of this 
PhD project was to explore the modifiable correlates of illness perceptions, physicians’ perceptions of 
SLE and SSc and the impact of illness perceptions on health outcomes in patients with SLE and SSc.  
To address this overall aim, the thesis is guided by four research questions:  
 
1. What are the modifiable correlates of illness perceptions in patients with chronic somatic 
conditions? (Chapter 2) 
2. What are the perceptions of healthcare professionals regarding patients with multisystem 
diseases?   
a. What are the psychometric properties of a modified illness perception questionnaire 
for healthcare professionals (IPQ-R HP)? (Chapter 3) 
b. What are the perceptions among physicians from the same and other medical 
disciplines about patients with SLE and SSc? (Chapter 4) 
3. What are the illness perceptions of patients with SLE and SSc, their rheumatologists and their 
GPs? (Chapter 5) 
4. What is the directionality of the associations between illness perceptions and health outcomes 
in patients with SLE and SSc?  (Chapter 6) 
 
In Chapter 2, we described the modifiable correlates of illness perceptions in adults with chronic 
somatic diseases. A systematic review was conducted in order to have an overview of these correlates. 
Moreover, from the correlates that were found in this study, three were selected for use in Chapter 6. 
The selected modifiable correlates were also outcomes of illness perceptions.  
 
In Chapter 3, we evaluated the preliminary validation and reliability of an illness perception 
questionnaire for healthcare professionals, the IPQ-R HP. This instrument was needed to assess 
perceptions of physicians in the studies described in Chapter 4 and Chapter 5.  
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In Chapter 4, we analyzed perceptions among physicians from the same and other medical disciplines 
using vignettes of SLE and SSc patients. This was a multicenter study in physicians from nine different 
medical disciplines working at three hospitals.  
 
In Chapter 5, we investigated differences and commonalities in illness representations of patients with 
SLE and SSc, their treating rheumatologists and their general practitioners.  
 
In Chapter 6, we conducted a prospective observational cohort study spanning one year in order to 
determine the directionality of the associations between illness perceptions and health outcomes in 
patients with SLE and SSc.  
 
In Chapter 7, we discussed the added value of this thesis, methodological considerations, implications 
for clinical practice, healthcare policy recommendations and horizons for further research. 
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Abstract 
Objective: When individuals become ill, they want to understand and give meaning to their illness. The 
interpretation of this illness experience or illness perception is associated with a range of individual, 
contextual and cultural factors. These correlates of illness perceptions can be categorized in modifiable 
and not modifiable factors. The purpose of this study was to investigate which modifiable factors were 
correlated with illness perceptions in adults with chronic somatic diseases.  
 
Methods: All potentially eligible studies identified in four electronic databases were reviewed by 2 
independent evaluators, and each relevant article was assessed for methodological quality. Data were 
extracted, organized and recorded using PRISMA flow diagram. Results were standardized by 
calculating correlation coefficients.  
 
Results: Fifteen papers met the inclusion criteria. These papers reported a diversity of chronic somatic 
diseases. We identified 5 groups of modifiable correlates of illness perceptions: illness-related factors, 
psychosocial factors, medication beliefs, information provision and satisfaction with information and 
quality of care.  
 
Conclusions: Our findings provide an added value to the knowledge of modifiable factors correlating 
with illness perceptions such as the importance of psychosocial factors like depression and anxiety and 
illness-related factors. Knowledge of these correlates can facilitate understanding of patients’ illness 
perceptions and is useful in developing interventions to alter maladaptive illness perceptions.  
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1. Introduction  
Individuals facing illness develop ‘common-sense’ constructions to conceptualize and give meaning to 
their illness and its consequences. The search for a meaning is a dynamic process with possible shifts 
in patients’ perceptions and ideas about their illness over time [1,2]. Illness perceptions are beliefs and 
expectations regarding one’s illness that directly influence the individual’s cognitive and emotional 
response to the illness and guide coping strategies to manage illness threat and distress  such as for 
instance seeking social support or problem-focused coping [1,3,4]. Even patients with the same 
medical condition can hold very disparate views of their illnesses.  
 Effective and efficient methods to alter dysfunctional illness beliefs, particularly at an early 
stage of a disease, might generate appropriate coping procedures for managing and living with a 
chronic disease [5].  At this early stage, the type and quality of the available information which patients 
use, is crucial in order to give meaning to and manage their illness. Interpreting this information is the 
first step in the self-regulation of illness which is associated with a range of individual, contextual and 
cultural factors [6,7]. These factors play an important role in establishing and shaping illness 
representations [8]. 
These correlates can be seen as modifiable or non-modifiable. In an exploratory phase, we 
performed a first literature search in several medical and psychological databases that yielded non-
modifiable as well as modifiable correlates associated with illness perceptions.   Examples of non-
modifiable factors that were significantly correlated with illness perceptions are older age [9–11], 
female gender [9,11,12] culture [13–15] educational level [9] and high income [11]. Other than the 
latter demographic factors, the following non-modifiable factors were also significantly related with 
illness perceptions: neuroticism [16], type D personality [17,18], personal illness experience [19] and 
symptom reporting [20,21]. Also modifiable correlates of illness perceptions were found  such as illness 
related factors [9], coping style [22], anxiety [20], depression [23] and depressive symptomatology 
[24], information from a physician and from the internet [22], social functioning and perceived 
competence [9,25].  
So, there is a diversity of literature available about correlates of illness perceptions. The 
correlates that are non-modifiable such as culture, gender or personality cannot be tackled with clinical 
interventions, but the illness perceptions that are generated based on these correlates, can.  For nurse 
researchers and clinicians, it is important to have in-depth insight in modifiable correlates, because 
these can be potential targets for nursing interventions and in that way anticipate the formation of 
maladaptive illness perceptions. To date, an overview of these modifiable correlates is not available 
and might therefore be useful for research and clinical purposes. Hence, the purpose of this systematic 
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review was to investigate which modifiable correlates are associated with illness perceptions in adults 
with chronic somatic diseases. 
 
2. Methodology 
A review protocol based on the PRISMA guidelines [26] for data reporting was developed and was 
registered in PROSPERO (International prospective register of systematic reviews) with registration 
number CRD42016047724. Additionally, we complied with the MOOSE guidelines [27]. 
 
Literature search and study selection 
Medline (via Pubmed), Ebsco host CINAHL, Embase (via embase.com) and Web of Science were 
searched for eligible articles published between January 1980 and August 2016. A search string for 
Pubmed was developed and verified by a health sciences librarian. Afterwards, that search string was 
translated under supervision of the health sciences librarian for use in the other databases. These 
search strings consisted of text words and controlled vocabulary representing illness perceptions and 
modifiable correlates (See Appendix 1). For the papers that were eligible for inclusion in this review, 
backward citations (reference lists) were manually checked for additional relevant articles. The titles 
and abstracts of citations were independently screened by two reviewers (SA and DDC) and checked 
for inclusion. Hereafter, full-text papers were screened for eligibility by the latter 2 reviewers and 
disagreements were resolved by consensus. A third reviewer (RW) was consulted in the case of 
disagreement.  
 
Domains of illness perceptions 
We used 5 core dimensions of illness perceptions as described in Leventhal’s Common-Sense Model 
of health and illness: identity (beliefs concerning illness symptoms; label of the illness), timeline 
(expected duration), consequences (expected effects on physical, social and psychosocial well-being), 
cause (causal attributions) and control/cure (to what extent the illness could be controlled or cured) 
(Leventhal, Nerenz, & Steele, 1984). Subsequent research [29] highlighted the importance of the 
dimension illness coherence and emotional representations. Illness coherence is the belief that the 
illness makes sense and was added as a sixth core dimension. Emotional representations, which are 
the emotional responses of patients generated by the illness and develop in parallel with cognitive 
representations, were also added. 
The most frequently used generic questionnaires that are based on Leventhal’s Common-Sense Model, 
and which are validated and translated into several languages are: the Illness Perception Questionnaire 
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(IPQ) [30],  the revised Illness Perception Questionnaire (IPQ-R) [29] and the Brief Illness Perception 
Questionnaire (Brief-IPQ) [31]. 
 
Inclusion and exclusion criteria   
This review included studies that met following inclusion criteria: 1) reporting the modifiable correlates 
of illness perceptions; 2) using the IPQ, IPQ-R or Brief-IPQ for measuring illness perceptions; 3) using 
quantitative research designs; 4) including adults with a chronic somatic disease aged 18 years or older; 
5) written in English, Dutch, French or German. Exclusion criteria were: 1) psychiatric pathology, 
dementia, fibromyalgia and chronic fatigue syndrome, as well as studies investigating patient groups 
with multiple disorders or healthy adults; 2) studies with a qualitative or mixed-methods research 
design; and 3) editorials, comments, reviews, case reports and letters to the editor and abstracts not 
accompanied by a full text.     
 
Assessment of methodological quality  
The quality of each included studies was assessed using a modified SIGN methodology checklist for 
cohort studies [32]. We used an adapted version of this checklist where we excluded items that were 
not applicable for our studies. Concretely, this meant that we selected 6 items (see Supplementary 
Table 1) which were relevant for observational studies. This checklist was extended with an item about 
the reporting of potential conflicts of interest. Using this checklist, data concerning methodological 
quality were independently extracted by two reviewers (SA and DDC) and checked for accuracy. 
Review authors resolved disagreements through discussion until consensus was reached. 
 
Data extraction and synthesis  
Firstly, we scanned the results section for studies that used the IPQ, IPQ-R and Brief-IPQ for 
operationalizing  illness perceptions. Secondly, we looked which modifiable correlates of illness 
perceptions were reported. We defined modifiable correlates, as correlates that can be changed by 
clinical interventions. Finally, we reported the results on the correlates we found. The process by which 
the correlates were grouped into 5 categories was based on thematic analysis [33]. This means that 
patterns across data were identified, analyzed and reported by two authors until agreement was 
reached. Also data were gathered from the included studies on sample size, condition studied, 
location, basic demographics of the population, type of questionnaire for measuring illness 
perceptions and study design. The correlation coefficients were withdrawn from the studies. If no r-
values were reported, results were standardized by converting reported coefficients into r-values [34].  
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However, for some studies insufficient data were reported to enable the calculation of these effect 
sizes.   
 
3. Results 
Search results 
Electronic database searches yielded 5373 articles (Figure 1). After removing duplicates, 3939 articles  
remained. Of these papers,  titles and abstracts were screened on in- and exclusion criteria yielding 85 
papers that were subject for full text review. Based on full text review, 70 studies were excluded for 
different reasons (Figure 1). This process yielded 15 papers to be included in our review.  
 
Figure 1: Flow chart of study selection process 
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Characteristics of the included studies 
An overview of the study characteristics of all included studies can be found in Table 1. 
The 15 selected articles encompassed patients with following chronic somatic diseases: chronic 
obstructive pulmonary disease (COPD) (n= 2) [35,36], psoriasis (n= 2)  [37,38], cancer survivors (n= 2)  
[39,40] coronary heart disease (CHD) (n= 1) [9], acromegaly (n= 1) [41], chronic low back pain (n= 1)  
[42],  sarcoidosis (n= 1) [43], breast cancer (n= 1 ) [44], chronic cardiovascular disease (n= 1)  [45] , 
rheumatoid arthritis (n= 1) [23], systemic sclerosis (n= 1) [46] and diabetes (n= 1)  [47]. A total of 8,619 
participants (sample size varied between 49 and 3130) were included. The majority of the studies were 
cross-sectional (13 studies) and the remaining 2 studies [9,45] had a longitudinal design. Eleven studies 
took place in Europe, two in Asia, one in US and one in New Zealand. Seven studies used the IPQ-R for 
measuring illness perceptions, five studies used the Brief-IPQ and three used the IPQ.  
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Table 1: Study characteristics 
Study nr: authors 
(year) 
Sample 
size 
Disease Country Basic demographics  Instrument Study design Quality  
Study 1: Aalto, 
Heijmans, 
Weinman, and Aro 
(2005) 
N=3130 
 
Coronary heart 
disease 
Finland 50.1% men; mean age 64.4 years 
(SD=7.0); 9.7 years of education (SD= 
2.1)  
 
IPQ Longitudinal  
observational 
Low risk 
of bias 
Study 2: Andela, 
Biermasz, Kaptein, 
Pereira, and 
Tiemensma (2015) 
N=73 Acromegaly The 
Netherlands 
55% men; mean age 60.1 years 
(SD=11.6); low education: 40.0%; 
medium education: 23.0%; high 
education: 37.0% 
IPQ-R Cross-sectional 
observational 
Low risk 
of bias 
Study 3: Borge, 
Moum, Lein, 
Austegard, and  
Wahl (2014) 
N=154 COPD Norway 51.3% men; mean age 64.6 years 
(SD=10.2); low education: 40.2%; 
medium education: 30.5% ; high 
education: 27.9%   
Brief-IPQ Cross-sectional 
observational 
Low risk 
of bias 
Study 4: Fortune, 
Richards, Main, and 
Griffiths (1998) 
N=162 Psoriasis UK 51.9% men; mean age 42 years 
(SD=14.0); no data on educational level 
 
IPQ Cross-sectional 
observational 
High risk 
of bias 
Study 5: Heyduck, 
Meffert, and 
Glattacker (2014) 
N=201 Chronic low back 
pain 
Germany 35.8% men; mean age 54.1 years 
(SD=11.4); elementary school: 42.8%; 
secondary school: 16.4%; technical 
school: 23.9%; university: 11.9%;  
no certificate: 2.5% 
 
IPQ-R Cross-sectional  
observational 
Low risk 
of bias 
Study 6: Howard, 
Hallas, and Carby 
(2009) 
N=59 COPD UK 39% men; mean age 62.4 years 
(SD=12.0); secondary school: 65.0%  
IPQ-R Cross-sectional 
observational 
Low risk 
of bias 
Study 7: Husson et 
al. (2013) 
N=3080 Cancer survivors The 
Netherlands 
56.3% men; mean age 62.6 years 
(SD=11.02); primary school: 23.9% ; 
secondary school: 32.6%; intermediate 
school: 28.8%; university: 14.6% 
Brief-IPQ Cross-sectional 
observational 
Low risk 
of bias 
Study 8: Ireland & 
Wilsher (2010) 
N=81 Sarcoidosis New-Zealand 48% men; mean age: 49 years 
(SD=13.0); no data on educational level 
IPQ-R Cross-sectional 
observational 
Low risk 
of bias 
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Study 9: 
Iskandarsyah et al. 
(2013) 
N=70 Breast cancer Indonesia 100% women; mean age: 45.6 years 
(SD=7.9); no education: 10%; 
elementary: 51%; junior high school: 
16%; senior high school: 14%; 
college/university: 9% 
Brief-IPQ Cross-sectional 
observational 
Low risk 
of bias 
Study 10: 
Karademas, 
Paschali, Hadjulis 
and Papadimitriou 
(2016) 
N=119 Chronic 
cardiovascular 
disease 
Greece 69.9% men; mean age: 62.4 years 
(SD=12.9); no data on educational level 
IPQ-R Longitudinal  
observational 
Low risk 
of bias 
Study 11: Murphy, 
Dickens, Creed and 
Bernstein (1999) 
N=62 Rheumatoïd 
arthritis 
UK 16.1% men;  median age: 59.5 years 
(IQR=50.8–68); no data on educational 
level 
IPQ Cross-sectional 
observational 
Low risk 
of bias 
Study 12: Richards 
et al. (2003) 
N=49 Systemic Sclerosis UK 14% men; mean age: 53 years 
(SD=12.0); no data on educational level 
IPQ-R Cross-sectional 
observational 
Low risk 
of bias 
Study 13: Thomas 
et al. (2014) 
N=89 Diabetes USA 39.3% men; age 65 or older: 50.5 %; no 
degree: 32.5%; high school diploma: 
28.1%; associate’s degree: 4.5%; 
bachelor’s degree: 16.8%; graduate 
degree: 18.1%  
Brief-IPQ Cross-sectional 
observational 
Low risk 
of bias 
Study 14: Wahl et 
al. (2014) 
N=254 Psoriasis Norway 60% men; mean age: 47 years 
(SD=12.0); primary school: 60%; 
university < 4 years: 20%;  
university ≥ 4 years: 19% 
IPQ-R Cross-sectional  
observational 
 
Low risk 
of bias 
Study 15: Zhang et 
al. (2016) 
N= 1036 Cancer survivors Hong Kong 40.1% men; mean age: 55.2 years 
(SD=11.9); no formal educational level: 
5.1%; primary educational level: 28.3%; 
secondary educational level: 52.4%; 
tertiary educational level: 14%; 
missing: 0.2% 
Brief-IPQ Cross-sectional  
observational 
Low risk 
of bias 
COPD: chronic obstructive pulmonary disease; IPQ: illness perception questionnaire; IPQ-R: revised illness perception questionnaire; Brief-IPQ: brief illness perception questionnaire 
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Methodological quality  
Thirteen of the fifteen studies had an appropriate focused clinical question. The selection of the cohorts 
from comparable source populations was clearly described in 13 of the 15 articles and the participation 
rate was reported in 14 of 15 studies. In all studies, the outcomes were clearly defined using reliable and 
valid methods.  Confidence intervals were reported in 14 of 15 studies. The main potential confounders 
were identified and taken into account in the design and analyses of all except for three studies.  Four of 
the 15 studies did not report potential conflicts of interest (see Supplementary Table 1). 
  
Modifiable correlates of illness perceptions  
The included studies identified 5 broad groups of correlates of illness perceptions: medication beliefs, 
information provision & satisfaction, quality of care, illness-related factors and psychosocial factors. An 
overview of these modifiable factors and its correlation with illness perception dimensions is provided in 
Tables 2-6. The correlations with the causal attributions are not shown in the tables. 
 
Medication beliefs (see Table 2) 
Regarding medication beliefs, three modifiable correlates were identified. In patients with acromegaly, 
general harm [41], i.e. the beliefs that medicines are poisonous, addictive or harmful and general overuse 
[41], i.e. the beliefs that medicines are overprescribed, were correlated with the emotional representation 
dimension which means that the greater the belief that there is general harm (r= 0.28, p<0.05) or general 
overuse of the medication (r= 0.27, p<0.05), the higher the emotional impact on the patient. A third factor, 
being the necessity of taking the medication from a medical perspective, which was studied in patients 
with sarcoidosis [43] was negatively correlated with emotional representations (r= -0.31, p<0.05), the 
perceived consequences of the disease (r= -0.25, p<0.05) and perceiving the time course as stable and less 
recurrent (r= -0.38, p<0.01). Higher scores on general harm were also associated with higher psychological 
attributions (r= 0.24, p<0.05) and higher perceived risk factors (r= 0.24, p< 0.05) as a cause of the disease 
(data not shown in table).   
 
Information provision and satisfaction (see Table 3) 
Cancer survivors receiving information about the disease [39], perceived a higher personal control (r= 0.11, 
p<0.01). Receiving information about care services in these patients [39] was correlated with more 
symptoms characterized with the disease  (r= 0.13, p<0.01), more severe consequences (r= 0.13, p<0.01), 
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controllability by treatment (r= 0.06, p<0.01), concern (r= 0.08, p<0.01) and emotionality (r= 0.10, p<0.01). 
In cancer survivors, a lower satisfaction with received information [39] was correlated with more 
symptoms characterized with the disease (r= -0.16, p<0.01), perception of more severe consequences (r= 
-0.23, p<0.01), more controllability by treatment (r= -0.11, p<0.01), perception of a chronic time course 
(r= -0.10, p<0.01), more understanding (r= -0.10, p<0.01), more concern (r= -0.19, p<0.01) and more 
emotional representations (r= -0.24, p<0.01). In breast cancer patients, satisfaction with the amount and 
content of information [44] was related with less emotionality (r= -0.25, p<0.05). Also in this patient 
population, satisfaction with form and timing of information [44] was correlated with less controllability 
of breast cancer by the patient herself (r= -0.24, p<0.05), less understanding of the disease (r= -0.25, 
p<0.05), less concern (r= -0.36, p<0.01) and less emotional impact (r= -0.33, p<0.01). Knowledge about 
psoriasis  [38] was correlated with the perception that psoriasis is chronic (r= 0.24, p<0.001), 
understandable (r= 0.27, p<0.001) and having less emotional impact on the patient (r= -0.17, p<0.01). 
  
Quality of care (see Table 4) 
Diabetes patients, reporting higher perceived chronic care quality also indicated better disease 
understanding (r= 0.24, p<0.05) [47].  In chronic back pain patients, trust in the physician [42] was related 
with perceiving less severe consequences to the disease (r= -0.18, NS). 
 
Illness-related factors (see Table 5) 
In COPD patients, breathlessness [35] was  related with more symptoms characterized with the disease 
(r= 0.62, p<0.001), severe consequences (r= 0.67, p<0.001) and more concern (r= 0.44, p<0.01) and 
emotionality (r= 0.45, p<0.001). In lung testing, FEV1% [35,36], -i.e. the percent predicted forced 
expiratory volume in the first second-  was correlated with a less symptoms characterized with the disease 
(r= -0.16, NS; r= -0.48, p<0.001), less perceived consequences (r= -0.32, p<0.05; r= -0.43, p<0.001), less 
chronic time course (r= -0.19, p<0.05), less concern (r= -0.24, p<0.001) and a low emotional impact of the 
disease (r= -0.21, p<0.01). In psoriasis patients, the PASI (Psoriasis Area and Severity Index) was correlated 
with experiencing more severe consequences due to the disease (r= 0.21, p<0.01) [38], less personal 
control (r= -0.39, p<0.05) [37], a chronic time course (r= 0.17, p<0.001) (Wahl et al.,  2014)  and 
emotionality (r= 0.13, p<0.05) [38]. Physical symptom distress [40] -which is any distress associated with a 
particular symptom- was correlated with all dimensions except for controllability by treatment. Pain in 
systemic sclerosis patients [46] was  related with more symptoms characterized with the disease (r= 0.36, 
p<0.05), high personal control (r= 0.54, p<0.01) and high emotionality (r= 0.38, p<0.05). CHD risk factors 
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and CHD related comorbidities [9] were correlated with more symptoms characterized with the disease 
(r= 0.06, p<0.01; r= 0.19, p<0.001, respectively), perceived severe consequences (r= 0.08, p<0.001; r= 0.14, 
p<0.001, respectively) and a chronic time course (r= 0.09, p<0.001; r= 0.09, p<0.001, respectively). CHD 
related comorbidities were only correlated with experiencing less personal control (r= -0.11, p<0.001).  
Concerning the correlations with causal attributions, CHD risk factors were associated with 
epidemiological risk factors (r= 0.22, p<0.001) and CHD comorbidities with stress (r= 0.08, p<0.001) and 
external factors (i.e. poor medical care, germ/virus, pollution, other people, chance/luck and diabetes) (r= 
0.06, p<0.001), health behavior (r= 0.06, p<0.01)  and epidemiological risk factors (r= 0.07, p<0.001).  
 
Psychosocial factors (see Table 6) 
In patients with CHD, higher perceived competence [9] -i.e. confidence in one’s personal competence in 
successfully attaining important life goals- was  associated with less symptoms characterized with the 
disease (r= -0.18, p<0.001), less severe consequences (r= -0.31, p<0.001), high personal control (r= 0.21, 
p<0.001) and a chronic disease course (r= 0.08, p<0.001). Receiving social support in CHD patients [9] was 
associated with less symptoms characterized with the disease (r= -0.10, p<0.001) and a higher personal 
control (r= 0.11, p<0.001).  
Depression in rheumatoid arthritis and COPD was associated with more symptoms characterized 
with the disease (r= 0.31, p<0.05) (Murphy et al., 1999), less personal control (r= -0.40, p<0.01) (Murphy 
et al., 1999), having an emotional impact on the patient (r= 0.53, p<0.001) [36], and perceiving severe 
consequences (r= 0.47, p<0.001; r= 0.48, p<0.001) [23,36],   which was also reported in sarcoidosis patients 
(r= 0.47, p<0.001)  [43]. In sarcoidosis patients [43], anxiety was associated with having a clear picture of 
the disease (r= 0.29, p<0.05). In COPD patients [36], anxiety was related with perceiving severe 
consequences (r= 0.43, p<0.001) and having an emotional impact (r= 0.61, p<0.001). Also in the latter 
patient population, panic severity was associated with perceiving severe consequences (r= 0.77, p<0.001) 
and having a high emotional impact (r= 0.75; p<0.001). Maladaptive health beliefs (Karademas et al., 2016) 
were negatively correlated with personal control (r= -0.25, p<0.01) and illness coherence (r= -0.22, p<0.05) 
and positively correlated with the biological causes a patient attributes to his/her illness to (r= 0.31, 
p<0.01). 
Concerning the causal attributions: perceived competence and social support in CHD patients [9] 
were associated with stress (r= -0.21, p<0.001;  r= -0.13, p<0.001, respectively), external factors (i.e. poor 
medical care, germ/virus, pollution, other people, chance/luck and diabetes) (r= -0.18, p<0.001; r= -0.08, 
p<0.001, respectively). Only perceived competence was also associated with life-course (r= -0.24, p<0.001) 
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epidemiologic factors (r= -0.10, p<0.001), health behavior (r= -0.11, p<0.001) and internal factors such as 
the patients’ own behavior, mental attitude and personality  (r= -0.21, p<0.001).   
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Table 2: Medication beliefs 
Modifiable 
correlate 
Identity Consequences Personal 
control 
Treatment 
control 
Timeline 
acute/chronic 
Timeline 
cyclical 
Illness 
coherence 
Concern Emotional 
Representations 
General harm r= 0.052 r= 0.012 r=  0.142 r= -0.112 r=  -0.192 r= -0.022 r= 0.012 / r= 0.28*2 
General overuse r= -0.042 r= -0.042 r= 0.142 r= -0.112 r= -0.202 r= 0.072 r= -0.012 / r= 0.27*2 
Necessity for 
medication 
/ r= -0.25*8 / / / r= -0.38†8 / / r= -0.31*8 
*: p<0.05; †: p<0.01; numbers in superscript refer to study number 
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Table 3: Information provision and satisfaction 
Modifiable 
correlate 
Identity Consequences Personal 
control 
Treatment 
control 
Timeline 
acute/chronic 
Timeline 
cyclical 
Illness 
coherence 
Concern Emotional 
Representations 
Info about disease r= 0.057 r= 0.027   r= 0.11†7   r= -0.107 r= -0.047 / r= -0.127 r= -0.057 r= 0.037 
Info about medical 
test 
r= -0.027 r= 0.017 r= -0.017  r= -0.057  r= 0.037   / r= -0.037  r=  0.047 r= -0.047 
Info about 
treatment 
r= -0.047  r= 0.027   r= -0.017  r= -0.037  r= -0.017  / r= -0.047 r=  0.047 r= 0.067  
Info about care 
services 
r= 0.13†7  r= 0.13†7  r= -0.047  r= 0.06*7   r= 0.047  / r= 0.057  r= 0.08†7   r= 0.10†7  
Satisfaction with 
information 
r= -0.16†7 r= -0.23†7  r= -0.057  r= -0.11†7  r= -0.10†7  / r= -0.10†7  r= -0.12†7  r=  -0.24†7 
Satisfaction with 
amount & content 
info 
r= -0.089 
 
r=-0.089  r= -0.019   r=-0.089  r= -0.129  / r= -0.099   r= -0.099 
 
r= -0.25*9   
Satisfaction with 
form & timing info 
r= -0.109 r= -0.059 r= -0.24*9  r= -0.219  r= -0.029  / r= -0.25*9  r=-0.36†9  r= -0.33†9   
Knowledge about 
disease  
/ Insufficient 
data14 
/ / r= 0.24‡14  / r= 0.27‡14  / r= -0.17†14 
*: p<0.05; †: p<0.01; ‡: p<0.001; numbers in superscript refer to study number 
 
P<0.05*  p<0.01†    p<0.001‡ 
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Table 4: Quality of care 
Modifiable 
correlate 
Identity Consequences Personal 
control 
Treatment 
control 
Timeline 
acute/chronic 
Timeline 
cyclical 
Illness 
coherence 
Concern Emotional 
Representations 
Perceived 
chronic care  
quality  
r= -0.1313    r= -0.1413  r= 0.1013  r=0.2213   r= -0.0313  / r= 0.24*13  r= -0.0613  r= -0.1213 
Trust in 
physician 
/ r= -0.185 / / / / / / / 
*: p<0.05; numbers in superscript refer to study number 
 
 
Table 5: Illness-related factors 
Modifiable 
correlate 
Identity Consequences Personal 
control 
Treatment 
control 
Timeline 
acute/chronic 
Timeline 
cyclical 
Illness 
coherence 
Concern Emotional 
Representations 
Breathlessness r= 0.62‡3 r= 0.67‡3 / / / / / r= 0.44†3 r=0.45‡3  
FEV1% r= -0.166 r= -0.32*6   r= -0.066  r= -0.086 r= -0.236 r= -0.016 r= -0.106  r=-0.076  
 r= -0.48‡3  r= -0.43‡3 / / r= -0.19*3 / / r= -0.24‡3 r= -0.21†3 
PASI / r= 0.21†14 r= -0.39*14   / r= 0.17‡14 / No data14 / r= 0.13*14 
Physical sympt 
distress  
r= 0.32†15   
 
r= 0.40 †15   
 
r= -0.08*15   r= -0.0615  r= 0.40†15   
  
/ r= -0.08†15   r= 0.29†15  
 
r= 0.39†15  
  
Pain r= 0.36*12  r= 0.54†12  r= -0.0612 r= -0.1112 r= 0.2212 r= 0.1912 r= -0.2512 / r= 0.38*12  
CHD risk 
factors 
r= 0.06†1  r= 0.08‡1  r= 0.011  / r= 0.09‡1   / / / / 
CHD 
comorbidities 
r= 0.19‡1  r= 0.14‡1 r= -0.11‡1  / r= 0.09‡1  / / / / 
 PASI: Psoriasis Area and Severity Index; FEV1%: percent predicted forced expiratory volume in the first second; CHD: coronary heart disease; *: p<0.05; †: p<0.01; ‡: p<0.001; numbers in 
superscript refer to study number 
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Table 6: Psychosocial factors 
Modifiable 
correlate 
Identity Consequences Personal 
Control 
Treatment 
control 
Timeline 
acute/chronic 
Timeline 
cyclical 
Illness 
coherence 
Concern Emotional 
Representations 
Perceived 
competence 
r= -0.18‡1  r= -0.31‡1  r= 0.21‡1  / r= 0.08‡1   / / / / 
Social support r= -0.10‡1  r= -0.051 r= 0.11‡1   / r= -0.011 / / / / 
Depression r= 0.31*11  r= 0.48‡11  r= -0.40†11 / r= 0.0611 / / / / 
 r= 0.206 r= 0.47‡6 r= -0.186 r= -0.026 r= 0.216 r=0.116 r= -0.016  r= 0.53‡6 
 / r= 0.47‡8 / / / / / / / 
Anxiety / / / / / / r= 0.29*8  / / 
 r=0.236 r=0.43‡6 r=0.096 r=0.096 r=0.106 r=0.246  r=0.026  r=0.61‡6 
Maladaptive 
health beliefs 
/ r=0.1210  r= -0.25†10 r= -0.25†10  r=0.0410  r=0.1410 r= -0.22*10 / r= 0.0210   
Panic severity r= 0.416 r=0.77‡6 r= 0.126 r=-0.106 r=0.186 r=0.406 r=0.076 / r= 0.75‡6 
*: p<0.05; †: p<0.01; ‡: p<0.001; numbers in superscript refer to study number
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4. Discussion 
This systematic review identified 5 categories of modifiable correlates of illness perceptions: medication 
beliefs; information provision and satisfaction; quality of care; illness-related factors and psychosocial 
factors.  
We found that medication beliefs were correlated with emotional representations but not with 
cognitive beliefs. Patients’ representations of illness and treatment show a ‘common-sense’ logic, even 
when treatment evaluations are based on misconceptions they appear to draw on [48]. Concerns about 
prescribed medication are not only related to side effects but also to more general concerns, even when 
medication is well tolerated. These concerns are often related to beliefs about the negative effects of 
medication such as long-term health effects, drug dependence, medication cost and dislike of having to 
rely on medicines [49]. Horne & Weinman (2002) [49] suggest that one strategy to shift patients’ beliefs 
about the necessity of their treatment is through their illness perceptions. Unfortunately, most studies 
investigating the relationship between medication beliefs and illness perceptions are cross-sectional. 
Hence, the directionality of the associations is not clear.  
Hagger & Orbell (2003) [6] describe that forming illness perceptions is influenced by somatic and 
symptomatic information and the information that patients  receive from healthcare professionals. In the 
present study, we found that not only the information a patient gets, but also the satisfaction with the 
information received, is a correlate of illness perceptions. Satisfaction with information has been shown 
to influence long-term outcomes after treatment such as depression and mental component scores of 
reported health [50]. Research has suggested that it is the inferences individuals make about the 
information that determine levels of distress rather than the meanings the information giver intends to 
convey. Hence, people interpret the information they have been given within their own framework of 
ideas and theories of their illness [51]. So, it is likely  to first access patients' views about their illness and 
treatments in relation to their satisfaction with information prior to and during their treatment.   
A closer look at the psychosocial factors shows that they are together with illness-related factors 
the most influencing factors which need to be tackled first in designing interventions. The correlation of 
depression and anxiety with illness perceptions was reported in four studies describing psychosocial 
factors. A recent meta-analysis [52] showed that perceptions of illness consequences and emotional 
representations had the strongest relationship with depression, anxiety and quality of life as seen in our 
study. This strong relationship between emotional representations and outcomes such as anxiety and 
depression raises the question about measuring comparable concepts. The differences between these two 
concepts are that emotional representations are specific to the illness under investigation whereas anxiety 
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and depression are measured more generically. However, their interdependence poses a problem in 
interpreting correlations.  
This review has some strengths and limitations. A strength of this review was that all the included 
articles defined illness perceptions by using Leventhal’s common-sense model. Hence, it was possible to 
generalize the results although the correlates were found in different patient populations. However, most 
studies using one of the aforementioned illness perception questionnaires, studied causal factors poorly 
probably because of the more time consuming analysis process. Another strength was that the 
methodological quality of the included studies was rated overall as good. A possible limitation might be 
that some relevant papers were missed despite our use of a search string per database, carefully 
developed in collaboration with a health sciences librarian or because there was a predefined selection of  
instruments for assessing illness perceptions (which was stated as an inclusion criterion). Secondly, no 
meta-analysis could be conducted due to the low number of studies investigating a specific correlate, the 
large variability in diseases and the lack of sufficient raw data.  
This study gives more insight in the correlates of illness perceptions that are modifiable and that 
can be handled by healthcare professionals. It supplies information in the form of an outline to guide 
healthcare professionals in the communication and education of their patients in daily clinical practice. 
For instance, a checklist with modifiable correlates can be an addition to the Representational Approach 
to patient education of Donovan and colleagues (2007)[53]. This approach requires eliciting and 
understanding patients’ pre-existing representations of illness before giving new information. In this way, 
healthcare professionals and patients have the opportunity to recognize gaps, confusions, and 
misconceptions in the patient’s representation [53]. Knowledge about the most influential correlates, i.e. 
anxiety, depression, illness-related factors, can be added to the different steps in this Representational 
Approach to patient education and tailored to each patient individually. Moreover, the first and second 
step that describes the representational assessment and identification or exploration of gaps, errors and 
confusions can be extended by the correlates found in this study. The modifiable correlates that are 
relevant for a specific patient situation can be withdrawn and can facilitate the patient education process.  
The findings of the current systematic review also  show important implications for future 
research. Firstly, knowledge about the modifiable correlates of illness perceptions also applies to research 
concerning adjustment to chronic illness. Working models for adjustment to chronic illness such as 
described by Moss-Morris (2013) [54] can be extended by filling out these correlates and more specifically 
the most influential correlates such as illness-related factors and psychosocial factors. For example 
personal background factors can be extended by adding depression and anxiety. 
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Secondly, more qualitative research is needed. Qualitative research provides an in-depth 
understanding to get more insight in the factors that are considered by patients themselves as correlates. 
These factors can be patient specific factors but also factors at the level of the health care provider, or the 
healthcare system. This design makes it possible to go in detail about why people think that certain 
correlates contribute to certain illness perceptions. Qualitative research about illness perceptions is 
available [55] but research about modifiable correlates is scarce. More qualitative research about the 
correlates of illness perceptions would add to the understanding of illness perceptions.  
Thirdly, the results of this review can make an attempt to address theoretical questions based on 
Leventhal’s Self-Regulation model. In this theory, illness perceptions are the building blocks of inquiry and 
intervention for altering and tackling ‘undesired’ outcomes. One important issue that can be discussed 
and investigated is that -in some situations- it is probably much more convenient to tackle the modifiable 
correlates of illness perceptions for altering outcomes than the illness perceptions per se. Hence, an 
overview of the types and characteristics of the correlates of illness perceptions is necessary which makes 
planning an intervention protocol much more easy.  
Fourthly, we found that some modifiable correlates are also outcomes of illness perceptions. The 
correlates depression, anxiety and illness-related factors, medication beliefs can be both determinants 
and outcomes of illness perceptions raising concern about the directionality of these relationships. Further 
longitudinal research needs to clarify the directionality  of the associations between modifiable correlates 
and illness perceptions.  
 
We can conclude that our findings provide an added value to the knowledge about illness perceptions 
such as the importance of psychosocial factors like depression and anxiety and illness-related factors.  Our 
findings could facilitate understanding of patients’ illness perceptions, enhances patient-provider 
communication and can be useful in developing effective interventions and tailored patient education 
programs to alter maladaptive illness perceptions and ultimately to improve care.   
  
46 |CHAPTER 2  
 
References 
1  Petrie KJ, Weinman J. Why illness perceptions matter. Clin Med 2006;6:536–9. 
2  Petrie KJ, Weinman J. Patients’ Perceptions of Their Illness: The Dynamo of Volition in Health 
Care. Curr. Dir. Psychol. Sci. 2012;21:60–5. doi:10.1177/0963721411429456 
3  Broadbent E. Illness Perceptions and Health: Innovations and Clinical Applications. Soc Personal 
Psychol Compass 2010;4:256–66. doi:10.1111/j.1751-9004.2010.00260.x 
4  Horne R. Treatment perceptions and self-regulation. In: Cameron LD, Leventhal H, eds. The self 
regulation of health and illness behaviour. London: : Routledge 2003. 138–53. 
5  Petrie K, Jago L a, Devcich D a. The role of illness perceptions in patients with medical conditions. 
Curr Opin Psychiatry 2007;20:163–7. doi:10.1097/YCO.0b013e328014a871 
6  Hagger MS, Orbell S. A Meta-Analytic Review of the Common-Sense Model of Illness 
Representations. Psychol Health 2003;18:141–84. doi:10.1080/088704403100081321 
7  Leventhal H, Brissette I, Leventhal EA. The common-sense model of self-regulation of health and 
illness. In: Cameron L, Leventhal H, eds. The Self-Regulation of Health and Illness Behaviour. New 
York: : Routledge 2003. 43–65. 
8  Heijmans M, De Ridder D. Assessing illness representations of chronic illness: Explorations of their 
disease-specific nature. J Behav Med 1998;21:485–504. doi:10.1023/A:1018788427100 
9  Aalto AM, Heijmans M, Weinman J, et al. Illness perceptions in coronary heart disease: 
Sociodemographic, illness-related, and psychosocial correlates. J Psychosom Res 2005;58:393–
402. doi:10.1016/j.jpsychores.2005.03.001 
10  Gump BB, Matthews KA, Scheier MF, et al. Illness representations according to age and effects on 
health behaviors following coronary artery bypass graft surgery. J Am Geriatr Soc 2001;49:284–9. 
11  Lange LJ, Piette JD. Personal models for diabetes in context and patients’ health status. J Behav 
Med 2006;29:239–53. doi:10.1007/s10865-006-9049-4 
12  Edelstein OE, Werner P, Dresner-Pollak R, et al. Illness perceptions among osteoporotic men and 
women: Correlates and gender differences. J Mens health 2012;9:168–75. 
doi:10.1016/j.jomh.2012.03.012 
13  Barnes L, Moss-Morris R, Kaufusi M. Illness beliefs and adherence in diabetes mellitus: A 
comparison between Tongan and European patients. N Z Med J 2004;117. 
14  Bean D, Cundy T, Petrie KJ. Ethnic differences in illness perceptions, self-efficacy and diabetes 
self-care. Psychol Heal 2007;22:787–811. doi:10.1080/14768320600976240 
15  Kim Y, Evangelista LS, Phillips LR, et al. Racial/ethnic differences in illness, perceptions in minority 
 Modifiable correlates of illness perceptions| 47 
 
 
 
patients undergoing maintenance hemodialysis. Nephrol Nurs J 2012;39:39–48. 
16  Persson LO, Sahlberg D, Report E. The influence of negative illness cognitions and neuroticism on 
subjective symptoms and mood in rheumatoid arthritis. Ann Rheum Dis 2002;61:1000–6. 
doi:10.1136/ard.61.11.1000 
17  Mols F, Denollet J, Kaptein AA, et al. The association between Type D personality and illness 
perceptions in colorectal cancer survivors: A study from the population-based PROFILES registry. J 
Psychosom Res 2012;73:232–9. doi:10.1016/j.jpsychores.2012.07.004 
18  Williams L, O’Connor RC, Grubb NR, et al. Type D personality and illness perceptions in myocardial 
infarction patients. J Psychosom Res 2011;70:141–4. doi:10.1016/j.jpsychores.2010.07.015 
19  Anagnostopoulos F, Spanea E. Assessing illness representations of breast cancer: A comparison of 
patients with healthy and benign controls. J Psychosom Res 2005;58:327–34. 
doi:10.1016/j.jpsychores.2004.09.011 
20  Cantillon P, Morgan M, Dundas R, et al. Patients’ perceptions of changes in their blood pressure. J 
Hum Hypertens 1997;11:221–5. 
21  Martin R, Lemos C, Rothrock N, et al. Gender disparities in common sense models of illness 
among myocardial infarction victims. Health Psychol 2004;23:345–53. doi:10.1037/0278-
6133.23.4.345 
22  Constant A, Castera L, Quintard B, et al. Psychosocial factors associated with perceived disease 
severity in patients with chronic hepatitis C: relationship with information sources and attentional 
coping styles. Psychosomatics 2005;46:25–33. 
23  Murphy H, Dickens C, Creed F, et al. Depression, illness perception and coping in rheumatoid 
arthritis. J Psychosom Res 1999;46:155–64. doi:10.1016/S0022-3999(98)00073-7 
24  Grace SL, Krepostman S, Brooks D, et al. Illness perceptions among cardiac patients: Relation to 
depressive symptomatology and sex. J Psychosom Res 2005;59:153–60. 
doi:10.1016/j.jpsychores.2005.05.005 
25  Lerdal A, Celius EG, Moum T. Perceptions of illness and its development in patients with multiple 
sclerosis: a prospective cohort study. J Adv Nurs 2009;65:184–92. 
26  Moher D, Liberati A TJ and AD. The PRISMA Group. Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses: The PRISMA Statement. Ann Intern Med 2009;151:264–9. 
doi:10.7326/0003-4819-151-4-200908180-00135 
27  Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a 
proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. 
48 |CHAPTER 2  
 
JAMA 2000;283:2008–12. doi:10.1001/jama.283.15.2008 
28  Leventhal H, Nerenz DR, Steele DJ. Illness representations and coping with health threats. In: 
Baum A, Taylor SE SJ, ed. Handbook of Psychology and Health. Volume IV: Social Psychological 
aspects of health. Hillsdale, New Jersey: : Lawrence Erlbaum Associates, Publishers 1984. 219– 
252. 
29  Moss-Morris R, Weinman J, Petrie KJ, et al. The revised Illness Perception Questionnaire (IPQ-R). 
Psychol Health 2002;17:1–16. doi:10.1080/08870440290001494 
30  Weinman J, Petrie KJ, Moss-morris R, et al. The illness perception questionnaire: A new method 
for assessing the cognitive representation of illness. Psychol Health 1996;11:431–45. 
doi:10.1080/08870449608400270 
31  Broadbent E, Petrie KJ, Main J, et al. The Brief Illness Perception Questionnaire. J Psychosom Res 
2006;60:631–7. doi:10.1016/j.jpsychores.2005.10.020 
32  SIGN. Critical appraisal: notes and checklists. 
2012.http://www.sign.ac.uk/methodology/checklists.html 
33  Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77–101. 
doi:10.1191/1478088706qp063oa 
34  Borenstein M, Hedges L V, Higgins JPT, et al. Converting Among Effect Sizes. Introd to Meta-
Analysis 2009;:45–9. doi:10.1002/9780470743386.ch7 
35  Borge CR, Moum T, Puline Lein M, et al. Illness perception in people with chronic obstructive 
pulmonary disease. Scand J Psychol 2014;55:456–63. doi:10.1111/sjop.12150 
36  Howard C, Hallas CN, Wray J, et al. The relationship between illness perceptions and panic in 
chronic obstructive pulmonary disease. Behav Res Ther 2009;47:71–6. 
37  Fortune DG, Richards HL, Main CJ, et al. What patients with psoriasis believe about their 
condition. J Am Acad Dermatol 1998;39:196–201. doi:10.1016/S0190-9622(98)70074-X 
38  Wahl AK, Robinson HS, Langeland E, et al. Clinical characteristics associated with illness 
perception in psoriasis. Acta Derm Venereol 2014;94:271–5. doi:10.2340/00015555-1673 
39  Husson O, Thong MSY, Mols F, et al. Illness perceptions in cancer survivors: What is the role of 
information provision? Psychooncology 2013;22:490–8. doi:10.1002/pon.3042 
40  Zhang N, Fielding R, Soong I, et al. Illness perceptions among cancer survivors. Support Care 
Cancer 2016;24:1295. 
41  Andela CD, Biermasz NR, Kaptein AA, et al. More concerns and stronger beliefs about the 
necessity of medication in patients with acromegaly are associated with negative illness 
 Modifiable correlates of illness perceptions| 49 
 
 
 
perceptions and impairment in quality of life. Growth Horm IGF Res 2015;25:219–26. 
doi:10.1016/j.ghir.2015.06.008 
42  Heyduck K, Meffert C, Glattacker M. Illness and treatment perceptions of patients with chronic 
low back pain: Characteristics and relation to individual, disease and interaction variables. J Clin 
Psychol Med Settings 2014;21:267–81. doi:10.1007/s10880-014-9405-4 
43  Ireland J, Wilsher M. Perceptions and beliefs in sarcoidosis. Sarcoidosis Vasc Diffus Lung Dis 
2010;27:36–42. 
44  Iskandarsyah A, De Klerk C, Suardi DR, et al. Satisfaction with information and its association with 
illness perception and quality of life in Indonesian breast cancer patients. Support Care Cancer 
2013;21:2999–3007. doi:10.1007/s00520-013-1877-5 
45  Karademas EC, Paschali A, Hadjulis M, et al. Maladaptive health beliefs, illness-related self-
regulation and the role of the information provided by physicians. J Health Psychol 2016;7:1–10. 
doi:10.1177/1359105314544072 
46  Richards HL, Herrick AL, Griffin K, et al. Systemic sclerosis: patients’ perceptions of their condition. 
Arthritis Rheum 2003;49:689–96. doi:10.1002/art.11385 
47  Thomas J, Iyer NN, Collins WB. Associations between perceived chronic care quality, perceived 
patient centeredness, and illness representations among persons with diabetes. J Healthc Qual 
2014;36:50–9. doi:10.1111/jhq.12077 
48  Horne R, Weinman J. Self-regulation and Self-management in Asthma: Exploring The Role of 
Illness Perceptions and Treatment Beliefs in Explaining Non-adherence to Preventer Medication. 
Psychol Health 2002;17:17–32. doi:10.1080/08870440290001502 
49  Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to 
treatment in chronic physical illness. J Psychosom Res 1999;47:555–67. doi:10.1016/S0022-
3999(99)00057-4 
50  Llewellyn CD, McGurk M, Weinman J. Illness and treatment beliefs in head and neck cancer: Is 
Leventhal’s common sense model a useful framework for determining changes in outcomes over 
time? J Psychosom Res 2007;63:17–26. doi:10.1016/j.jpsychores.2007.01.013 
51  Leventhal H, Meyer D, Nerenz D. The common sense representation of illness danger. In: 
Rachman S, ed. Contributions to medical psychology. New York: : Pergamon 1980. 7–30. 
52  Dempster M, Howell D, McCorry NK. Illness perceptions and coping in physical health conditions: 
A meta-analysis. J. Psychosom. Res. 2015;79:506–13. doi:10.1016/j.jpsychores.2015.10.006 
53  Donovan HS, Ward SE, Song MK, et al. An update on the representational approach to patient 
50 |CHAPTER 2  
 
education. J Nurs Scholarsh 2007;39:259–65. doi:10.1111/j.1547-5069.2007.00178.x 
54  Moss-Morris R. Adjusting to chronic illness: Time for a unified theory. Br J Health Psychol 
2013;18:681–6. doi:10.1111/bjhp.12072 
55  Wiginton KL. Illness Representations: Mapping the Experience of Lupus. Heal Educ Behav 
1999;26:443–53. doi:10.1177/109019819902600403 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Modifiable correlates of illness perceptions| 51 
 
 
 
Appendix 1: Search strings of the 4 databases  
1. Pubmed 
(“Perception”[Mesh:NoExp] OR illness perception*[tiab] OR illness cognition*[tiab] OR perceived illness*[tiab] OR leventhal[tiab] 
OR illness belief*[tiab] OR illness representation*[tiab] OR illness schema[tiab] OR illness model*[tiab] OR “health appraisal”[tiab] 
OR “health perception*”[tiab] OR “patient perception*”[tiab] OR “self regulation”[tiab] OR “self regulatory”[tiab] OR “common 
sense model”[tiab]) AND ("Adult"[Mesh] OR adult*[tiab] OR elder*[tiab] OR grown-up*[tiab] OR aged pat*[tiab]  OR aged 
pers*[tiab]OR aged people[tiab] OR aged person[tiab] OR elderly patient[tiab] OR elderly people [tiab]OR elderly person*[tiab]) 
AND ("Chronic Disease"[Mesh] OR chronic disease*[tiab] OR chronic disorder*[tiab] OR chronic ill*[tiab] OR chronically ill*[tiab] 
OR persistent ill*[tiab] OR chronic patient* OR persistent disease*[tiab] OR persistent disorder*[tiab] OR systemic disorder*[tiab] 
OR systemic disease*[tiab] OR "Patient Acuity"[Mesh] OR Patient Acuit*[tiab] OR illness [tiab]) AND (correlat*[tiab] OR 
"Association"[Mesh:NoExp] OR associat*[tiab]  OR determinant*[tiab] OR Influencing factor*[tiab] OR relat*[tiab]) 
2. Embase 
('perception'/de OR 'illness perception*':ab,ti OR 'illness cognition*':ab,ti OR 'perceived illness*':ab,ti OR ‘leventhal’:ab,ti OR  
'illness belief*':ab,ti OR 'illness representation*':ab,ti OR ‘illness schema’:ab,ti OR 'illness model*':ab,ti OR “health appraisal”:ab,ti 
OR “health perception*”:ab,ti OR “patient perception*”:ab,ti OR ‘self regulation'/de OR “self regulation”:ab,ti OR “self 
regulatory”:ab,ti OR “common sense model”:ab,ti) AND ('adult'/de OR 'adult':ab,ti OR 'grown-up*':ab,ti OR 'grownup':ab,ti OR 
'grownups':ab,ti OR 'aged patient':ab,ti OR 'aged people':ab,ti OR 'aged person':ab,ti OR 'elderly patient':ab,ti OR 'elderly 
people':ab,ti OR 'elderly person':ab,ti) AND ('chronic disease'/de OR 'chronic disease*':ab,ti OR 'chronic illness':ab,ti OR 'chronic 
disorder*':ab,ti  OR 'chronic patient'/de OR 'chronic patient*':ab,ti  OR 'persistent ill*':ab,ti OR 'persistent disease*':ab,ti OR 
'persistent disorder*':ab,ti OR 'systemic disease'/de OR 'systemic disease*':ab,ti  OR 'patient acuity'/de OR 'patient acuit*':ab,ti 
OR ‘illness’:ab,ti) AND ('correlat*':ab,ti OR ‘association’/de OR 'associat*':ab,ti OR 'determinant*':ab,ti OR 'influencing 
factor*':ab,ti OR ‘relat*’:ab,ti) 
3. Web of Science 
TS=(“perception” OR “illness perception*” OR “illness cognition*” OR “perceived illness*” OR “leventhal” OR  “illness belief*” OR 
“illness representation*” OR “illness schema” OR “illness model*”OR “health appraisal” OR “health perception*” OR “patient 
perception*” OR “self regulation” OR “self regulatory” OR “common sense model”) AND TS=(“adult” OR “grown-up*” OR 
“grownup*” OR “aged patient” OR “aged people” OR “aged person” OR “elderly patient” OR “elderly people” OR ”elderly person”) 
AND TS=("chronic disease*" OR "chronic disorder*" OR “chronic illness”OR “chronic patient” OR "persistent ill*" OR "persistent 
disease*" OR "persistent disorder" OR "systemic disease" OR "Patient Acuit*" OR illness) AND TS=(“correlate*” OR “associate*” 
OR “determinant*” OR “influencing factor*” OR “relat*”) 
4. Cinahl 
((MH "Perception") OR (TI illness perception* OR AB illness perception*) OR (TI illness cognition* OR AB illness cognition*) OR (TI 
perceived illness* OR AB perceived illness*) OR (TI leventhal OR AB leventhal) OR (TI illness belief* OR AB illness belief*) OR (TI 
illness representation* OR AB illness representation*) OR  (TI illness schema OR AB illness schema) OR (TI illness model* OR AB 
illness model*) OR (TI “health appraisal” OR  AB “health appraisal”) OR (TI “health perception*” OR AB “health perception*”) OR 
(TI “patient perception*”OR AB “patient perception*”) OR (MH "Self Regulation") OR (TI “self regulation”  OR AB “self regulation”) 
OR (TI “Self regulatory” OR AB “Self regulatory”) OR (TI “common sense model” OR AB “common sense model”)) AND ((MH"Adult") 
OR (TI adult OR AB adult) OR (TI grownups OR AB grownups) OR (TI grown-up* OR AB grown-up*) OR (TI grownup OR AB 
grownup)OR (TI aged patient  OR AB aged patient)  OR (TI aged people  OR AB aged people)  OR (TI aged person  OR AB aged 
person)  OR (TI elderly patient OR AB elderly patient) OR (TI elderly people OR AB elderly people)OR (TI elderly person OR AB 
elderly person)) AND ((MH “chronic disease”) OR (TI chronic disease* OR AB chronic disease*) OR (TI chronic illness OR AB chronic 
illness) OR (TI chronic disorder* OR AB chronic disorder*) OR (TI chronic patient* OR AB chronic patient*) OR (TI persistent ill* OR 
AB persistent ill*) OR (TI persistent disease* OR AB persistent disease*)  OR (TI persistent disorder* OR AB persistent disorder*) 
OR (TI systemic disease* OR AB systemic disease*) OR (TI patient acuit* OR  patient acuit*) OR (TI illness OR AB illness)) AND ((TI 
correlat* OR AB correlate*) OR (TI associat* OR AB associate*) OR (TI determinant* OR AB determinant*) OR (TI influencing 
factor* OR AB influencing factor*) OR (TI relat* OR AB relat*)) 
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Supplementary Table 1: Methodological quality appraisal using the SIGN methodology checklist for cohort studies 
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Abstract 
 
Objective: Diverging perceptions between individual patients with somatic diseases and their 
healthcare professionals might cause problems in communication and decision-making. To date, no 
measurement tool is available to compare the illness perceptions between these two groups. The 
Revised Illness Perception Questionnaire (IPQ-R) is a validated, widely used instrument in many patient 
populations with somatic conditions. The aim of this study was to adapt the IPQ-R to a healthcare 
professional’s version (IPQ-R HP) and to perform a preliminary evaluation of its validity and reliability.  
 
Methods: After adaptation of the IPQ-R HP, 17 doctors from 3 general hospitals and 9 head nurses 
from a university hospital evaluated the face and content validity of the IPQ-R HP. The results were 
quantified using the content validity index (CVI) and a modified kappa index (k*). For the reliability 
measurements a group of nurses from 4 nursing wards participated at 2 time points with an interval 
of 4 weeks. Internal consistency and test-retest reliability were calculated.   
 
Results: Twenty-eight of the 38 items demonstrated excellent content validity and four items showed 
good content validity. Four items had a sufficient k* and two items had a low CVI. The average CVI of 
the 7 dimensions ranged from 0.66 to 0.89. The Cronbach’s alpha scores for the seven dimensions, 
intraclass coefficients and effect size estimates were acceptable.  
 
Conclusions: This preliminary evaluation of the IPQ-R HP shows an acceptable to good validity and 
reliability. Further exploration of the psychometric properties of this questionnaire in a large cohort of 
healthcare professionals is warranted. 
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1. Introduction  
Illness perceptions are the cognitive beliefs that patients have about their condition. They refer to the 
cognitive depiction of an illness, reflecting how the illness is ‘pictured and stored’ in the mind [1,2]. 
Illness perceptions directly influence the individual’s emotional response to the illness and guide 
coping behavior such as adherence to treatment and health care use in a positive or negative way 
[1,3,4].  Over time, researchers have used various methodologies to measure the patients’ illness 
perceptions, ranging from questionnaires in early studies to in-depth semi-structured interviews [5]. 
Unfortunately, these questionnaires were not based on a generally accepted theory nor were they 
evaluated in different patient groups [6,7].  
Currently, the majority of studies focusing on patients’ illness perceptions are based upon 
Leventhal’s Self-Regulatory Model. In 1980, Leventhal and colleagues [8] developed this theoretical 
framework to explain why and how illness representations can differ. They identified different 
components including the labels, timeline, cause(s), consequences and control.  This work resulted in 
the development of the Illness Perception Questionnaire (IPQ) that assesses these five components of 
illness representation. A revised version (IPQ-R) was developed in 2002 by Moss-Morris and colleagues 
[9]. The IPQ-R is widely used in various patient populations such as systemic sclerosis [10] rheumatoid 
arthritis [11,12], psoriasis [13] and can be modified for use in a particular disease of interest. It has 
good psychometric properties with a good internal reliability, discrimination and predictive validity 
and has already been translated in different languages [9]. 
In daily clinical practice, the patient and the healthcare professional (HP) often have different views 
on the illness and its impact on a particular patient. Awareness of these divergent illness perceptions 
is crucial, as they can result in misunderstandings and disrupted communication when unrecognized 
[14–16]. Previous research evaluating the patient-professional encounter described clear differences 
between the perceptions of the patients with chronic obstructive pulmonary disease and asthma on 
the one hand and the physicians and nurse specialists on the other hand concerning timeline, control, 
consequences and  outcomes [17]. Interestingly, a Japanese study [18] demonstrated that a gap 
between the patient’s and the doctor’s perceptions was the most significant predictor of doctor-
shopping behavior.  
Detection of misperceptions is possible by matching a scale that assesses patients’ perceptions and 
perceptions of healthcare professionals (HPs). There is no appropriate and validated instrument 
available to measure illness perceptions of HPs caring for patients with physical diseases. At this 
moment questionnaires are available to measure lay perceptions of healthy people [19], illness 
perceptions of carers of schizophrenia patients [20] and a modified version of the illness perception 
questionnaire for mental health practitioners[21]. In the latter study the utility of a modified version 
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of the IPQ was investigated to detect changes in mental health practitioners’ illness perceptions about 
schizophrenia after undertaking psychosocial intervention training. The modified IPQ was completed 
before and after the training. Afterwards the psychometric properties of the modified IPQ were tested 
using confirmatory factor analysis showing that a six factor model was most appropriate, but also that 
there was a poor fit of the items in each factor. This implied that the instrument was not valid and 
reliable enough to detect changes in illness perceptions. 
The purpose of this study was to adapt the IPQ-R to a healthcare professional’s version and to 
perform a preliminary evaluation of its validity and reliability.  
 
2. Methods 
The first step in the methodology was an adaptation and rewording of the IPQ-R to a healthcare 
professionals version. Secondly, face validity and content validity of this adapted version was evaluated 
in a group of physicians and head nurses. At last, the reliability measurements, i.e. the internal 
consistency and test-retest reliability, were assessed in a group of nurses. 
 
Adaptation/rewording of the IPQ-R for healthcare professionals  
Four authors (SA, PM, JV and RW) discussed and agreed upon the adaptation of the 9-dimension Dutch 
version of the IPQ-R [22] to a healthcare professionals version (IPQ-R HP). This process comprised 
several rounds. An item-by-item approach was followed by a dimensional and overall evaluation. The 
primary goal of the process was to focus on the perception of the HP regarding the disease of a 
particular patient (dimensions 1, 2, 3, 4 and 6). The secondary focus of the IPQ-R HP was the view of 
the HP on the perceptions of that particular patient, regarding his/her illness and about its emotional 
impact on the patient (dimensions 5 and 7). The reformulation of the latter 2 dimensions was done in 
this way because these dimensions have an emphasis on the emotionality and understanding of the 
patient and not on the disease of the patient.  We did not include the dimensions ‘illness identity’ (= 
perceptions of symptoms associated with the illness) and ‘causal attributions’ in the IPQ-R HP. From a 
HP’s perspective,  these 2 dimensions are also part of illness perceptions but more related to medical 
knowledge or a medical judgment of the illness in comparison with patients’ illness perceptions 
because of their biomedical education. The other 7 dimensions of the original IPQ-R were reworded to 
a HP’s version. Finally, this IPQ-R HP consisted of  7 dimensions: 1) consequences (the HPs’ perception 
of the consequences of the illness for a particular patient); 2) timeline acute/chronic (the HPs’ 
perception about the illness passing quickly or not in a particular patient); 3) personal control (the HPs’ 
perception of the patient’s ability to control the illness); 4) treatment control (the HPs’ perception 
about the effectiveness of any treatment or approach to control the illness in a particular patient); 5) 
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illness coherence (the HPs’ perception of the extent to which a particular patient understands their 
illness); 6) timeline cyclical (the HPs’ perception of the cyclical nature of the illness across time); and 
7) emotional representations (the HPs’ perception of the patients’ emotional experience of their 
illness). In general, besides the rewording and reformulation, the difference between the IPQ-R and 
IPQ-R HP were the terms ‘I’ and ‘this patient’. 
 
Sampling strategy - Procedure 
To measure the face and content validity, a purposive sampling strategy was conducted. We had a list 
with the names of 20 physicians from 3 general hospitals and 11 head nurses from a large university 
hospital in Belgium and invited them to participate. Two sampling criteria were used to recruit the 
healthcare professionals: they had to be specialized in internal medicine and have active patient 
contact at an outpatient clinic or inpatient service. They were visited in their respective hospitals and 
introduced in the study (by AVdZ and MVR).  Oral and written information about the study was given 
together with the scoring instructions and the IPQ-R HP. After one week, researchers AVdZ and MVR 
contacted the physicians and head nurses personally and reminded them to complete the 
questionnaire if needed.   
For the reliability measurement, head nurses of 11 nursing wards from the university hospital were 
approached and asked if their nurses could participate. At these 11 nursing wards a total of 242 nurses 
are working.  We opted for nurses to score the reliability measurements because for the face and 
content validity measurements already more physicians than nurses were present. Nurses received 
first oral information during a team meeting, after which they received written information regarding 
the study. They were asked to complete the IPQ-R HP on the basis of 4 patient vignettes. After an 
interval of 4 weeks, they were asked to complete the IPQ-R HP on the basis of 1 patient vignette that 
was included in the first round. The reason for reducing the number of vignettes from 4 to 1 was the 
indication of survey fatigue among  respondents which could have an impact on the response rate.  
These patient vignettes were developed by SA and RW and comprised information regarding 2 patients 
with systemic lupus erythematosus and 2 patients with systemic sclerosis based on real patients seen 
in the clinic. The information in the vignettes pertained to the patients’ clinical condition (i.e. a 
description of antibody profile, characteristics and complication of the disease), the medical treatment 
and eventual psychosocial complications and coping styles having a possible or probable impact on 
daily life.    
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Validity 
Face Validity 
Face validity is the extent to which a test is representative for covering the concept it purports to 
measure at first sight [23]. The IPQ-R HP was accompanied by four questions about each dimension 
and also a general question at the end. These four questions were: “Are these questions a correct 
representation of the dimension?”; “Are the questions clear?”, “Are there questions lacking?” and “Are 
there redundant questions?” At last, there was an open question for further remarks. The reason why 
we asked, if the items per dimension are representative for a particular dimension, is because the 
concept of illness perceptions consists of several dimensions. So, we used the theory behind the 
concept of illness perceptions [8] as a backbone to rely on. In this phase, the emphasis was on the 
representativeness of the items covering the concept on first sight and not on removing or adding new 
items because of their content [24]. 
 
Content validity 
The IPQ-R HP was also tested for content validity. Content validity is the extent to which a measure 
represents all facets of a given construct [25]. In other words, the items on the test represent the entire 
range of possible items the test should cover [26,27] . 
Physicians and head nurses, this was the same group as for the appraisal of the face validity, were 
instructed to rate the 38 items of the IPQ-R HP on a 4-point Likert scale as: “1 = not relevant”, “2= 
somewhat relevant”, “3= quite relevant”, “4= highly relevant”. An appropriate sample size for 
calculating content validity ranges between 5 and 10 [26].  
Based on these data, the item Content Validity Index (I-CVI) was calculated. The I-CVI is the 
proportion of items that received a rating of 3 or 4 by the experts. For the total instrument and each 
scale, a scale content validity index (S-CVI) was calculated. This is the average of all the I-CVI’s of the 
individual items (S-CVIave). An I-CVI of 0.78 and an S-CVIave of 0.90 is considered to be excellent [27] . 
To counter the limitations of the CVI, each I-CVI was adjusted for chance agreement by calculating 
the modified kappa statistic (k*) [28]. To compute the modified kappa, the probability of chance 
agreement was computed first: Pc = [N!/A! (N−A)!]× 0.5N where N is the number of experts and A is the 
number agreeing on good relevance (rating 3 and 4). Next, the k* was calculated with the formula k* 
= [I-CVI− Pc ]/[1− Pc] [26]. According to the standards of Fleiss (2003)  [29] and Cicchetti and Sparrow 
(1981) [30] the value of each k* was evaluated as poor (k <0.40), fair (k of 0.40 to 0.59), good (k of 0.60 
to 0.74), or excellent (k of > 0.74).  
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Reliability 
To measure the internal consistency, Cronbach’s alpha values per vignette were calculated and also a 
total Cronbach’s alpha value was computed. Sample size estimations to accurately determine the 
internal consistency showed that a minimum of 17 subjects was necessary.  
To evaluate the test-retest reliability, nurses were asked at time point 1 (T1) to complete the 4 
vignettes and at time point 2 (T2) they were asked to complete vignette number 4 because this vignette 
had the best alpha values and the content was a good mix of psychosocial and clinical information. 
Intraclass correlation (ICC) was computed to describe how strongly illness perception dimensions in 
the same group resemble each other. It is a measure of the reliability of measurements. ICC can be 
interpreted as follows: 0-0.2= poor agreement; 0.3-0.4= fair agreement; 0.5-0.6= moderate 
agreement; 0.7-0.8= strong agreement; and >0.8= almost perfect agreement. These values are 
arbitrary cutoffs, but similar to those used by Landis and Koch [31] for agreement of categorical items. 
We also looked for differences in illness perception scores between T1 and T2 which are expressed 
in effect sizes. For the continuous variables, an effect size for the Wilcoxon signed rank test was 
calculated by   where Z is the normal approximation of the Wilcoxon test statistic and N is the 
total number of participants on which Z is based. To appraise the magnitude of the effect sizes we used 
the cutoff values for Cohen’s r: small effect size= between 0.10 and 0.30; medium effect size= between 
0.30 and 0.50 and large effect size= 0.50 or higher [32]. 
 
Statistical analysis 
Descriptive statistics were used to calculate the I-CVI values, the S-CVIave values, the Pc and k*. These 
data were analysed using Microsoft Excel (version 2011). The calculation of the Cronbach’s alpha, ICC 
and Wilcoxon signed rank test was carried out with SPSS version 22.0.  
 
Ethics approval and consent to participate 
By answering the questions and completing the questionnaire concerning face and content validity 
potential respondents (physicians and head nurses) gave their consent to participate in the study. 
Participation was voluntary and questionnaires were treated anonymously. 
For the construction of the patient vignettes and completion of the IPQ-R HP on the basis of the 
vignettes, ethical approval by the Institutional Review Board of the University Hospitals Leuven was 
received (study number S57719). Only the patient vignettes of the patients who gave permission to 
put their medical and psychosocial data in the format of a vignette, were included. Nurses, who had 
to complete the IPQ-R HP on the basis of the patient vignettes, were included after they gave written 
informed consent. 
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3. Results 
Experts scoring validity 
Seventeen doctors and 9 head nurses participated (response rate = 84%). The sample of the physicians 
consisted of 9 men and 8 women and was composed of 4 gastroenterologists; 3 endocrinologists; 2 
rheumatologists; 2 cardiologists; 2 pulmonologists; 1 nephrologist; 1 neurologist; 1 dermatologist and 
1 oncologist. No further demographic data were available. The 3 doctors who did not participate were 
all men and gave a lack of time as a reason for not participating. The 9 head nurses, 6 women and 3 
men, worked at following disciplines: cardiology; gastroenterology; rheumatology; nephrology; 
gynecology; ophthalmology; otorhinolaryngology and 2 pulmonology wards. One head nurse declined 
participation because of insecurity concerning scoring the questions correctly.  The other gave no 
reason.   
 
Face validity 
In Table 1, the face validity scores of the IPQ-R HP are tabulated. One of the 9 head nurses did not 
score the face validity questions. For almost all healthcare professionals, the questions were a correct 
representation of the dimensions and the questions were clear. Physicians wanted to add more 
questions such as items concerning self-appearance, autonomy and quality of life in the 
‘Consequences’ dimension. In the ‘Timeline’ dimension they wanted to add questions regarding 
curability of the patient and worsening of the disease.  The most redundant or overlapping questions 
for the physicians and head nurses were found in the dimensions Timeline acute/chronic; Personal 
control; Illness coherence and Emotional representations. More specifically, for the dimension 
‘timeline acute/chronic’, the experts found an overlap in items 7, 8, 10 & 11. For the dimension 
‘personal control’, following items were comparable for the experts: 14, 15, 17, 18. For the dimension 
‘illness coherence’, the experts scored items 25, 26, 27 as comparable items. For the dimension 
‘emotional representations’, items 37 & 38 were comparable.  
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Table 1: Overview appraisal face-validity of the IPQ-R HP 
Dimensions 
IPQ-R HP  
Are the questions 
a correct 
representation  
of the dimension? 
Are the 
questions clear? 
Are there 
questions 
lacking? 
Are there 
questions 
redundant? 
 Doctors 
n=17 
Nurses 
n= 8 
Doctors 
n= 17 
Nurses 
n=8 
Doctors 
n= 17 
Nurses 
n=8 
Doctors 
n= 17 
Nurses 
n=8 
Consequences 17/17 8/8 17/17 6/8 4/17 1/8 6/17 1/8  
Timeline 
acute/chronic  
16/17 8/8 15/17 8/8 4/17 0/8 7/17 4/8  
Personal Control  14/17 8/8 14/17 8/8 2/17 0/8 8/17 3/8  
Treatment 
Control 
15/17 8/8 14/17 7/8 1/17 0/8 2/17 2/8 
Illness 
Coherence 
15/17 8/8 12/17 7/8 1/17 0/8 7/17 4/8  
Timeline Cyclical 15/17 8/8 15/17 8/8 3/17 0/8 4/17 2/8  
Emotional 
Representations 
15/17 8/8 15/17 8/8 2/17 0/8 12/17 4/8  
 
Content validity 
A total of 16 physicians and 9 head nurses completed the 4-point Likert scale (see Table 2). Three 
doctors did not complete one question or one dimension. They gave no reason why they left these 
items blank. This means that 12 items were rated by 15 doctors and 26 items were assessed by 16 
doctors.  
Twenty-eight of the 38 items had an excellent content validity (I-CVI ≥ 0.78 and k* > 0.74), 4 of the 
38 items had a good content validity (I-CVI <0.78 and 0.60 ≤ k* ≤ 0.74) and 4 of the 38 items had a fair 
content validity (I-CVI <0.78 and 0.40 ≤ k* ≤ 0.59) (see Table 1). Two items (item 4 and item 10) had a 
very low modified kappa (k*< 0.40) and were considered content invalid.  
The average scale content validity (S-CVIAve) for each of the 7 dimensions was as follows: 
Consequences was 0.75; Timeline acute/chronic was 0.75; Personal control was 0.81; Treatment 
control was 0.89; Illness coherence was 0.74; Timeline cyclical was 0.66; and Emotional 
representations was 0.77. The S-CVIAve  for the entire questionnaire was 0.79. 
After omitting items with a fair and very low k* value the S-CVIAve  for Consequences was 0.88  
(without item 3 and 4), for Timeline acute/chronic was 0.83 (without item 10), Illness coherence was 
0.88 (without item 25 and 27) and Emotional representations was 0.80 (without item 34). The S-CVIAve 
for the entire questionnaire after removing items 3, 4, 10, 25, 27 and 34 was 0.82. 
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For the group of the nurses, very low modified kappa values (k*< 0.40) were present for item 3 (k*= 
0.26), 10 (k*=0.09) and 27 (k*=0.26). Item 4 had a k* value of 0.42. 
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Experts scoring reliability 
Four head nurses of following wards agreed with the participation of their nurses: pulmonology, 
rheumatology, nephrology and internal medicine. A total of 20 nurses gave consent for participation, 
comprising 15 women and 5 men, with a mean age of 39 years (SD= 12) and mean years of working 
experience of 17 years (SD= 12). Information about the non-responders is not available. 
 
Internal consistency 
Depending on the sample size estimations, a sample of 20 nurses was large enough to adequately 
compute the Cronbach’s alpha. Total Cronbach’s alpha values on all vignettes rated by 20 nurses are: 
Consequences= 0.78; Timeline acute-chronic= 0.77; Personal control = 0.80; Treatment control = 0.50; 
Illness coherence = 0.75; Timeline cyclical = 0.80; Emotional representations= 0.86 (see Table 3). 
Table 3: Cronbach’s alpha values for the four patient vignettes 
Dimensions 
 IPQ-R HP 
Alpha 
 value 
Vignette 1  
Alpha 
 value 
Vignette 2 
Alpha 
value 
Vignette 3 
Alpha 
value 
Vignette 4 
Alpha value 
            
All vignettes   
Consequences 0.77 0.81 0.73 0.83  0.78 
Timeline acute-chronic 0.89 0.67 0.78 0.75 0.77 
Personal control 0.80 0.88 0.77 0.76  0.80 
Treatment control 0.48 0.66 0.30 0.54  0.50 
Illness coherence 0.77 0.63 0.75 0.86 0.75 
Timeline cyclical 0.80 0.72 0.84 0.84  0.80 
Emotional representations 0.86 0.85 0.93 0.81  0.86 
 
Test-retest reliability 
Thirteen nurses completed the IPQ-R HP on the basis of vignette 4 at T2. Table 4 displays the ICC values 
and Wilcoxon z-score with effect size calculation for all dimensions. The ICC values were strong for all 
dimensions, except for Personal control (ICC= 0.444) and Timeline cyclical (ICC= 0.417). For the latter 
two dimensions the ICC values can be considered as fair which means that there is a fair agreement of 
Personal control and Timeline cyclical at the two time points.  The effect size estimates between the 2 
moments was small, which means that differences in the scores of the nurses between the two time 
points were small. 
 
 
 
a I-CVI (item content validity index) = number giving a rating of 3 or 4 / number experts    
b pc (probability of chance occurrence) = [N!/ A!(N-A)!] x 0,5N where  N = number of experts and A = number agreeing on good relevance 
c  k* = kappa designating agreement on relevance: k* = (I-CVI – pc) / (1 – pc) 
d  Evaluation criteria for kappa: poor = k < 0.40; fair = k of 0.40-0.59; good = k of 0.60-0.74; excellent = k > 0.74 
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Table 4: Test-retest intraclass correlation and Wilcoxon signed rank test 
IPQ-R HP subscales 4 weeks test-retest 
 intraclass correlation 
(95% CI) 
4 weeks test-retest  
Wilcoxon z score 
 (effect size*) 
 
Consequences  0.866 (0.618-0.957) -1.221 (-0.24)) 
Timeline acute/chronic 0.751 (0.364-0.917) -0.938 (-0.18) 
Personal control 0.444 (-0.116-0.790) -0.237 (-0.05) 
Treatment control 0.839 (0.553-0.948) -0.289 (-0.06) 
Illness coherence 0.713 (0.264-0.908) -1.086 (-0.21) 
Timeline cyclical 0.417 (-0.148-0.777) -0.843 (-0.17) 
Emotional representations 0.844 (0.567-0.950) -1.370 (-0.27) 
* Effect size: small = between 0.10 and 0.30; medium = between 0.30 and 0.50; large = 0.50 or higher 
 
4. Discussion  
The purpose of this study was to adapt and to perform a preliminary evaluation of the validity and 
reliability of the IPQ-R HP. At first sight, this IPQ-R HP has a good and acceptable face and content 
validity, and reliability. Experts judged the majority of the items as relevant. Item 4 and 10 were the 
only items with a poor or very low kappa value, indicating that these items are not valid to measure 
the construct, i.e. illness perceptions. Nonetheless, we decided to keep all items in the IPQ-R HP and 
did not omit item 4 and 10. The reason why we did not delete item 4 and 10 was that these low scores 
are probably due to the fact that a mix of professions, nurses and physicians, scored these items which 
means that they maybe gave a different meaning or interpretation to this. Only a confirmatory factor 
analysis can give information about items that certainly should be omitted. 
The internal consistency of the 7 dimensions was acceptable and the instrument had overall good 
scores for the reliability measurements except for the treatment control dimension. The treatment 
control dimension with an alpha value of 0.50 (calculated for all vignettes) was the lowest in 
comparison with the other dimensions.  Literature [33] states that possible reasons for a low value of 
alpha could be a low number of questions, poor interrelatedness between items or heterogeneous 
constructs. Therefore, we think that in our study  a combination of a low number of items -namely, 5 
items- and a low interrelatedness of these items are possible reasons why the treatment control 
dimension has the lowest alpha value in comparison with the other dimensions. On the other hand, 
experts in our study had the opinion that the items of the treatment control dimension were 
representative for this dimension at first sight and they also scored the content validity of this 
dimension as excellent. Probably a confirmatory factor analysis in a large sample of HPs can give us 
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more insight. By comparison of the alpha values of the study of Fleming et al. (2009) [21] with the total 
alpha values of our study, we found that our alpha scores were higher. A possible reason is that in our 
study at least 4 items per dimension are present. The study of Fleming et al. (2009) [21]had 2 items 
per dimension. Fleming et al. (2009) [21] not only calculated Cronbach’s alpha values, but went a step 
further and used factor analysis to determine the underlying structure of the IPQ that they modified. 
The authors stated that a six factor model was the most appropriate model in comparison with a five 
factor model or one-dimensional model. However, no extra information was given about the p-values 
or correlations between the items and construct (factor) in the model. Their shortcoming was also the 
limited number of items (2) per factor leading to a non-representative result. A strength was the 
sample size of 245 mental health practitioners which was sufficient for this kind of analysis. 
The strengths of our study are that we conducted this research in a group of physicians, head nurses 
and nurses employed in different medical disciplines and four hospitals. The sample size to measure 
the content validity was also much larger than previously used in similar studies [26]. The high response 
rate was probably due to the personal contact that we had before conducting the study. Another 
strength is that almost all physicians and head nurses considered the questions to be clear and 
providing a correct representation of the dimension at first sight. We were able to keep the original 
construction of the questions, which allows for matching with patients’ questionnaires at individual 
item level. The method of Lynn [26] is considered as an extensive method to evaluate the content 
validity and has shown valuable results. The results of both measurements, I-CVI and k* were in line 
with each other, with items not meeting the I-CVI criterion of 0.78 not showing excellent k* values and 
vice versa, indicating that both methods resulted in the same conclusion and were strengthening 
current evidence. For the reliability analyses we calculated the alpha value for each vignette 
separately. This gave us an idea about the amount of influence of the quality of the vignette on the 
reliability estimate and revealed that vignette 4 had the best alpha values. 
Shortcomings of this study concerning the validity measurements, is that the use of cognitive 
interviewing techniques asking physicians and head nurses about their reflections concerning the 
individual items would, have given more background information about questions that were not clear 
or were skipped. Another shortcoming was that the sample size was not large enough to compute a 
confirmatory factor analysis because we needed then a sample between 380-570 healthcare 
professionals (i.e. 10-15 respondents per item) [34]. A confirmatory factor analysis would give 
information regarding the unidimensionality of the subscales and also provides information about the 
relationship between each item and the subscale.  For the reliability measurements,   it was difficult to 
motivate the nurses to complete the 4 vignettes and it was even much more difficult to motivate them 
to complete one vignette for a second time. Therefore, we used vignette 4 for the retest, which was a 
good mix of clinical and psychosocial information and had also the highest alpha value. This could have 
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led to an overestimation of the intraclass coefficient because we used the vignette with the highest 
interrelatedness of items. Reasons for the low response rate were no time, too many questionnaires 
and too difficult vignettes. For planning further research, the number of the vignettes have to be taken 
into consideration.  
Another limitation was that the reliability estimates are based just on a sample of nurses.  It is 
unclear whether these results are generalizable to physicians because nurses and physicians differ in 
a variety of aspects like education, patient contact, responsibility for diagnostics and treatment.  As a 
last point to consider we want to mention that in the adaptation process of the IPQ-R to the IPQ-R HP 
we omitted the identity and causality dimensions of illness representations. Our reasoning was that 
these 2 dimensions are –in comparison with patients’ perceptions- more related with biomedical 
knowledge. A remark on this is on the one hand, that treatment decisions are often based on 
physicians’ representations of the identity and causal attributions dimensions and on the other hand 
it is possible that conflicts between patients and physicians arise when they differ in their opinions 
about which symptoms relate to a specific illness or which factors caused a particular disease.  
After a comprehensive validation process, we can explore the potential applications of this 
questionnaire in patient care.  This tool is useful for investigating the causes of misunderstandings and 
conflicts that have arisen between medical staff and patients. When differences in perceptions 
between patients and HPs are detected than these differences can be discussed using this tool by 
comparing the patient’s  and HP’s version with each other. In this way, HPs can reflect upon their own 
beliefs and how much it differs from patients’ beliefs. When HPs are aware of these differences they 
can work in a patient-centered manner during patient education sessions which means that some 
items or some dimensions can be a stepping stone to tailor information for a particular patient. With 
the IPQ-R HP areas of disagreement between patients’ and HPs’ perceptions can be pinpointed in a 
more detailed way which is an advantage because in this way the communication and shared 
understanding between HPs and patients can be enhanced. This is important because doctor–patient 
communication is a powerful indicator to achieve quality in care determining patients’ self-
management behavior and ultimately health outcomes [35,36].  
Practically, the patient can complete their version in the waiting room- this means before the doctor 
has seen him/her- and the doctor or other HP can complete the IPQ-R HP after the patient’s visit.  
These questionnaires can be completed in every setting, i.e. an inpatient or outpatient setting.  It is 
important that this happens when the HP has formed an idea about the patient’s physical and mental 
condition. The next stage is the comparison of these 2 instruments which can be done easily by the 
HP. We do not think it is useful to complete this questionnaire each moment the patient encounters 
an HP.  The completion of these instruments can have an added value especially at diagnosis and when 
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there is a flare or acute exacerbation of the patient’s condition because illness perceptions are 
relatively stable but may show some fluctuations at those time points [37]. 
In conclusion, the IPQ-R HP appears adequate and useful to assess the perception of healthcare 
professionals concerning the illness of an individual patient and produces -in this preliminary phase- 
reliable and valid output. A more extensive validation process is needed in a large cohort of healthcare 
professionals to explore the psychometric properties of this questionnaire prior to a widespread use 
in clinical practice. Moreover, a large cohort of healthcare professionals is needed to investigate the 
factor structure of the IPQ-R HP with the aim to determine which of the items best represent each of 
the illness perception dimensions. In this way it is possible to have more insight in the construct validity 
of the IPQ-R HP. 
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Table 2: Evaluation of the content validity of the IPQ-R for healthcare professionals 
a I-CVI (item content validity index) = number giving a rating of 3 or 4 / number experts    
b pc (probability of chance occurrence) = [N!/ A!(N-A)!] x 0,5N where  N = number of experts and A = number agreeing on good relevance 
c  k* = kappa designating agreement on relevance: k* = (I-CVI – pc) / (1 – pc) 
d  Evaluation criteria for kappa: poor = k < 0.40; fair = k of 0.40-0.59; good = k of 0.60-0.74; excellent = k > 0.74 
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Abstract  
Objective: Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc) are complex chronic auto-
immune diseases characterized by multiple organ involvement, comorbidities and complications. This 
complexity results in a need for a multidisciplinary management and treatment of SLE and SSc by 
physicians from a number of medical disciplines, all of who may have different perceptions concerning 
the condition of a particular patient. The aim of this study was to explore differences in physicians’ 
perceptions on the illness of SLE and SSc patients. 
 
Methods: Physicians from nine disciplines working at three hospitals in Belgium completed illness 
perception questionnaires for healthcare professionals based on 4 patient vignettes, i.e. 2 vignettes 
per disease (SLE-SSc). Statistical analysis was carried out by a k-means clustering technique for 
clustering physicians according to their illness perceptions.  
 
Results: Fifty physicians, 62% men with a mean age of 42.8 years (SD =11.3) and mean working 
experience of 12.7 years (SD=11.6), participated. For each disease, three clusters of physicians with 
different scores in illness perceptions were identified. For SLE, these clusters were specified as the 
‘optimistic’ group, the ‘realistic’ group and the ‘overwhelming impact by disease’ group. For SSc, the 
clusters were characterized as the ‘optimistic’ group, the ‘realistic’ group and the ‘skeptical’ group.  
 
Conclusions: We found divergent illness perceptions across physicians of the same and other 
disciplines. Our study yielded three clusters of physicians per disease with a large variability in illness 
perceptions. Further studies should focus on the factors that determine these differences and their 
consequences for patient care. 
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1. Introduction 
Systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) are chronic systemic auto-immune 
diseases characterized by multiple organ involvement and many related morbidities. For example, 
SSc patients experience a high disease burden with potential digital ulcers, dyspnea, fecal 
incontinence, and erectile dysfunction [1,2]. While, in SLE, Raynaud’s phenomenon, skin, kidney, and 
cerebral involvement might occur and SLE patients are at risk of cardiovascular complications and 
avascular necrosis. An eventual pregnancy poses specific challenges [3]. 
In practice, patients are treated by often prolonged and complex immunosuppressive 
strategies with regular monitoring. Yet, these diseases are driven by often insufficiently controlled 
inflammation and it is clear that the complexity of multiple organ involvement, comorbidities and 
complications implies that the treatment approach needs to be multidimensional by relieving 
symptoms, reducing and preventing organ dysfunction and slow down disease progression [4]. 
Moreover, besides the specific organ impact, literature shows that these diseases also have a 
considerable impact on the health-related quality of life of patients and their ability to carry out 
activities at home and at work due to for instance fatigue [5], pain (from digital ulcers, 
musculoskeletal pain, etc.) [6], decreased physical functioning in upper and lower extremities (caused 
by contractures, joint pain, skin tightness, Raynaud’s phenomenon, etc.) [7–10]. 
Thus, not only the drug treatment but also the global management of these two potentially 
devastating chronic diseases needs monitoring by a multidisciplinary team [11]. A multidisciplinary 
care team for SLE and SSc patients should involve healthcare professionals from different professions 
and different specialties, including physicians, specialist nurses, physical therapists, occupational 
therapists, psychologists, and social workers. The coordination of the care team may fall to a 
dedicated specialist, often a rheumatologist, who will act as the clinical architect, coordinating the 
care and referring the patient to and working together with multiple specialists of other disciplines 
who deal with organ-specific manifestations, comorbidities or complications [12]. 
However, physicians may hold certain views or perceptions about the condition of their 
patients, the disease characteristics, the treatment, and the prognosis, which, amongst other things, 
may be based on eminence or personal experience in daily clinical practice, on the frequency of 
patient contact, or on a broader focus of the physician than on only disease-specific characteristics 
such as an additional focus on quality of life and societal participation. Hence, a rheumatologist, who 
coordinates the care for systemic diseases, might perceive the illness of a patient with SLE and SSc in 
a different way compared to colleagues from other medical disciplines or colleagues of the same 
discipline involved in a multidisciplinary approach to care. 
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Such illness perceptions of physicians which are relatively enduring cognitive schemes that stimulate 
and guide action are important because on the one hand doctors’ explanations will affect patients’ 
thinking about their condition [13], and on the other hand differences in perceptions regarding the 
illness of a patient could adversely affect patient care or cause inconsistent advice, confusions, and 
misconceptions amongst patients and physicians. 
Despite the likely relevance of doctors’ illness perceptions for the management of patients 
with rheumatic conditions, relatively few studies have addressed this topic. One UK study [14] in 
rheumatoid hand surgery, detected differences in perceptions, related to the main indications and 
expected results for surgery between rheumatologists, surgeons, and therapists in every aspect of 
the procedure of management of the hand. Evidence from other disease specialties such as epilepsy 
and nonepileptic seizures describes [15] similar discrepancies between specialists from different 
disciplines. Neurologists perceived epilepsy as a more chronic condition and having a less emotional 
impact for the patient in comparison with psychiatrists. In the case of nonepileptic seizures, 
psychiatrists perceived less negative consequences of this condition for the patient than the 
neurologists do. These studies demonstrate the potential for problems with communication, 
treatment, and outcome, which might arise as patients are referred from one specialty to the other. 
Currently, no evidence on differences in perceptions of systemic diseases between physicians 
from several disciplines is available. For this purpose, we sought to gather more insight in the 
perceptions of different medical specialists concerning the illness of a patient with SLE and SSc. The 
aim of this study was to explore differences in physicians’ perceptions on the illness of patients with 
SLE and SSc in a current practice setting in Belgium. 
 
2. Methods 
Procedure 
Until now, patient vignettes were mostly used in the literature for measuring clinical decision making 
and the efficiency of clinical care [16,17]. In this study, we used patient vignettes, as a novel technique 
to get more insight in the cognitive and emotional representations of physicians about a particular 
patient with SLE or SSc. 
Four patients—two patients with SLE and two patients with SSc—who are currently followed 
in our outpatient clinic, were selected by two researchers (SA and RW) based on their multiple organ 
involvement and comorbidities. Vignettes, which focused on the whole person with a disease, were 
constructed based on these patients’ clinical condition, complications, antibody profile, the current 
and previous medical treatment, and the psychosocial situation. The accuracy and correctness of each 
80 |CHAPTER 4 
 
vignette was separately reviewed by the respective patients whose names were changed for 
anonymity reasons. A description of the vignettes is available as an additional file (see Appendix 1). 
Between October 24, 2014 and January 31, 2015, physicians employed in the largest 
university hospital and two of the largest general hospitals in Belgium were approached for 
participation. The physicians approached were from nine medical disciplines: rheumatology, 
cardiology, pulmonology, gynecology, internal medicine, nephrology, ophthalmology, dermatology, 
and gastroenterology. Postal questionnaires and 4 patient vignettes together with a pre-stamped 
return envelope were sent to physicians. Electronic reminders were sent 14 and 28 days after sending 
the questionnaires. 
The inclusion criteria were that physicians had to be certified in their specialty or in the last 2 
years of their specialist training, and had a former experience with SLE or SSc patients. We choose a 
convenience sampling technique because many different physicians may take an interest in the care 
for patients with systemic diseases. 
Measures 
Demographic questionnaire 
Age, gender, frequency of contact with SLE or SSc patients, years of working experience and hospital 
of employment were recorded. 
 
Revised Illness Perception Questionnaire for Healthcare Professionals (IPQ-R HP) 
Each physician was asked to read each of the four vignettes and to answer the IPQ-R HP that 
accompanied each vignette. The IPQ-R HP [18]is an adapted version of the IPQ-R [19] for healthcare 
professionals (HP). The IPQ-R HP is a 38-item questionnaire rated on a 5-point Likert scale (1 = 
“strongly disagree”—5 = “strongly agree”) and captures seven dimensions: (1) consequences of the 
illness for a particular patient as assessed by the HP; (2) timeline acute/chronic: the HP’s perception 
about the illness passing quickly or not in a particular patient; (3) personal control: the HP’s 
perception of the patient’s ability to control the illness; (4) treatment control: the HP’s perceptions 
about the effectiveness of any treatment or approach to control the illness in a particular patient; (5) 
illness coherence: the HP’s perception of the extent to which a particular patient understand his/her 
illness; (6) timeline cyclical: the HP’s perception of the cyclical nature of the illness across time; and 
(7) Emotional representations: the HP’s perception of the patient’s emotional experience of their 
illness. 
The IPQ-R HP has an acceptable to good face and content validity, internal consistency, and test–
retest reliability [18]. 
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Statistical analysis 
Descriptive analyses were carried out with Excel version 2010. A k-means clustering technique was 
performed to identify groups of physicians according to their illness perceptions [20,21]. Prior to 
cluster analysis, the mean z-scores of the seven illness perception dimensions of the IPQ-R HP were 
calculated. 
The process begins by choosing k observations to serve as the center of each proposed cluster. 
Then, the distance from each of the other observations is calculated for each of the k clusters, and 
observations are put in the cluster to which they are the closest. After each observation has been 
assigned to a cluster, the center of the clusters is recalculated, and every observation is checked to 
see if it might be closer to a different cluster. This is an iterative process until convergence. The cluster 
analysis was conducted separately for both diseases and was carried out with SAS version 9.4. The 
further labeling of the clusters was based on thematic analysis. This means that patterns across data 
were identified, analyzed, and reported by two authors (SA and RW). 
 
Ethical approval 
All procedures performed in studies involving human participants were in accordance with the ethical 
standards of the institutional and/or national research committee and with the 1964 Helsinki 
declaration and its later amendments or comparable ethical standards. Ethical approval was obtained 
from the Institutional Review Board of the University Hospital and the local ethics committee of the 
participating centers (IDnr. B322201421473). 
 
3. Results 
Descriptive analysis 
Questionnaires were sent to 284 physicians of whom 81 responded. Compared to non-responders, a 
greater proportion of those who responded were male (63.3 vs 50.3%). No other data are available. 
Of these 81 physicians, 50 were eligible for participation in the study (see Fig.1). 
 
Flow diagram of inclusion procedure 
The demographic data of the 50 participating physicians and their distribution per discipline are 
presented in Table1 Ten physicians were in the last 2 years of their specialist training. The sample 
consisted of 31 men and 19 women with a mean age of 42.8 years (SD 11.3) and a mean working 
experience of 12.7 years (SD 11.6). Nine physicians (19.2%) had contact with SLE or SSc patients 
several times a week and 16 patients (34%) several times a year. A total of 13 rheumatologists were  
employed at the three hospitals, of those, 5 (38%) took part in the study.  
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Figure 1: flow diagram of inclusion procedure 
 
Table 1: Demographics and distribution of all participating physicians 
All medical specialists N= 50 
Gender (n) 
Men  
Women  
  
31 (62.0%) 
19 (38.0%) 
Age (in years), mean +/- SD 42.8 +/-11.3 
Work experience (in years)*, mean +/- SD 12.7+/-11.6 
Frequency of contact with SLE or SSc patients ° (%) 
Several times a week 
Once a week 
Several times a month 
Once a month 
Several times a year 
Once a year 
  
9 (19.2%) 
6 (12.8%) 
5 (10.6%) 
8 (17.0%) 
16 (34.0%) 
3 (6.4%) 
Hospital  (n) 
University Hospital 
General hospital 1 
General hospital 2 
  
26 (52.0%) 
10 (20.0%) 
14 (28.0%) 
Distribution per discipline (n) 
Rheumatology 
Cardiology 
Pulmonology 
Nephrology 
Gastroenterology 
Internal medicine 
Dermatology 
Ophthalmology 
Gynaecology 
 
5 (10.0%) 
4 (8.0%) 
2 (4.0%) 
11(22.0%) 
5 (10.0%) 
6 (12.0%) 
5 (10.0%) 
7 (14.0%) 
5 (10.0%) 
  *calculated on n= 40; °calculated on n= 47 
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Main analysis 
Description of the clusters 
Cluster analysis revealed three clusters of physicians’ perceptions per disease (SLE-SSc). The mean z-
scores of the illness perception dimensions of the three obtained clusters per disease are shown in 
Figs. 2 and 3, respectively. 
 
Mean z-scores of the illness perception dimensions per cluster for SSc 
For SLE, the physicians in cluster 1 (42%) reported less severe consequences of the disease for the 
patient, less emotional impact and believed that the disease was clearly understood by the patient. 
They also perceived the time course of SLE as more acute and less recurrent and had the opinion that 
the patient herself and the treatment can control the illness. Cluster 1 was called the ‘optimistic’ 
group. Cluster 2 (36%), reported more severe consequences of the disease for the patient and a more 
chronic, and cyclical disease course. These physicians perceived SLE as controllable by the patient but 
less so by treatment. They also reported an emotional impact of SLE on the patient and less 
understanding of SLE by the patient. This cluster was specified as the ‘realistic’ group. Cluster 3 (22%) 
reported less severe consequences of SLE for the patient and a more acute and less recurrent disease 
course. These physicians perceived SLE as less controllable by the patient and by the treatment and 
had the opinion that the patient does not fully understand her illness. Furthermore, they perceived a 
high emotional impact of SLE for the patient, which was the reason why we identified this cluster as 
the ‘overwhelming impact of disease’ group. 
For SSc, cluster 1 (22%) comprised the physicians who reported less severe consequences due 
to SSc for the patient; a time course that was perceived as acute but recurrent; less emotional impact 
of the illness. They also felt that the condition could be controlled by the patient and by treatment 
and held the opinion that the patient has a clear understanding of SSc. To this end, we specified this 
cluster as the ‘optimistic’ group. Cluster 2 (42%), reported more severe consequences for the patient 
due to SSc. Physicians believed that SSc had a chronic time course with a cyclical nature and somewhat 
believed that it could be controlled by the patient and by the treatment. They also believed that 
patients understood their SSc. Cluster 2 was called the ‘realistic’ cluster. Cluster 3 (36%) describes the 
perception of some consequences of SSc for the patient, the chronicity and noncyclical time course; 
the perception that the patient has less personal control and less control by treatment; a less 
emotional patient with some understanding of SSc. Cluster 3 was labeled as the ‘skeptical group’. 
Cross-tabulation of cluster membership between the diseases showed that 15 physicians who 
were assigned to the SLE realistic group were also in the SSc realistic, suggesting good correspondence 
between the physicians in both disease groups. Just eight physicians of those in the SLE optimistic 
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group were also present in the SSc optimistic group, suggesting little concordance between these 
groups. 
 
Figure 2: Mean z-scores of the illness perception dimensions per cluster for SLE 
 
 
Figure 3: Mean z-scores of the illness perception dimensions per cluster for SSc 
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Characteristics of the physicians per cluster 
The descriptive analysis and distribution per specialism of the three obtained clusters are shown in 
Tables 2 and 3, respectively. 
For SLE, in the ‘optimistic’ group, the proportion of men and women was almost equal, with 
a mean age of 39 years (range 27–35) and a mean of 9 years of working experience (range 0–35). In 
the ‘realistic’ group, 72% men, with a mean age of 48 years (range 32–66) and a mean working 
experience of 18 years (range 0–46) were detected. In the ‘overwhelming impact of disease’ group, 
64% male physicians with a mean age of 42 years (range 27–59) and a mean of 11 years of working 
experience (range 0–30) were present. Three of the five ophthalmologists were present in the 
‘optimistic’ group. The ‘realistic’ group comprises three of the five rheumatologists and the 
distribution of the dermatologists and internists was the largest (3/5) in the ‘overwhelming impact of 
disease’ group. 
For SSc, in the ‘optimistic’ group, 64% of the physicians were male with a mean age of 40 years 
(range 27–55) and a mean of 10 years of working experience. In the ‘realistic’ group, 76% were men 
with a mean age of 44 years (range 27–66) and a mean working experience of 14 years (range 0–46). 
In the ‘skeptical’ group, 56% women with a mean age of 44 years (range 28–65) and a mean working 
experience of 13 years were present (range 0–35). The distribution per specialism was as follows: the 
‘optimistic’ group consisted of the two pulmonologists but none of the rheumatologists. The ‘realistic’ 
group comprised three of the five rheumatologists, dermatologists and gastroenterologists. Finally, 6 
of the 11 nephrologists were present in the ‘skeptical’ group. 
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Table 2: Descriptive analysis and distribution per specialism of the 3 obtained clusters for SLE  
 Cluster 1 
Optimistic group 
Cluster 2 
Realistic group 
Cluster 3 
Overwhelmed by 
disease group 
N 21 18 11 
Age, mean (range) 39 (27-65) 48 (32-66) 42 (27-59) 
Females (%) 48 28 36 
Years’ experience, mean (range) 9 (0-35) 18 (0-46) 11 (0-30) 
Frequency of patient contact* 4 (1-6) 4 (1-6) 4 (1-6) 
Dermatologists (n=5) 1 1 3 
Ophthalmologists (n=7) 5 2 0 
Gynecologists (n=5) 3 2 0 
Rheumatologists (n=5) 2 3 0 
Internists (n=6) 1 2 3 
Cardiologists (n=4) 2 2 0 
Pulmonologist  (n=2) 1 1 0 
Nephrologists (n=11) 4 3 4 
Gastroenterologist (n=5) 2 2 1 
 
 
Table 3: Descriptive analysis and distribution per specialism of the 3 obtained clusters for SSc 
 Cluster 1 
Optimistic group 
Cluster 2 
Realistic group 
Cluster 3 
Skeptical group 
N 11 21 18 
Age, mean (range) 40 (27-55) 44 (27-66) 44 (28-65) 
Females (%) 36 24 56 
Years’ experience, mean (range) 10 (0-25) 14 (0-46) 13 (0-35) 
Frequency of patient contact* 4 (1-6) 4 (1-6) 3 (1-6) 
Dermatologists (n=5) 0 3 2 
Ophthalmologists (n=7) 3 3 1 
Gynecologists (n=5) 2 2 1 
Rheumatologists (n=5) 0 3 2 
Internists (n=6) 1 2 3 
Cardiologists (n=4) 1 2 1 
Pulmonologist  (n=2) 2 0 0 
Nephrologists (n=11) 2 3 6 
Gastroenterologist (n=5) 0 3 2 
*1= once a week; 2= several times a week; 3= once a month; 4= several times a month; 5= once a year; 6= several times a year 
  
 
*1= once a week; 2= several times a week; 3= once a month; 4= several times a month; 5= once a year; 6= several times a year
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4. Discussion 
The aim of this study was to explore differences in physicians based on their perceptions of patients 
with SLE and SSc, using patient vignettes as a novel technique. We observed a large variability in 
illness perceptions among physicians from different disciplines and within physicians of the same 
discipline. Differences in illness perceptions of physicians were not based on the frequency of patient 
contact. 
Closer inspection of the clusters based on the SLE vignettes revealed that physicians who 
belong to cluster 1 are more optimistic about the disease than the physicians in the two other clusters. 
A possible explanation for this is that they underestimate the severity and burden of this illness and 
are less familiar with SLE compared to their colleagues. They have the lowest years of working 
experience and are younger in comparison with the two other clusters. The same is applicable for the 
SSc vignettes. 
Most of the rheumatologists are situated in the ‘realistic’ group for both SLE and SSc vignettes. 
For the SSc vignettes, the ‘realistic’ group had the best understanding of SSc, with the most years’ of 
experience and was characterized by the least female physicians in comparison with the other 
clusters. We suppose that the ‘realistic’ group has another view in comparison with the other clusters 
because of more clinical experience and focus on psychosocial aspects. For the SLE vignettes, cluster 
3 was called the ‘overwhelming impact of disease’ group because we assumed that the perceptions 
of these physicians are more driven by their perception that SLE has an overwhelming emotional 
impact on the patient. The latter cluster had some comparable perceptions with the perceptions of 
last-year medical students in the recent study of Nowicka-Sauer et al. [22]. In this study, doctors-to-
be perceived SLE as being less controllable, more burdensome, having more consequences, more 
symptoms and more emotional impact. Cluster 3 of the SSc vignettes was called the ‘skeptical’ group 
because these physicians seemed somewhat doubtful or uncertain of the impact of the disease on 
the patient in comparison with the other two groups of physicians. 
This study is one of the few to investigate the cognitive basis of physicians’ perceptions of 
patients with rheumatologic conditions. Although evidence from all pathologies is limited, and the 
use of different methodologies or analysis techniques makes it difficult to compare study results, it is 
increasingly recognized that there are discrepancies in illness perceptions between medical staff from 
different disciplines. For instance, compared to oncology nurses, radiation therapists, overestimated 
the impact of treatment for, and perceived duration of, breast cancer [23]. In the study of Dickman 
et al.[24], doctors perceived irritable bowel syndrome and inflammatory bowel disease as more 
chronic, having less severe consequences and being less understandable for the patients than the 
nurses did. Moreover, staff working in a neuroscience ward have been shown to have a greater 
understanding of epilepsy and psychogenic nonepileptic seizures in comparison to emergency care 
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staff. The latter staff perceived psychogenic nonepileptic seizures as less chronic in comparison with 
the neuroscience staff[25]. 
There are a number of strengths and limitations of this study which should be considered. 
First, our use of case-based study research implies that generalizability may be limited. However, we 
chose to use vignettes as a tool for measuring illness perceptions, because previous evidence has 
shown that certain concepts such as perception, health or freedom are sometimes defined more 
clearly with reference to real-life patient examples [26]. Moreover, it would not have been possible 
to explore the views of different physicians who care for the same patient in a real-world setting 
because it is not realistic to investigate this for each individual patient. 
Another limitation is that the sample was limited to physicians and that other healthcare 
professionals such as specialist nurses, physical therapists, social workers, psychologists, etc., were 
not included in the study. That being said, the participating physicians are a representative sample of 
physicians who were employed in the largest university hospital and two of the largest general 
hospitals in Belgium and likely to be actively treating patients such as those described in the vignettes. 
That said, some physicians had an infrequent exposure to these patient populations. There was no 
problem of selection bias because the sample of physicians, who have knowledge and expertise in 
these patient populations, was representative for Belgium. Belgium is a small country and in the 
hospitals that we contacted there were not many doctors with expertise in SLE or SSc. Second, we 
choose to use paper surveys instead of email surveys and used a personalized covering letter in order 
to enhance participation. Reminders were sent via email and the rheumatologists from the two 
general hospitals were also asked to stimulate participation. 
The existence of these different physician profiles has consequences for daily clinical practice 
because when physicians with different beliefs about illnesses are responsible for giving information 
about the course, consequences and controllability of these diseases to patients discrepancies or 
confusions may arise. If physicians give distinct, wrong or insufficient information, based on their own 
perception, the communication between the patient and the doctor may be impacted, leading to 
mistrust [27]. Moreover, discrepancies between medical professionals’ perceptions and their 
attitudes and patients’ attitudes may affect patients’ subsequent health behavior [28]. 
This raises the question about who is the best to coordinate these pathologies and how 
patient care should be managed and planned posing of course a fundamental challenge in organizing 
care by several physicians for these entities. Evidence about physicians’ perceptions concerning the 
organization of care for patients with SLE and SSc is scarce. Only one viewpoint article [29] described 
a fictional debate between a dermatologist and rheumatologist about the management of SLE 
patients with a discrepancy between these two physicians on who can handle lupus patients best. In 
Belgium and other European countries, a certification of specialization in SSc or SLE does not exist. 
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This means that evaluating perceptions only in doctors specialized in SSc and SLE does not make 
sense. Nevertheless, we assume that a solution for the evaluation and treatment of complex systemic 
diseases such as SLE and SSc would be the organization of centers that can function as reference or 
expert centers and where integrated care is developed and guided. 
In conclusion, our study has shown that physicians from a number of disciplines hold different 
perceptions on the consequences, controllability, time course, and emotional impact of these two 
rheumatic diseases. This highlights the need for healthcare providers to consider how best to manage 
and plan, not only patient treatment, but also patient communication. Although it is clear that careful 
consideration should be given to the consequences for organizing future care in these multisystem 
diseases to enhance the quality needs, we also propose that further research should focus on 
differences in perceptions between different health care professionals such as specialist nurses, 
psychologists, etc., to better understand factors that influence differences in perceptions and their 
consequences for patient care. 
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Appendix 1: Description of the four patient vignettes 
-The first vignette describes a 28-year old Systemic Lupus Erythematosus (SLE) patient with a positive 
auto-antibody profile, proteinuria and lupus nephritis. She develops an epileptic attack and medication 
is started by her treating physician for the epileptic attack and lupus nephritis. Hereafter, her condition 
stabilizes. The patient herself wants a dose reduction of the anti-epileptic medication but is also afraid 
for a new epileptic attack after the dose reduction. 
-The second vignette describes a 38-year old man who develops diffuse Systemic Sclerosis (SSc) with 
organ involvement more specifically the heart, lungs and muscles are involved. He has also a more 
progressive skin fibrosis due to his condition. Medication to stop disease progression is started but his 
physical condition deteriorates. The organ involvement spreads with chronic diarrhea and erectile 
dysfunction as a result. After intravenous infusions of a biological medication, disease activity stabilizes 
and he can fulfill his daily activities. Currently, he works part-time in an administrative function. His 
functionality and coping with his chronic condition improved.     
-The third vignette is about a 35-year old women, diagnosed with SLE, and who develops 9 years after 
diagnosis, lupus nephritis. Medication has been started but the renal function deteriorates. This 
patient has a relationship and an 8-year old son. She works fulltime as a shop assistant. At the last 
consultation she had no complaints due to her disease except some fatigue. Her medication was 
switched because of a pregnancy wish.  
-The fourth vignette is concerning a 42-year old patient diagnosed with diffuse SSc and interstitial lung 
disease. A year after diagnosis, she complains of dyspnea, coughing and itching. The coughing is very 
disturbing because of social isolation. Two years after the diagnosis of SSc her lung function 
deteriorates. After several intravenous infusions of a biological medicine, her disease activity does not 
improve and her treating physicians decide to conduct autologous stem cell transplantation. Hereafter, 
her quality of life improves but she finds it difficult to cope with the uncertainty of her future and the 
unpredictability of her disease. At this moment, she has no relationship but gets most of the emotional 
social support from her brothers and friends.  
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Abstract  
Objective: Discrepancies in illness representations between patients and physicians result in 
treatment difficulties, decreased well-being of patients, but also to misunderstandings and disrupted 
communication. Hence, the objective of this study was to compare illness perceptions of individual 
patients with systemic lupus erythematosus (SLE) and systemic sclerosis (SSc), their rheumatologists 
and their GPs and explore potential differences. 
 
Methods: This study has a cross-sectional design. Patients with SLE and SSc, who were followed at the 
rheumatology department of the University Hospitals Leuven (Belgium), completed the revised Illness 
Perception Questionnaire (IPQ-R) which measures patients’ perceptions of their condition and 
captures 9 dimensions. Physicians completed the Revised Illness Perception Questionnaire for 
Healthcare Professionals (IPQ-R HP) which consists of 7 dimensions and measures perceptions of the 
healthcare professional regarding the disease of their patients. Intraclass correlation was performed 
to examine relationships between pairs of respondents; Cohen’s d for estimating the magnitude of the 
difference. 
 
Results: Questionnaires were sent to 284 patients of whom 241 (113 SSc and 128 SLE patients) were 
included. Five rheumatologists and 160 GPs participated. For both diseases, positive correlations 
were found for ‘consequences’, ‘illness coherence’ and ‘emotional representations’ between 
patients, rheumatologists and GPs. GPs scored higher on the ‘consequences’ of these diseases for the 
patient (d=0.71 for SLE; d=0.80 for SSc). Differences between rheumatologists and GPs were small for 
SSc and moderate to large for ‘consequences’ (d=0.56) and ‘timeline acute/chronic’ (d=0.95) in SLE 
with higher scores for GPs. 
 
Conclusions: For both diseases and between the 3 groups significant correlations are detected for 
the dimensions ‘consequences’, ‘illness coherence’ and ‘emotional representations’. Differences 
between rheumatologists and GPs were mainly detected in the case of SLE patients. This can have 
implications for the collaboration between these two groups of physicians in daily clinical practice. 
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1. Introduction  
Systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) are severe and complex chronic  auto-
immune diseases characterized by multiple organ involvement, a heterogeneous presentation and an 
unpredictable disease course often leading to important morbidity and mortality.[1,2] Both diseases 
can have an important impact on patients’ quality of life and the ability to carry out activities at home 
or at work due to pain, decreased physical functioning, fatigue and dyspnea. [3–6] These progressive 
or recurrent symptoms might influence the perceptions patients have about their condition.  
Ideas about illness are an essential part of the self-regulation model, which proposes that 
behavior in relation to illness depends on an individual’s perception or representation of his/her 
condition. In this model, Howard Leventhal and colleagues (1984)[7] postulated that illness 
representations consist of five elements:  identity (symptoms), cause, consequences (effects on life), 
time line (duration), and controllability or cure of the condition. Studies in patients with SLE have 
demonstrated that illness perceptions are related to outcomes such as  changes in psychological well-
being over time [8], sexual (dys)functioning[9], (non-)adherence to therapy [10] and in SSc with 
physical and mental health but not with disease related characteristics. [11,12]  
Most studies only focus on patients’ illness perceptions and their association with clinical or 
patient-related outcomes[13] but the extent to which healthcare providers’ ideas about the 
consequences of a chronic disease in specific patients match with those expressed by individual 
patients, is unknown. This could be important because the management of SLE and SSc requires a 
therapeutic relationship between patients and providers over years, which makes adequate health 
care a joint responsibility of both providers and patients. Moreover, it is possible that because of this 
relationship for years, physicians’ perceptions can be influenced by patients and vice versa.  
In one of the first studies [14] describing beliefs about arthritis in patients and physicians (most 
of them were rheumatologists), differences were detected about what physicians think patients 
believe and what patients actually believe about causes of arthritis or what helps in arthritis. In a study 
about epilepsy and seizure disorders, there were differences between the illness perceptions of 
patients and their doctors, especially about the controllability of the condition, which could represent 
barriers to successful clinical management[15]. In another study about breast cancer[16], medical 
professionals’ perceptions of the consequences of treatment and duration of cancer did not match 
patients’ beliefs: oncology nurses underestimated, whereas radiation therapists overestimated the 
impact of treatment and perceived duration of the disease. A study in osteoarthritis and diabetes 
showed that incongruence in patients and general practitioners’ perceptions regarding stressors 
accompanying chronic disease  is larger in diseases with a less clear treatment policy and may influence 
healthcare use and physical and mental functioning [17].  
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So, detecting discrepancies between healthcare providers and patients is of utmost 
importance because these may lead to problems in treatment, decreased well-being of patients [18], 
but also to misunderstandings and disrupted communication [17,19,20]. Differences in illness 
perceptions between patients with systemic auto-immune diseases, rheumatologists and general 
practitioners (GPs) are likely to be relevant because the knowledge and disease-related experience of 
these 3 groups is different. This is the first study to investigate these differences and to attempt a 
direct comparison between physicians and  particular patients with SLE and SSc they care for. Hence, 
the aim of this study was to investigate similarities and differences in illness perceptions of individual 
patients with SLE and SSc with that of their rheumatologists and GPs.  
 
2. Methods 
Design  
The present study has a cross-sectional design. However, it was part of a larger longitudinal project in 
patients with SLE and SSc. This study has been registered in clinicaltrials.gov with IDnr. NCT02655640. 
The data for the current evaluation where those collected at baseline between November 2015 and 
February 2016. 
 
Study population 
The study population consisted of patients, rheumatologists and GPs. A total of 284 patients with SLE 
and SSc, who were in follow-up at the University Hospitals Leuven (Belgium) and fulfilled the inclusion 
criteria, were approached and invited for participation. The inclusion criteria were as follows: the 
patient’s medical and cognitive condition allows him/her to complete questionnaires; the patient has 
no severe psychiatric problems; the patient is proficient in Dutch and able to complete the 
questionnaires in Dutch. The five rheumatologists who were asked for participation worked at the 
systemic diseases care program at the rheumatology department of the University Hospitals Leuven. 
In addition to the rheumatologists, also the patients’ GPs were asked to participate.  
 
Procedure 
Patients received a letter with information about the goal of the study, a questionnaire pack and an 
informed consent form together with a pre-stamped envelope. Patients were asked to complete the 
informed consent and the questionnaire pack and return it within 2 weeks.  
After the patients gave informed consent, the treating rheumatologist and GP of each patient were 
approached. The physicians were asked to fill out an illness perception questionnaire developed for 
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healthcare professionals after completing an informed consent form. While completing the 
questionnaire, they had to rely on the most recent medical and psychosocial situation of the patient. 
The physicians were requested to complete the questionnaires as soon as possible after the patient 
consulted them. A maximum interval of 6 months between the consultation of the patient and 
completion of the questionnaire by the physician was allowed. Additionally, for both patients and 
physicians 3 reminders were sent after 3 weeks, 5 weeks and 7 weeks. After 9 weeks, patients were 
contacted by telephone if they were persistent non- responders.  
 
Measures 
Demographic characteristics 
Age, gender, educational level, employment status, social status and living situation were collected 
from SLE and SSc patients (see Table 1). 
 
Clinical data 
Disease duration and disease activity were measured. In SLE patients, disease activity was assessed by 
the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score with the Safety of Estrogens 
in Lupus Erythematosus National Assessment (SELENA) modification (i.e. SELENA-SLEDAI).[21] The 
SLEDAI is a valid and reliable index,  which measures disease activity within the last 10 days [22] 
including 24 weighted objective clinical and laboratory variables. Disease activity can range from 0 to 
105. The following activity categories have been defined on the basis of SLEDAI scores: no activity 
(SLEDAI=0), mild activity (SLEDAI=1–5), moderate activity (SLEDAI=6–10), high activity (SLEDAI=11–19), 
very high activity (SLEDAI≥20)[23].  
In SSc patients, the SSc disease activity index (2003)[24] was used for measuring disease 
activity. This is a preliminary validated index to assess disease activity in SSc which consists of clinical 
and laboratory measures of disease activity as well as measures of disease activity being assessed by 
the patient only. It captures 10 weighted measures and the scores have a range from 0-10. SSc is 
considered to be active if the disease activity is ≥ 3. 
 
Illness perceptions of patients and physicians 
Patients completed the Dutch version[25] of the revised Illness Perception Questionnaire (IPQ-R) 
developed by Moss-Morris and colleagues.[26] This questionnaire measures perceptions of patients 
regarding their disease and consists of 9 dimensions or subscales: an illness identity dimension, 7 illness 
perception subscales and a causal attributions dimension. It has demonstrated good reliability and 
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validity across several illness groups and is one of the most widely applied instruments for assessing 
perceptions about illness.[27] 
For the purpose of this study, we only used the 7 illness perception subscales (38 items) that 
include views about how long the disease will last (timeline acute/chronic); the recurrent nature of the 
condition (timeline cyclical); perceived consequences of the condition; perceptions of personal control 
and treatment control; patient’s overall illness comprehension (illness coherence);  and emotional 
representations. The items for all subscales are rated by the patient on a 5-point Likert scale from 1 
(‘strongly disagree’) to 5 (‘strongly agree’). Scores were calculated as the sum of the items per scale 
(as in the original publication). 
The physicians completed the Revised Illness Perception Questionnaire for Healthcare 
Professionals (IPQ-R HP)[28]. The IPQ-R HP [28] is an adapted version of the IPQ-R[26]  which is devised 
to be completed by healthcare professionals (HP). It is a 38-item questionnaire rated on a 5-point Likert 
scale from 1 (‘strongly disagree’) to 5 (‘strongly agree’) and consists of the same 7 dimensions as 
described above. The key characteristic of the IPQ-R HP is that healthcare professionals are asked to 
indicate what they think that the perceptions of the particular patient are. Sample items read as: “The 
illness of my patient has major consequences on his/her life; “The illness of my patient will last for a 
long time”; or “The symptoms of the condition of my patient are puzzling to him/her”. 
 
Statistical analysis 
Sociodemographic variables, clinical variables and self-reported data from the questionnaires were 
summarized using descriptive statistics such as frequencies, means and standard deviations (SDs). To 
check the normality of the data the Kolmogorov-Smirnov test was used. 
Intraclass correlation was performed to examine agreement between the 3 groups of 
respondents regarding the 7 illness perception dimensions: rheumatologists and their patients; GPs 
and their patients; rheumatologists and GPs. Cut-off values for the intraclass correlation are: trivial: 
<0.1; small: 0.1–0.29; moderate: 0.3–0.49; large: 0.5–0.69; very large: 0.7–0.89; almost perfect: 
>0.9[29].  
A paired t-test was conducted to detect differences in these 7 dimensions between the 3 pairs 
of respondents as described above. The choice for a paired t-test was made on the basis of the 
distribution of the data and the link between patients and physicians; and rheumatologists and GPs. In 
addition, to appraise the magnitude of potential differences in perceptions between the groups, 
Cohen’s d was calculated to estimate how large the difference was between the mean scores on the 
dimensions for each group. The cut-off values for Cohen’s d are as follows: small= 0.20-0.50; medium= 
0.50-0.80; large= ≥0.80 [30]. 
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Analyses were carried out with Statistical Package for the Social Sciences, SPSS version 24.0 (SPSS, Inc., 
Chicago, IL, USA).  
Ethical approval 
Ethical approval was obtained from the Institutional Review Board of the University Hospitals Leuven 
(IDnr. B322201526067).  
 
3. Results 
Respondents 
Questionnaires were sent to 284 patients who fulfilled the inclusion criteria,  of which 241 participated 
(113 SSc patients and 128 SLE patients). The 5 rheumatologists and GPs of these  patients were also 
asked for participation. The rheumatologists completed together a total of 229 questionnaires. A total 
of 240 GPs received questionnaires, 160 of which returned completed questionnaires (response rate= 
66.7 %) (See Figure 1 for detailed information). The demographic and clinical information of the 
patients is shown in Table 1.  
The group of the rheumatologists consisted of 2 women and 3 men. The group of the GPs 
consisted of 99 men and 61 women. The gender distribution in the group of the non-responders was 
comparable to that of the responders (60.0% vs 61.9%). No information on other characteristics was  
available. 
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Figure 1: Flow diagram of inclusion procedure patients and physicians 
   Patients                          Physicians  
          Rheumatologists               General Practitioners 
        
 
                                                                                                 
 
n=43 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                  
Gave consent for participation 
      n=243 
 
  
           Included sample 
     n=241 
 
SLE= 128     SSc= 113 
Fulfilled inclusion criteria 
  n= 284 
 
5 rheumatologists 
received questionnaires 
of 241 patients 
240 GPs received 
questionnaires 
Sent blank 
questionnaire: n=2 
Declined participation:  
n=41 
-no reason: n=23 
-not able to complete  
  Dutch questionnaire:     
  n=3 
-not in follow-up: n=3 
-not reachable: n=3 
-other severe health  
 problem: n=4 
-survey fatigue: n=2 
-died: n=2 
-abroad: n=1 
 
 
 
Completed questionnaires       
n=229 
80 did not complete 
questionnaire 
 -no reason: n=65 
- following reasons (n=15): 
    no contact with 
         patient: n=11    
    difficulty with  
completion because of 
complexity of condition or 
relative of patient: n=3 
   died: n=1 
160 GPs returned completed 
questionnaires  
12 questionnaires 
were not completed 
because last 
consultation was > 6 
months ago 
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Table 1: Demographic and clinical characteristics of patients 
 Systemic sclerosis 
(n=113) 
Systemic lupus erythematosus 
(n=128) 
Gender 
Women (n-proportion) 
 
n=76     (67.3%) 
 
n=123   (96.1%) 
Age in years (mean-SD) 60.17 (±10.82) 46.28 (±14.97) 
Social status (n-proportion) 
Married 
Cohabitation 
Single 
Divorced 
Widow 
Other 
 
83 (73.5%) 
3 (2.7%) 
8 (7.1%) 
12 (10.6%) 
7 (6.2%) 
/            / 
 
78 (60.9%) 
23 (18.0%) 
11 (8.6%) 
9 (7.0%) 
5 (3.9%) 
2 (1.6%) 
Living situation (n-proportion) 
Living alone 
Cohabitation with partner & kids 
Cohabitation with partner 
Cohabitation with kids 
Cohabitation with friends 
Other 
 
20 (17.7%) 
24 (21.2%) 
59 (52.2%) 
4 (3.5%) 
3 (2.7%) 
2 (1.8%) 
 
16 (12.5%) 
46 (35.9%) 
53 (41.4%) 
6 (4.7%) 
7 (5.5%) 
/             / 
Education (n-proportion) 
Primary school 
Secondary school 
Bachelor degree 
Master degree 
 
21 (18.6%) 
68 (60.2%) 
17 (15.0%) 
7 (6.2%) 
 
10 (7.8%) 
58 (45.3%) 
41 (32.0%) 
18 (14.1%) 
Work status (n-proportion) 
Fulltime 
Part-time because of illness 
Part-time (personal choice) 
Retired  
Student 
Unemployed 
Disablement benefit 
Sickness benefit 
Other 
 
14 (12.4%) 
7 (6.2%) 
3 (2.7%) 
49 (43.4%) 
/             / 
2 (1.8%) 
18 (15.9%) 
8 (7.1%) 
12 (10.6%) 
 
33 (25.8%) 
13 (10.2%) 
16 (12.5%) 
20 (15.6%) 
6 (4.7%) 
4 (3.1%) 
24 (18.8%) 
2 (1.6%) 
10 (7.8%) 
Disease duration in years          
(mean ± SD) 
8.48       (±9.14)  13.90    (±9.31)   
Disease activity (mean ±  SD) 1.51       (±1.49) 3.40      (±3.27)  
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Comparisons between illness representations of SLE patients,  their rheumatologists and their GPs 
(see Table 2) 
Between patients and rheumatologists a large positive intraclass correlation was found for the 
perceived consequences of SLE. Moderate intraclass correlations were observed for controllability by 
treatment, illness coherence  and the emotional impact of SLE. Looking at the Cohen’s d, differences 
between patients and their rheumatologists were futile or small for all dimensions, except for timeline 
cyclical, on which the patients scored higher with a moderate difference.  
Between patients and GPs, moderate positive correlations were found for the perceived 
consequences, illness coherence, and the emotional impact of SLE. A moderately large difference was 
found for consequences, on which GPs scored higher than their patients.  
Between rheumatologists and GPs, moderate but statistically significant correlations were 
found for the perceived consequences, chronicity of the time course, illness coherence, and the 
emotional impact of SLE. For consequences, the difference in mean score was moderate, with higher 
scores in GPs than in rheumatologists, and for timeline acute/chronic, the difference was large. 
 
Comparisons between illness representations of SSc patients, their rheumatologists and their GPs 
(see Table 3) 
Also for SSc, moderate positive intraclass correlations were found between patients and  
rheumatologists on the consequences dimension, illness coherence and emotional representations. 
Patients scored lower in comparison with rheumatologists, with a moderate difference for the 
consequences dimension. 
 Between patients and GPs, moderate positive correlations were found for consequences and 
illness coherence and large intraclass correlations for personal control. Patients had lower mean scores 
on the perceived consequences with a large difference for consequences and moderate difference for 
timeline acute/chronic and illness coherence. 
Between rheumatologists and GPs, large positive correlations were found for the perceived 
consequences, and moderate correlations for personal control, illness coherence  and the emotional 
impact of SSc. A large difference was found for consequences, on which GPs scored higher than 
patients. For timeline acute/chronic and treatment control a moderate difference was found with also 
higher scores for GPs than patients. The detected differences between rheumatologists and GPs were 
small for all dimensions.  
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Table 2 : Comparison between SLE patients, their rheumatologists and their GPs based on 7 illness perception dimensions 
 ICC 
Patients –
Rheumatologists 
(n=115) 
 
Patients 
(n=115) 
 
 
Mean (SD) 
Rheumatologists 
(n=115) 
 
 
Mean (SD) 
Cohen’s 
d 
ICC 
Patients- 
GPs 
(n=83) 
Patients 
(n=83) 
 
 
Mean (SD) 
GPs 
(n=83) 
 
 
Mean (SD) 
Cohen’s 
d 
ICC 
Rheumatologists-
GPs (n=79) 
Rheumatologists 
(n=79) 
 
 
Mean (SD) 
GPs 
(n=79) 
 
 
Mean (SD) 
Cohen’s 
d 
Consequences 0.523‡ 17.6 (5.3) 18.3 (5.6) 0.11 
 
0.397‡ 17.6 (5.1) 21.5 (4.3) 0.71 
 
0.407† 18.2 (5.5) 21.4 (4.2) 0.56 
 
Timeline 
acute/chronic 
0.226 24.7 (3.8) 22.9 (3.2) 0.38 
 
0.261 24.9 (3.6) 26.4 (3.3) 0.33 
 
0.331† 22.7 (3.1) 26.3 (3.3) 0.95 
 
Personal control -0.076 18.6 (4.2) 17.3 (4.0) 0.22 
 
-0.145 18.1 (4.4) 17.3 (4.3) 0.12 
 
-0.108 17.3 (4.1) 17.4 (4.3) 0.02 
 
Treatment control 0.360† 17.1 (2.8) 18.1 (1.9) 0.31 
 
0.154 17.1 (2.9) 17.9 (2.4) 0.22 
 
0.101 18.1 (1.7) 17.9 (2.3) 0.07 
 
Illness coherence 0.388† 17.2 (4.2) 18.5 (4.3) 0.25 
 
0.325* 16.9 (4.2) 18.9 (3.1) 0.46 
 
0.415† 18.6 (4.4) 18.9 (3.0) 0.07 
 
Timeline cyclical 0.158 14.7 (3.6) 12.1 (3.6) 0.54 
 
0.152 15.2 (3.2) 13.6 (2.5) 0.42 
 
0.102 11.9 (3.4) 13.6 (2.5) 0.40 
 
Emotional 
representations 
0.371† 16.7 (5.5) 16.1 (5.7) 0.08 
 
0.440† 16.7 (5.5) 18.3 (4.1) 0.28 
 
0.462‡ 15.7 (5.6) 18.3 (4.1) 0.46 
 
ICC: intraclass correlation coefficient; GP: general practitioner; *p≤0.05; †p≤0.01; ‡p≤0.001 
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Table 3: Comparison between SSc patients, their rheumatologists and their GPs based on 7 illness perception dimensions 
 ICC  
Patients –
Rheumatologists 
(n=111) 
 
Patients 
(n=111) 
 
 
Mean (SD) 
Rheumatologists 
(n=111) 
 
 
Mean (SD) 
Cohen’s 
d 
ICC 
Patients
- GPs 
(n=74) 
Patients 
(n=75) 
 
 
Mean (SD) 
GPs 
(n=75) 
 
 
Mean (SD) 
Cohen’s 
d 
ICC 
Rheumatologists-
GPs (n= 77) 
Rheumatologists 
(n=77) 
 
 
Mean (SD) 
GPs 
 (n=77) 
 
 
Mean (SD) 
Cohe
n’s 
d 
Consequences 0.339† 18.5 (4.8) 22.4 (5.7) 0.61 
 
0.424‡ 18.0 (4.7) 22.2 (4.6) 0.80 
 
0.628‡ 23.2 (5.3) 22.2 (4.6) 0.19 
 
Timeline 
acute/chronic 
0.078 24.9 (4.0) 25.9 (3.2) 0.20 
 
-0.047 24.7 (4.1) 27.5 (2.7) 0.56 
 
0.134 26.2 (3.2) 27.5 (2.6) 0.31 
 
Personal control 0.166 17.1 (3.4) 17.9 (4.2) 0.16 
 
0.575‡ 16.9 (3.6) 16.1 (4.3) 0.18 
 
0.371* 17.9 (4.6) 16.2 (4.3) 0.31 
 
Treatment control -0.040 14.9 (2.6) 16.6 (2.6) 0.44 
 
0.168 15.0 (2.4) 16.7 (2.3) 0.55 
 
0.108 16.4 (2.8) 16.7 (2.4) 0.09 
 
Illness coherence 0.320* 15.8 (3.8) 16.1 (4.0) 0.07 
 
0.439† 15.5 (4.1) 17.5 (3.4) 0.44 
 
0.295* 15.2 (4.3) 17.5 (3.5) 0.46 
 
Timeline cyclical 0.058 14.2 (3.2) 12.9 (2.9) 0.31 
 
0.170 13.9 (3.1) 12.9 (2.2) 0.29 
 
-0.191 12.6 (2.7) 12.8 (2.2) 0.04 
 
Emotional 
representations 
0.319* 18.1 (5.2) 19.7 (5.1) 0.24 
 
0.040 18.4 (5.7) 18.0 (4.5) 0.05 
 
0.313* 19.9 (5.1) 18.0 (4.5) 0.31 
 
ICC: intraclass correlation coefficient; GP : general practitioner; *p≤0.05; †p≤0.01; ‡p≤0.001 
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4. Discussion 
The aim of this paper was to explore commonalities and differences in perceptions between patients 
with SLE and SSc, their rheumatologists, and their GPs on the individual representations of their illness.  
For both diseases, we found moderate to large correlations in the consequences, illness 
coherence and emotional representations dimension between patients, rheumatologists and GPs. The 
GPs scored higher on these dimensions in comparison with the patients were the difference was mostly 
small to moderate. They seemed to overestimate the consequences of these diseases for the patient, 
the understanding of these diseases by the patient and the emotional impact for SLE patients but not 
for SSc patients. Our results are in concordance with a number of studies in epilepsy [15,31,32] in 
which the neurologists score higher on the aforementioned dimensions than the patients. The 
rheumatologists scored also higher on these dimensions than the patients, but the differences were 
mostly small. Except in SLE, patients had the perception of a more recurrent time course than 
rheumatologists. This difference was moderate.  
A closer look at comparisons between rheumatologists and GPs shows that for SLE, GPs have 
higher scores on consequences, illness coherence, timeline acute/chronic and emotional 
representations and for SSc, rheumatologists score higher than the GPs on these dimensions (except 
for illness coherence). This reflects that GPs consider SLE to be a much more severe condition than 
rheumatologists and patients do. This could be attributed to lack of knowledge or the fact that they 
rely on general information about SLE –for instance coming from textbooks, which tend to put too 
much emphasis on severe SLE manifestations- when scoring the questionnaire.  
For SSc, moderate to large correlations were found for personal control in both patients and 
GPs and GPs  and rheumatologists. The difference between these groups was statistically small but can 
have clinical implications. The fact that there is a difference  can be related to the rarity of SSc,  inter-
patient differences, both in the type of controllable symptoms and the level of control[33] and that 
personal control is a construct of illness perceptions which is the most complex and multifactorial in 
relation to the other dimensions [34]. Another explanation is that GPs might have lack of knowledge 
or limited patient contact and therefore rely more on the information provided by the patient. This 
emphasizes the importance of the collaboration between GPs and rheumatologists for receiving and 
providing up-to-date disease-related information. In daily clinical practice, perceived control is based 
on knowledge about the disease -for instance provided by a healthcare professional- and also on the 
patients’ personal experience. This dimension is important because of several reasons. The first reason 
is that personal control is one of the dimensions that predicts outcomes and is easily changeable with 
interventions. Much more than the other dimensions personal control can be altered by  patient 
education sessions and self-management programs [35–37]. Dedicated educational programs with an 
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emphasis on the perceptions of patients, initiated by physicians, could reduce the knowledge deficit in 
the patients. Also, as the GP often remains the primary caregiver, it is crucial that the illness 
perceptions of both GP and rheumatologists are aligned. For this, communication modalities between 
these 2 groups of health professionals should be optimized. 
Strengths of this study are that we had dyads of patients, rheumatologists and GPs and a high 
response rate. The number of GPs that participated was considerable. The study setting was a large 
university hospital in Belgium. The results of this study should be interpreted in light of some 
methodological limitations. A small number of GPs sent us a blank questionnaire with a note that they 
did not want to complete the IPQ-R HP because the patient visited them too long ago or not frequently 
so that they did not feel comfortable to judge in detail the patient’s health situation. Another limitation 
is that the rheumatologists who completed the IPQ-R HP mentioned that completing the questionnaire 
was not always easy. Some dimensions such as for instance timeline  acute/chronic, treatment control, 
personal control were mainly based on medical knowledge. Other dimensions such as the emotional 
representations and illness coherence, were completed much more subjectively by putting their selves 
in place of the patient. So, the set-up of the IPQ-R HP needs further exploration.  
Another point for consideration is the external validity of the study results. This study has been 
conducted in a large single center which implies that the generalizability can be limited. Furthermore, 
the current study has a cross-sectional design which implies that it cannot establish the directionality 
of the associations between rheumatologists or GPs and patients. It is possible that the physicians’ 
perception is influenced by the way a patient perceives and reports his condition, or vice versa. Other 
implications for further research are that the uncovered differences in illness perceptions between 
patients and medical staff can now be studied for their impact on outcomes. The current study 
provides insights in illness perception dimensions that are important for inclusion in future research  
about the influence of illness perceptions on outcomes such as for instance patient satisfaction, 
adherence, healthcare utilization, etc. 
 
In conclusion, we can state that for both diseases and between patients, rheumatologists and GPs 
significant correlations in illness perceptions are detected for the dimensions consequences, illness 
coherence and emotional representations. For SLE, we found that GPs perceived the consequences of 
SLE as more severe than patients and rheumatologists do and that GPs also perceived SLE as more 
chronic than rheumatologists. GPs perceived SSc as more severe, chronic and controllable by 
treatment than patients. These differences can have implications for the communication and 
collaboration in daily clinical practice.   
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Abstract 
Objectives: Literature states that illness perceptions of patients with systemic lupus erythematosus 
(SLE) and systemic sclerosis (SSc) are strongly associated with physical and psychological outcomes. 
This relation is most likely dynamic which means that outcomes can possibly predict perceptions of 
patients. This interplay is not fully investigated yet and clarity regarding the directions of associations 
is needed when designing interventions to alter illness perceptions. Therefore, this study aimed to 
investigate the prospective associations between illness perceptions and depressive symptoms, 
anxiety, perceived health status and disease activity in SLE and SSc patients. 
 
Methods: Patients with SLE and SSc from a single-center university hospital participated in a 
longitudinal study spanning one year. Participants completed at both time points the revised Illness 
Perception Questionnaire; the HADS for measuring depressive symptoms and anxiety; the EQ-5D-5L 
for assessing perceived health status. Disease activity was also recorded. The directionality of the 
associations was investigated using cross-lagged path analysis controlling for age, gender and disease 
duration. 
 
Results: A total of 128 SLE and 113 SSc patients with a mean age of 46.28 (±14.97) years and  60.17 
(±10.82) years, respectively and disease duration of 13.90 (±9.31) years and 8.48 (±9.14) years, 
respectively participated.  In SLE, reporting more depressive symptoms, more anxiety and worse 
perceived health status predicted a relative decrease in illness coherence one year later. More severe 
perceived consequences predicted a relative decrease in health status. The perception of a more 
chronic time course predicted an increase in depressive symptoms. In SSc, reporting more depressive 
symptoms and more anxiety predicted a relative decrease in illness coherence. A good perceived 
health status and less reporting of depressive symptoms predicted a relative decrease in perceived 
consequences.  
 
Conclusions: Evidence was obtained for reciprocal pathways between health outcomes and illness 
perceptions although the predominant direction of effects was found to be from health outcomes to 
illness perceptions.  
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1. Introduction  
Systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) are characterized by multiple organ 
involvement, a heterogeneous presentation and an unpredictable disease course often leading to 
important morbidity and mortality [1,2]. Both diseases affect more women than men, with a sex ratio 
for SLE: 9:1 ratio and for SSc: 3:1 ratio. SSc is considered a rare disease (prevalence <1/5000) and has 
one of the highest mortality rates amongst all rheumatic diseases [3,4]. Beside  the organ involvement, 
SLE and SSc patients might experience difficulties with personal care, household chores, work and 
leisure activities due to fatigue, dyspnea and impairments in physical functioning [5–8]. In addition to 
physical impairments, patients might experience psychological consequences such as depressive 
symptoms and anxiety. A recent meta-analysis stated that the prevalence estimates for SLE of major 
depression was 30%  and  major anxiety occurred in 40% of the patients [9]. Also, for SSc, this burden 
was high with 56% reporting major depression and 37% SSc patients having anxiety disorders [10] . 
Physical and psychological impairment might influence patients’ illness perceptions, which are the 
mental constructions patients develop about their illness. 
Researchers found that illness perceptions in SLE and SSc are associated with physical and 
mental functioning and other health outcomes such as sexual functioning, treatment adherence and 
depressive symptomatology [11–14] independently from disease-related characteristics or from the 
medical severity of the patients’ condition. In the early 1980s, Leventhal and colleagues [15] 
conceptualized illness perceptions in the Common-Sense Model (CSM). The CSM shows that internal 
stimuli (e.g., symptom experience such as pain) and external stimuli (e.g., disease-related information 
from family or healthcare professionals) generate cognitive representations and emotional responses 
which  guide the selection of coping procedures in order to eliminate and control potential or ongoing 
illness threats [16].  
Research based on the CSM is mostly focused on illness perceptions predicting health 
outcomes but the relation is most likely dynamic which means that outcomes can possibly predict 
perceptions of patients. So, some of these health outcomes, such as anxiety and depression, perceived 
health or even disease activity as a more objective outcome, can potentially influence illness 
perceptions but this is not fully established or investigated [17]. Clarity regarding the direction of 
associations is needed when designing interventions to alter illness perceptions, as clinicians need to 
know how and where to intervene [18]. The available studies on illness perceptions and anxiety, 
depression, and perceived health status in patients with SLE and SSc are scarce and most of them are 
cross-sectional, except for one study [19] which describes correlations of illness perceptions with 
changes in psychological outcomes without information on the directionality of the associations. We 
assume- based on the CSM [15] that the predominant direction of effects goes from the illness 
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perception dimensions to subjective outcomes (i.e., depressive symptoms, anxiety, perceived health 
status) and also disease activity as an objective outcome. This hypothesis is based on previous 
literature in diabetes patients [20] which shows that illness perceptions precede the formation of 
depressive symptoms and stress over time. The aim of this study was to investigate the directionality 
of effects linking illness perceptions and health outcomes in SLE and SSc patients.  
 
2. Methods 
Design  
The present study is a longitudinal observational cohort study of patients with SLE and SSc in which all 
variables of interest were measured at two time-points with an interval of 12 months. The data of time 
1 were collected between November 2015 and February 2016 and the data for time 2 were collected 
between November 2016 and February 2017. This study has been registered in clinicaltrials.gov with 
ID nr. NCT02655640.  
 
Study population  
Patients were eligible for inclusion if their medical and cognitive condition allowed them to complete 
questionnaires; if they did not have severe psychiatric problems; if they were proficient in Dutch and 
were able to complete the questionnaires in Dutch. Overall, 284 patients with SLE and SSc who were 
in follow-up in our center fulfilled the inclusion criteria, and were therefore invited for participation.  
 
Procedure 
We sent at both time points a letter with information about the purpose of the study, a questionnaire 
pack and an informed consent form together with a pre stamped envelope to all eligible patients. They 
were asked to complete the questionnaires and the informed consent form and return it within two 
weeks. In case of non-response, reminders were sent after three weeks, five weeks and seven weeks. 
After nine weeks, patients were contacted by telephone if they were persistent non-responders. As an 
incentive, patients who completed the questionnaires at both time points received a voucher of 20 
EUR. 
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Measures 
Clinical data  
Both disease duration and disease activity were measured. In SLE patients, disease activity was 
evaluated using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score with the 
Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA) modification (i.e. SELENA-
SLEDAI)[21]. The SLEDAI is a valid and reliable index that measures disease activity over the past 10 
days [22]. It includes 24 weighted objective clinical and laboratory variables. The SLEDAI scores can 
range from 0 to 105 and allows to categorize patients into: no activity (SLEDAI=0), mild activity 
(SLEDAI=1–5), moderate activity (SLEDAI=6–10), high activity (SLEDAI=11–19), very high activity 
(SLEDAI≥20)[23].  
In SSc patients, disease activity was measured using the SSc disease activity index (2003)[24]. 
This index consists of both self-reported data and clinical and laboratory measures of disease activity. 
It consists of 10 weighted measures and the scores can range from 0-10. An index score ≥ 3 reflects 
SSc that is active. 
 
Illness perceptions  
Patients’ perceptions about their illness were measured with the Dutch version [25] of the revised 
Illness Perception Questionnaire (IPQ-R) developed by Moss-Morris and colleagues [26]. The IPQ-R is 
a self-report instrument which consists of 9 dimensions or subscales: an illness identity dimension, 7 
illness perception subscales and a causal attributions dimension. It is a widely applied instrument 
across several disease groups and has demonstrated good reliability and validity [27]. The items for all 
subscales are rated by the patient on a 5-point Likert scale from ‘strongly disagree’ (1) to strongly agree 
(5). Scores were calculated as the sum of the items per scale. For the present study, we focused on 4 
illness perception dimensions: the degree to which an illness was viewed as acute or chronic (timeline 
acute/chronic); the perceived seriousness of the condition (consequences); patient’s perceptions 
regarding personal control they possessed over their illness; and patient’s overall illness 
comprehension (illness coherence).  The choice for these 4 dimensions was made because of reasons 
of parsimony regarding the applied statistical technique and was also based on previous findings from 
literature and correlational analyses.  
 
Symptoms of anxiety and depression 
Anxiety and depression were assessed with the Hospital Anxiety and Depression Scale (HADS) [28], a 
self-report questionnaire with seven items assessing anxiety and seven items assessing depressive 
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symptomatology. The HADS was chosen for use in this study because it is widely used, easily applied, 
avoids assessment of physical symptoms of depression, and has been validated in patients with 
rheumatic conditions and used in patients with SLE and SSc [9,10,29]. All items are scored on a 4-point 
scale from zero (not present) to three (considerable). The cut-off scores for the diagnosis of probable 
depression/presence of depressive symptoms is a score of ≥8 on the depression subscale and the cut-
off scores for the diagnosis of probable anxiety was also a score of ≥8 on the anxiety subscale. The 
higher the score, the greater the degree of depressive symptoms and anxiety.   
 
Perceived health status 
Perceived health status was measured using the visual analogue scale of the EuroQol ﬁve-dimensions 
with 5 response levels (EQ-5D-5L) [30–32]. This standardized, self-report questionnaire consists of two 
parts: a health profile based on a descriptive system that defines health in terms of five dimensions 
and self-rated health. For assessing perceived health status, we used the second part of the EQ-5D-5L 
which measures the respondent’s self-rated health on a visual analogue scale (EQ-5D VAS), with a score 
ranging from 0 (worst imaginable health status) to 100 (best imaginable health state) on the day of 
completion. 
   
Statistical analysis 
Cross-lagged analyses using structural equation modeling was conducted to examine prospective 
associations among illness perceptions and health outcomes (i.e. anxiety, depression, perceived health 
status and disease activity). A separate model was fitted for depressive symptoms, symptoms of 
anxiety, perceived health status, and disease activity. In all four models, all within-time associations, 
stability paths, and cross-lagged paths were estimated (except for the cross-lagged paths among the 
four illness perceptions). In addition, baseline age, gender, and illness duration were controlled for by 
estimating paths to each construct in the model. Only the significant paths with these control variables 
were retained in order to make the estimated cross-lagged model more parsimonious. Cross-lagged 
paths are an indication of the predominant direction of effects over time but should not be interpreted 
as definite proof of causation. In Figure 1, we described a cross-lagged model in which variables A and 
B are measured at two time points, resulting in three types of relations: within-time relations (1 and 
2); autoregressive or stability relations (3 and 4); and cross-lagged relations (5 and 6). The estimated 
cross-lagged estimates can be interpreted as A1 predicting relative changes (i.e., relative increases or 
decreases) in B2 [33]. 
Maximum likelihood estimation with robust standard errors (MLR) was used to take into 
account the non-normality of the data. To assess model fit, the following fit indices were used: the 
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root mean square error of approximation (RMSEA, which should be <0.08); the comparative fit index 
(CFI, which should be >0.90) and the robust Satorra-Bentler scaled chi-square statistic (SBS χ² ) which 
should be as small as possible [34]. Data were analyzed with Mplus version 7. Missing data were dealt 
with using Full Information Maximum Likelihood (FIML).  
 
Figure 1: Cross-lagged correlational model describing three types of relations adapted from Anderson 
& Kida (1982) 
 
    Time point 1        Time point 2 
 
 
 
 
 
 
Ethical approval 
All patients gave their consent for participation in the study and the Institutional Review Board of the 
University Hospitals Leuven provided ethics approval for this study (ID nr. B322201526067).  
 
3. Results 
Sample characteristics 
Out of the 284 eligible patients, 241 participated (113 SSc patients and 128 SLE patients) at time 1 
(response rate = 84.86%). These patients were asked to participate at time 2, of which 221 agreed 
(response rate= 91.70%). There was a drop-out rate of 8.3 % between times 1 and 2. Table 1 describes 
the demographic, clinical characteristics and health outcomes of the SLE and SSc patients at time 1.  
 
 
 
 
 
 
 
 
A1 
B1 
A2 
B2 
1 2 
3 
4 
5 
6 
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Table 1: Overview patient characteristics at time point 1 
 Systemic Sclerosis 
n=113 
Systemic Lupus Erythematosus 
n=128 
Gender 
Women (n-proportion) 
 
76         (67.3%) 
 
123      (96.1%) 
Age in years (mean ± SD) 60.17 (±10.82) 46.28 (±14.97) 
Social status (n-proportion) 
Married 
Cohabitation 
Single 
Divorced 
Widow 
Other 
 
83 (73.5%) 
3 (2.7%) 
8 (7.1%) 
12 (10.6%) 
7 (6.2%) 
/            / 
 
78 (60.9%) 
23 (18.0%) 
11 (8.6%) 
9 (7.0%) 
5 (3.9%) 
2 (1.6%) 
Living situation (n-proportion) 
Living alone 
Cohabitation with partner & kids 
Cohabitation with partner 
Cohabitation with kids 
Cohabitation with friends 
Other 
 
20 (17.7%) 
24 (21.2%) 
59 (52.2%) 
4 (3.5%) 
3 (2.7%) 
2 (1.8%) 
 
16 (12.5%) 
46 (35.9%) 
53 (41.4%) 
6 (4.7%) 
7 (5.5%) 
/             / 
Education (n-proportion) 
Primary school 
Secondary school 
Bachelor degree 
Master degree 
 
21 (18.6%) 
68 (60.2%) 
17 (15.0%) 
7 (6.2%) 
 
10 (7.8%) 
58 (45.3%) 
41 (32.0%) 
18 (14.1%) 
Work status (n-proportion) 
Fulltime 
Part-time (because of illness) 
Part-time (personal choice) 
Retired  
Student 
Unemployed 
Disablement benefit 
Sickness benefit 
Other 
 
14 (12.4%) 
7 (6.2%) 
3 (2.7%) 
49 (43.4%) 
/             / 
2 (1.8%) 
18 (15.9%) 
8 (7.1%) 
12 (10.6%) 
 
33 (25.8%) 
13 (10.2%) 
16 (12.5%) 
20 (15.6%) 
6 (4.7%) 
4 (3.1%) 
24 (18.8%) 
2 (1.6%) 
10 (7.8%) 
Disease duration in years  
(mean ± SD) 
8.48    (±9.14)   13.90  (±9.31) 
Disease activity (mean ± SD) 1.51    (±1.49) 3.40    (±3.27)  
Anxiety (mean ± SD) 6.77    (±3.54)  7.39    (±4.07)  
Depression (mean ± SD) 5.59    (±3.71)  4.89    (±4.25)  
Perceived health status  
(mean ± SD) 
63.63  (±16.79)  68.32  (±15.64)  
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Cross-lagged analysis between illness representations of SLE patients and health outcomes 
In Figure 2, all significant stability coefficients and cross-lagged paths for SLE are presented. The first 
cross-lagged model linking the four illness perceptions to anxiety (Fig. 2a) shows that high levels of 
anxiety predicted a relative decrease in illness coherence one year later. In the second cross-lagged 
model, described in Figure 2b, the presence of depressive symptoms predicted a relative decrease in 
illness coherence one year later. Furthermore, a chronic perception of the time course at time 1 
predicted a relative increase in depressive symptoms at time 2. The third cross-lagged model (see 
Figure 2c) shows that high levels of perceived health status at time 1 predicted a relative increase in 
illness coherence at time 2 and that stronger perceptions of severe consequences predicted a relative 
decrease in perceived health status one year later. Finally, in the last model (see Figure 2d) no cross-
lagged paths were found linking illness perceptions to disease activity. As shown in these figures, all 
models provided a good fit to the data. 
 
Cross-lagged analysis between illness representations of SSc patients and health outcomes 
In Figure 3, all significant stability coefficients and cross-lagged paths for SSc are presented. The first 
cross-lagged model, presented in Figure 3a, shows that high levels of anxiety predicted a relative 
decrease in illness coherence one year later. The second cross-lagged model in Figure 3b, shows that 
high levels of depressive symptoms at time 1 predicted a relative decrease in illness coherence and a 
relative increase in perceived consequences at time 2. Figure 3c, shows that high levels of perceived 
health status at time 1 predicted a relative decrease in perceived consequences one year later. In 
Figure 3d, only non-significant associations were present. As shown in these figures, all models 
provided a good fit to the data. 
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Figure 2: Overview of the cross-lagged path estimations between illness perceptions and health outcomes in SLE 
 
Figure 2a: Cross-lagged model linking illness perceptions to anxiety                 Figure 2b: Cross-lagged model linking illness perceptions to depressive sympt 
T1   T2  T1   T2 
Consequences   Consequences  Consequences   Consequences 
         
Timeline (a/c)   Timeline (a/c)  Timeline (a/c)   Timeline (a/c) 
         
Personal control   Personal control  Personal control   Personal control 
         
Coherence   Coherence  Coherence   Coherence 
         
Anxiety   Anxiety  Depressive sympt   Depressive sympt 
S-B χ² (36) = 52.22, p = .0393; RMSEA = .059; CFI = .966                        S-B χ² (37) = 55.77, p = .0245; RMSEA = .063; CFI = .962  
**p < .01, ***p < .001          *p < .05, **p < .01, ***p < .001      
  
Figure 2c: Cross-lagged model linking illness perceptions to perceived health status  Figure 2d: Cross-lagged model linking illness perceptions to disease activity  
T1   T2  T1   T2 
 Consequences   Consequences  Consequences   Consequences 
         
Timeline (a/c)   Timeline (a/c)  Timeline (a/c)   Timeline (a/c) 
         
Personal control   Personal control  Personal control   Personal control 
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Figure 3: Overview of the cross-lagged path estimations between illness perceptions and health outcomes in SSc 
 
Figure 3a: Cross-lagged model linking illness perceptions to anxiety                     Figure 3b: Cross-lagged model linking illness perceptions to depressive symptoms 
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Figure 3c: Cross-lagged model linking illness perceptions to perceived health status       Figure 3d: Cross-lagged model linking illness perceptions to disease activity 
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4. Discussion 
This study was the first to investigate prospective associations among illness perceptions and health 
outcomes in patients with SLE and SSc. For both diseases, we found that the predominant direction of 
effects goes in most cases from depressive feelings, anxiety and perceived health status to the illness 
perception dimensions.  
For SLE patients, we found that high levels of anxiety, experiencing depressive feelings, and a 
low perceived health status predicted relative decreases in illness coherence one year later. No other 
illness perception dimensions were predicted by these outcomes. Illness coherence is the degree to 
which a person holds a coherent understanding of the illness; it is a metacognition that taps whether 
the illness “makes sense” to the patient [17]. Our results state that when patients report more 
depressive feelings or perceive their health status as worse, this may lead to a less coherent 
understanding of the disease. Broadbent and co-workers [20] mention that illness coherence can be 
seen as a summary of how the other perceptions fit together to provide a coherent model rather than 
being an independent illness perception per se. So, experiencing depressive symptoms may activate 
beliefs about the disease in general which implies that patients can become insecure about their 
condition.  A closer look at the illness perception dimensions shows that perceiving the illness as more 
chronic predicts depressive symptomatology and that more perceived consequences predicted a 
poorer perceived health status in the case of SLE.  Cross-sectional literature about illness perceptions 
in SLE and depression also found that the more chronic the perception of the disease, the more 
depressive symptoms. The finding that more severe consequences predicted worse perceived health 
status is in line with literature concerning other conditions [36] and also in line with literature stating 
that the consequences dimension is often a major factor in explaining or predicting outcomes [18]. 
Patients also report this in daily practice. Patients who experience consequences on social or financial 
level, for instance SSc patients who lost work because of their condition or SLE patients who experience 
fatigue, have a more negative view on their condition[19,35].  
 For SSc patients, we found that high levels of anxiety and depressive symptomatology 
predicted relative decreases in illness coherence and increase in perceived consequences and personal 
control, in the case of depressive symptomatology, one year later. A positively perceived health status 
also predicted less perceived consequences due to the disease which is comparable with what we 
found in SLE patients. Probably, the explanation for this is that in SSc the skin involvement and damage 
is more visible and debilitating in SSc patients which can explain why in SSc perceived health status 
precedes the formation of the consequences dimension[36].  
 A closer look at disease activity shows that in the SLE group disease activity levels were low 
and that no cross-lagged associations were found linking illness perceptions with disease activity. This 
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is in line with a SLE study [19] published 20 years ago and also with Hagger and Orbell (2003) [37] who 
state that illness perceptions are unrelated or weakly related to disease state. A possible reason is that 
disease activity is measured by the SLEDAI, an index which is solely based on more ‘objective’ 
biochemical and clinical characteristics and no ‘subjective’ patient reported characteristics or 
measurements. In SSc, the perceived consequences of the disease predicted disease activity at a 
marginally significant level. 
We found that outcomes predominantly predicted illness perceptions and that perceived 
consequences and timeline acute/chronic predicted relative change in outcomes in SLE. Our findings 
stress the importance of holistic care and implies that healthcare professionals need to pay attention 
to their patients’ perceptions, psychological wellbeing and perceived health status. Inaccurate 
perceptions can be tackled with specific counseling techniques, e.g. cognitive behavioral therapy. 
because  Before drawing up further practical implications, further research in this area is needed.  
Some limitations need to be taken into account when interpreting the study results. Kline 
(2005) [34] described that for structural equation modeling a sample of 5-10 respondents per variable 
is needed which was not feasible in the present study. We need to emphasize the relative rarity of 
these complex diseases and the exploratory nature of this study. Another limitation is the single-center 
setting which can reduce the generalizability of the findings to other settings. 
Despite these limitations and suggestions for future research, the present study has also 
several strengths. Although this is a single-center study, the number of patients per disease group is  
appropriate because SSc and SLE have a rather low prevalence rate in Belgium and Europe compared 
to the US and Southern countries. Furthermore, these two diseases are sample cases of complex 
chronic diseases with an unpredictable course which makes extrapolation to other chronic conditions 
possible.  Another strength is that we had a very good response rate at both time points. At time point 
2, only  8.3 % of eligible patients did not participate. A possible reason for the high response rate are 
incentives and personal reminders in order to reduce non-response.  
 
In conclusion, we can state that for SLE and SSc, anxiety, depressive feelings and perceived health 
status predict illness perceptions. Also for SLE, perceived consequences and the perception of a chronic 
disease course predicted perceived health status and depression, respectively.  The finding that health 
outcomes precede illness perceptions shows that self-regulation is dynamic as described in the CSM.  
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Major progress in the understanding and treatment of severe complex diseases like multisystem auto-
immune diseases has already been achieved or is awaited achievement in the near future but still 
witness a high unmet medical need. Classical innovative research is mainly focusing on somatic disease 
processes while aspects of illness perceptions and illness behavior also contribute importantly to 
outcome. Illness perceptions do matter since they have been reported in research concerning chronic 
diseases to be stronger associated with outcomes than purely disease related characteristics [1]. 
A closer look at the concept of illness perceptions, shows that when patients are confronted 
with a chronic condition, such as SLE and SSc, the type and quality of the available information provided 
to them, is crucial in order to give meaning to and manage their illness. Interpreting this information 
is the first step in the self-regulation of illness [2,3] and could be influenced by several factors which 
play an important role in establishing and shaping illness representations [4]. Since not all factors are 
already identified, it is of interest to have an overview of these and specifically the modifiable ones 
that could be adjusted by an intervention. One possible modifiable factor influencing patients’ illness 
perceptions is the perception of healthcare professionals regarding the illness of a patient. Literature 
states that there are differences in illness perceptions between patients and their healthcare 
professionals [5]. Understanding the perceptions of various physicians concerning a particular patient 
they care for, could contribute to detect discrepancies with the patient’s perception and to minimize 
or avoid eventual miscommunication or misconceptions.  
Another point of attention is that the directionality of the associations between illness 
perceptions and health outcomes –such as anxiety, depression, mental and physical functioning- 
remains unclear in literature. On the one hand, publications state that health outcomes are correlates 
or determinants of illness perceptions, while on the other hand, others describe the importance of 
illness perceptions in influencing or predicting those health outcomes.  
This PhD thesis identifies the modifiable correlates of illness perceptions and sheds light on 
the perceptions of physicians who are involved in the multidisciplinary care of patients with SLE and 
SSc. For measuring the perceptions of these physicians a preliminary validation of the illness 
perception questionnaire for healthcare professionals (IPQ-R HP), was conducted. Furthermore, we 
investigated if specific modifiable correlates of illness perceptions are to be considered as 
determinants or as outcomes of illness perceptions in patients with SLE and SSc.  
 
In the next sections, reflections about the different chapters are summarized in terms of the value of 
this thesis to amplify the literature concerning illness perceptions, methodological considerations, 
implications for clinical practice, healthcare policy recommendations and horizons for further research.  
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1. Added value of this PhD study to the unknowns in literature 
It is known that for developing effective interventions, researchers need to know how and where to 
intervene. In this regard, more research was needed to investigate the determinants or correlates of 
illness perceptions [6]. We provided an overview of the modifiable correlates of illness perceptions in 
Chapter 2 and found following factors: medication beliefs, information provision and satisfaction with 
received information, quality of care such as trust in the physician and perceived chronic care quality, 
illness-related factors and psychosocial factors. Such overview is important for HPs working in clinical 
practice because this added knowledge about the modifiable correlates of illness perceptions can 
structure patient education sessions and a HP’s history taking. Working models for patient education 
[7] can be extended with this overview in order to tackle the formation of maladaptive illness 
perceptions.  
Secondly, we conducted a preliminary validation of the IPQ-R HP (Chapter 3). The IPQ-R HP 
appears adequate and useful to assess the perception of HPs concerning the illness of an individual 
patient and produces -in this preliminary phase- reliable and valid output. Until now, researchers did 
not use a validated but a partially validated instrument for research purposes. In previous studies a 
modified version of the Brief-IPQ was used for measuring illness perceptions of medical students or 
nurses [8,9]. The preliminary version of the IPQ-R HP, validated in this thesis, can be utilized for 
research purposes but needs further psychometric exploration before application in daily clinical 
practice.  
Thirdly, by measuring illness perceptions in rheumatologists, GPs and their patients using the 
IPQ-R HP (Chapter 5), we found small differences between rheumatologists’ and GPs’ perceptions in 
context of SSc and moderate to large differences for the dimensions ‘consequences’ and ‘timeline 
acute/chronic’ in context of SLE with higher scores for GPs in comparison with rheumatologists. 
Between patients, rheumatologists and GPs positive correlations were found for ‘consequences’, 
‘illness coherence’ and ‘emotional representations’. The uniqueness of this study was not only that we 
looked for commonalities and differences in illness perceptions in the aforementioned groups but that 
we had pairs of physicians and patients. The physicians were asked to complete the IPQ-R HP based 
on the knowledge and perceptions they have about their own patients, i.e. patients they know and 
treat in real life and not patient cases or diseases in general. This is in contrast to almost all previous 
illness perception research in HPs or students which is based on fictive patients or on a disease as such. 
Fourthly, we answered an intriguing question, posed by researchers [2,6] experienced in illness 
perception research: are illness perceptions causally related to physical and psychological outcomes 
or vice versa? In Chapter 6, we conducted a cross-lagged analysis which shows the predominant 
direction of effects between illness perceptions and health outcomes such as anxiety symptoms, 
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depressive symptoms and perceived health status over time. We found that health outcomes at time 
point 1 predicted illness perceptions, mostly ‘illness coherence’ at time point 2 for both SLE and SSc 
patients and ‘consequences’ at time point 2 for SSc. Only the dimensions ‘timeline acute/chronic’ and 
‘consequences’ in SLE predicted depressive symptoms and less perceived health status one year later, 
respectively. 
Fiftly, we conducted the first longitudinal study in patients with SSc that investigates 
associations between illness perceptions and health outcomes. All other studies conducted in the area 
of illness perceptions in SSc have a cross-sectional design. For SLE, only one longitudinal study [10] in 
the format of a conference paper was available without the investigation of prospective associations 
between illness perceptions and health outcomes. In Chapter 6, we found that illness perceptions of 
patients with SLE and SSc are relatively stable over time. The fact that illness perceptions are stable 
over time is comparable with other studies in other diseases such as irritable bowel disease, diabetes 
or low back pain were the follow-up period ranged between 6 months and 2 years [11–13].  
 
2. Reflections on the conducted studies: focus on participants and methods 
Description of the patient population (at baseline) 
The population of interest in this thesis comprised patients with two different diseases, i.e. patients 
with SLE and patients with SSc. This means that there was a certain variability in our cohort study. This 
variability was present at different levels. Firstly, we had within the group of SSc patients, two 
subgroups: the lcSSc subtype and dcSSc subtype. The difference between these subtypes lies in their 
severity; IcSSc has limited organ involvement, whereas dcSSc is generally perceived as a more severe 
disease with a lower life expectancy. We chose not to make a distinction between the subgroups of 
SSc in our studies because previous research in SSc, regarding the impact of illness perceptions on 
mental and physical functioning, concluded that the subtype of SSc does not contribute to differences 
in illness perceptions [14]. 
Furthermore, disease activity between these two illness groups was measured with two 
different measures as appropriate. For SLE patients, we used the SLEDAI and for SSc patients we used 
the SSc disease activity index. The difference between these two indices lies not only in their disease 
specificity but also in the composition of the parameters of the instruments. Concretely, the SLEDAI 
includes only objective parameters for measuring disease activity; the SSc disease activity index 
includes beside objective parameters also three subjective measures assessed by the patient only. 
These are: worsening of cutaneous involvement, worsening of vascular symptoms, and worsening of 
cardiopulmonary symptoms. Therefore, the SSc disease activity index might have correlations with 
illness perception measurements, which is not the case for the SLEDAI. Literature describes the lack of 
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correlations between disease activity measured by SLEDAI and subjective measurements of disease 
activity and also poor correlations between disease activity and quality of life in SLE patients [15,16]. 
Another important remark is that we were only able to measure disease activity in SSc patients in 
follow-up at the Belgian Systemic Sclerosis Cohort (BSSC). For the other SSc patients, not included in 
the BSSC, no data on disease activity was present because this is not a standard measurement in daily 
clinical practice. The same was applicable for disease activity in SLE patients. Also for this group no 
standardized measurement of disease activity in daily clinical practice is available. The SLEDAI was 
completed for the purpose of this study by the researchers and/or rheumatologists.  
Another remark is that the study sample was relatively small but one has to be aware that SSc 
is a rare and SLE a less prevalent disease. This implies that a multi-center study could be the best way 
to have a larger sample size for the cross-lagged analysis conducted in Chapter 6 but this was currently 
not feasible. 
 
Cross-lagged analysis: what and why?  
A cross-lagged analysis is an analysis technique which investigates the predominant direction of effects 
over time. It is an indicator of temporal precedence and not a positive proof of causation [17]. In other 
words, it is a technique which gives more information about which variable precedes another variable. 
Within this analysis technique, one can control for the within-time relations, stability relations (i.e. 
between two time points) and also for background variables. The effect sizes of cross-lagged 
associations used in longitudinal research are much smaller than effect sizes in cross-sectional studies. 
The reason is that this analysis technique controls for stability relations in order to predict change in 
levels of the outcome over time which implies that it reduces the magnitude of the effect [18].  
In our research, we were interested in this predominant direction of the associations between 
variables over time, because previous research in SLE and SSc, conducted in the area of illness 
perceptions, is of cross-sectional nature and assumes that the direction of the associations goes from 
illness perceptions to health outcomes. The performed longitudinal research in illness perceptions of 
patients with chronic conditions is generally focused on intervention research or on the capacity of 
(mal)adaptive illness perceptions to predict outcomes assuming that the direction of the relationship 
between illness perceptions and outcomes starts from illness perceptions. So, there is no clear answer 
on the question whether the illness perceptions precede the health outcomes or vice versa. In other 
words, in case of anxiety: do patients view their illness more negatively because they are anxious, or 
do they become anxious because they consider their illness so severe and feel they have no control 
over it?   
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The sample size needed for a cross-lagged analysis technique is between 5 to 10 respondents 
per variable [19]. We had data from 113 SSc patients and 128 SLE patients at baseline, satisfying the 
needed number of patients to calculate the cross-lagged correlations. Furthermore, this amount of 
data helped to form a basis for hypothesis building in a patient population where research was virtually 
not existing. In order to obtain a larger sample size, we could have studied these diseases as one 
systemic disease group. However, since SLE and SSc are different diseases with different phenotypes 
and according to the Common-Sense Model (CSM) which states that illness representations are 
generated and shaped by the experience of disease biology, we analyzed them separately. Another 
remark is that illness perceptions are not stand-alone constructs. This means that you cannot rule out 
that between time point 1 and time point 2 a stressful event occurs that can influence patients’ 
perceptions. Moreover, such an event could not be controlled for because one does not know exactly 
when it happened. A possible solution for this is a diary study during 1 year where patients are asked 
to complete a daily diary in order to record thoughts and actions. The disadvantage of this research 
method is that it is an intensive and expensive design and that it might artificially increase ruminating 
about the disease and possibly induce inappropriate illness behavior.  
 
The IPQ-R HP 
The initial reason for developing  the IPQ-R HP was in first instance the need for a questionnaire that 
measures illness perceptions of physicians and HPs. We adopted the IPQ-R as the basis for constructing 
the HP’s questionnaire. Another reason was that there was a need for a questionnaire that resembled 
the IPQ-R, because in that way comparing HPs’ responses and patients’ responses was much more 
easy.    
 
Why the IPQ-R and not the Brief-IPQ as a backbone for the IPQ-R HP?  
We chose the IPQ-R, instead of the Brief-IPQ, for measuring illness perceptions in patients and as the 
core for developing the IPQ-R HP because of several reasons. The first reason was that the Brief-IPQ 
does not count all illness perception dimensions. For instance, the Brief-IPQ does not provide a detailed 
analysis of patients’ identity beliefs and gives no information on cyclical timeline beliefs. For SLE and 
SSc patients, the recursive pattern and unpredictable disease course are disease specific and from that 
perspective also important. The second reason is that a single-item measure, such as the Brief-IPQ, is 
less reliable than a multi-item measure. Single items must capture the content of the dimension 
succinctly and internal reliability measurements are not possible [20]. The third reason is that 
Broadbent and colleagues [21] also mention that the IPQ-R in comparison to the Brief-IPQ may also be 
more sensitive to changes in illness perceptions due to the larger score range of the subscales. On the 
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other hand, a possible disadvantage of the IPQ-R is that it is longer and therefore more time consuming 
for HPs. However, HPs who completed the IPQ-R HP, did not specify this as a problem.  
For patients, the completion of the IPQ-R and other self-report questionnaires was feasible 
judging by the high response rate at both time points. We offered them a voucher of 20 EUR after they 
completed the questionnaire pack at both time points. Probably, the incentive was large enough to 
motivate them for completing the questionnaires twice.  
 
Impressions of rheumatologists concerning the structure of the IPQ-R HP 
The five rheumatologists who completed the IPQ-R HP relied upon medical knowledge for the 
completion of some dimensions and on the patients’ perspective for other dimensions. 
Rheumatologists stated that when there was a regular follow-up, such as in the BSSC, it was easier to 
complete the IPQ-R HP because they had more patient contact and therefore knew that particular 
patient better. Rheumatologists were surprised about the results in Chapter 5. The answers from 
rheumatologists on the questions differed less from patients than GPs’ answers. However, 
rheumatologists did not expect this because they assumed that GPs knew their patients for a relatively 
longer period and are much more acquainted with them than rheumatologists are.  
Rheumatologists also mentioned that completing the IPQ-R HP was not always easy. After the 
longitudinal study was conducted we went through all items of the IPQ-R HP and asked 
rheumatologists’ thoughts about each item separately. They mentioned that some questions, for 
instance the items in Timeline acute/chronic, resembled each other or that there was some 
repetitiveness; or that some questions were unclear because they wondered if these items concerned 
the disease or symptom experience. Their completion of some dimensions such as for instance timeline  
acute/chronic, treatment control, personal control were mainly based on medical knowledge with 
sometimes the ‘disease’ in mind and not the particular patient. Other dimensions such as the 
emotional representations and illness coherence, were completed much more patient focused by 
putting themselves in place of the patient which was perceived as rather difficult. Some 
rheumatologists were also bothered by the fact that the IPQ-R HP was a generic questionnaire. 
The advantage for rheumatologists of completing the IPQ-R HP was that they now had to 
overthink and deal with aspects they did not focus on previously or where they lacked knowledge. 
Rheumatologists also brainstormed about terminology of certain items such as the difference between 
‘fear’ and ‘anxiety’ and reflected on questions regarding financial consequences of the disease for the 
patient because they were not aware of this. One rheumatologist mentioned that -in the case of dcSSc 
which is the most severe form of SSc- the consequences of the disease were not always communicated 
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to the patient. The reason was that the rheumatologist wanted to provide this information only when 
judged appropriate without worrying the patient too much. 
We also wondered if rheumatologists were in agreement with each other on the scores of the 
IPQ-R HP items. We asked them to complete the IPQ-R HP based on four patient vignettes and found 
that the interrater agreement between the rheumatologists was low. This indicates that they 
perceived the same patient differently which can be attributed to the fact that their perceptions are 
subjective and that some of them did not work in centers where an integrated care program with 
regular patient case discussions was organized.  
 
When should a healthcare professional complete the IPQ-R HP?  
The IPQ-R HP should be preferably completed by the HP or physician at the moment when also the 
patient completes the IPQ-R. Since, illness perceptions are relatively stable, the IPQ-R should be 
completed at those time points when illness perceptions are prone to change. Leventhal and 
colleagues [22]  described that illness representations are constantly being updated when new illness 
experience and knowledge regarding the illness are acquired. They stated this with an acute illness 
model in mind. Whereas for chronic diseases, which are relatively stable in time, aspects at disease 
start, or at diagnosis, would be more expected to induce change in perceptions [23]. Also, fluctuations 
in illness perceptions are detected during flares or acute exacerbations of the patient’s condition [24]. 
So, illness perceptions will change when symptom experience changes [13], when there are changes 
in the clinical states of the patient or treatment [11]. 
In Chapter 3, we described that these questionnaires can be completed in an inpatient or 
outpatient setting. For instance, when patients are waiting in the waiting room. The doctor or other 
HP can complete the IPQ-R HP after the patient’s visit because it is required that the HP has an idea 
about the patient’s physical and psychosocial condition. Hereafter, these two instruments can be 
compared easily by the HP. Every HP also needs instructions before using this questionnaire.  
 
3. Implications for clinical practice and healthcare policy recommendations 
The results conceived from this PhD project have implications for clinical practice and healthcare 
policy. 
Clinical practice   
In clinical practice, HPs and doctors-to-be are not always aware of the commonalities and differences 
between their own perceptions and the perceptions of patients. They are also not aware that these 
discrepancies can create problems and difficulties in the patient-provider interaction such as doctor 
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shopping, miscommunication or mistrust. So, awareness of the importance of illness perceptions by 
HPs is the first step. The second step is assessing illness perceptions of patients in daily care in order 
to have knowledge about their perceptions. Not only assessing but also using the CSM as a basis in 
their communication with their patients. This will give a fast and increased insight in the perceptions 
of the patient that can be compared immediately with available knowledge of the medical condition 
or the HP’s own representation. The third step is that in the design and construction of clinical 
interventions, HPs need to address illness perceptions but also the determinants of illness perceptions. 
The results of the cross-lagged analysis between illness perceptions and health outcomes (Chapter 6) 
show that in daily clinical practice, beside tackling maladaptive perceptions with for instance cognitive 
behavioral therapy [25] also a routine screening of depressive feelings and patients’ feelings of anxiety 
is needed. Currently, this is not systematically the case also not in our rheumatology department. The 
nurse specialist can integrate this in her history taking, make it discussable during interdisciplinary 
team meetings and ultimately a patient could be referred to a psychologist or psychiatrist. Hereafter, 
psychological interventions such as specific counseling techniques could be started in order to tackle 
anxiety and depressive feelings.  
Nurses can be trained to give psychoeducation and psychotherapeutic interventions in order 
to reduce anxiety and depressive feelings. Psychoeducation and psychoeducational interventions 
cover a broad range of educational activities in combination with counseling and support. Education 
includes information on treatments, symptoms, training to respond to disease-related problems, and 
problem-solving strategies to cope with disabilities due to systemic diseases etc. Psychotherapeutic 
interventions are for instance cognitive-behavioral interventions designed to help patients identify 
negative or unhelpful thoughts, beliefs, and behaviors, establishing goals to change them, and 
developing skills to implement helpful behaviors [26] 
As mentioned before illness perceptions are significantly associated with various physical, 
mental and emotional outcomes. When interventions are developed in order to modify illness 
perceptions, than this might improve patient outcomes. In literature, several interventions are 
described to tackle illness perceptions, but rare in systemic diseases. For instance, Goodman et al. 
(2005) [25] found in SLE patients that Cognitive Behavioral Therapy (CBT) changed participants’ 
perceptions of treatment control and emotional representations, and that perceived stress was 
reduced following the intervention. Chilcot and Moss-Morris (2013) [27] described that in irritable 
bowel disease, CBT self-management enhanced perceived control over irritable bowel disease, 
facilitated a more coherent understanding of the illness, and reduced perceptions of the severe and 
distressing consequences of irritable bowel disease (Chilcot and Moss-Morris, 2013). The CBT based 
intervention altered illness perceptions which mediated the treatment effects. Also, Broadbent et al. 
(2009) [28] and Petrie et al. (2002) [29] found that a brief illness perceptions modification programme 
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in patients with myocardial infarction -which consisted of a patients’ personalized education and 
action plan based on the self-regulation framework- improved patients’ perceptions of illness 
coherence, consequences, timeline and causes ánd could increase the likelihood of their return to 
usual activities and work. 
So, the results described in Chapter 6 show that in clinical practice and in a holistic care 
approach not only an evaluation of the patients’ illness perceptions is needed but also screening of 
physical and psychological outcomes. Also, in Chapter 2, we found that they were the most influential 
correlates of illness perceptions and important to take into account when designing interventions.  
The results of this PhD thesis show indirectly that in the courses for HPs and doctors-to-be, the 
concept of illness representations should be mentioned and explained more systematically in addition 
to the relevance of illness perceptions to understand patients’ behavior. Insights about illness 
perceptions will help HPs not only in understanding their patients’ health behavior but also in how 
they need to give medical information to their patients. They need to know that illness perceptions 
are less responsive to medical information that is inconsistent with prior or current beliefs or 
sensations [23] and that if they give information based on the CSM during the medical encounter, the 
better their perceptions will match with patients’ perceptions [30]. Without insight into patients’ 
common-sense representations, medical recommendations often lack relevance and/or context for 
patients [31].  
 The results of this PhD study are not only important for the education of physicians but also 
for the education of nurses. There is a need for more teaching about the importance of illness 
perceptions of patients and the impact of illness perceptions on patient reported outcomes. When 
nurses-to-be have knowledge and insight in illness perceptions, its conceptual model and advantages 
of using this model in daily clinical practice, than they will perhaps be able to unravel and understand 
maladaptive perceptions of patients and also unexpected health behavior of patients. Nurses and 
nurses-to-be should be taught to listen to the patients’ story, to analyze patients’ perceptions and to 
ask questions directed at gaining more insight in patients’ perceptions and tackling maladaptive 
perceptions. This is possible when they have knowledge about the concept of illness perceptions and 
practice, for instance in workshops, designing patient education plans and incorporating specific 
questions about patients’ perceptions as the starting point of the education session. Eventually, when 
they are familiar with the concept of illness perceptions they will be motivated to have attention for it 
and for its use in routine care. Nurses can educate patients better when they can rely on a model that 
guides the nurse in different steps until they eventually come to change. For instance, the 
representational approach to patient education [32] has been developed by nurses and postulates that 
effective patient education occurs when a nurse starts from patients’ knowledge and beliefs before 
providing new information. Patients’ beliefs about their illness are viewed as critical gateways to 
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change. The model consists of seven key elements and goals in a linear stepwise fashion. This approach 
can be seen as an interview and is adequately flexible to guide interventions for many different patient 
care situations. 
 
Healthcare policy recommendations 
We found in Chapter 4, that there are different physicians’ profiles, that physicians’ perceptions about 
SLE and SSc can be clustered, and that there are divergent illness perceptions among physicians of the 
same and other disciplines. This poses a challenge  in organizing care by several physicians for patients 
with systemic diseases which are less prevalent and complex. Medical specialists who care for patients 
with complex multisystem diseases need to have concentrated knowledge concerning all aspects of 
the disease and resources. The care for these entities should be organized in that way that early 
diagnosis, patient management and care delivery will be improved [33]. Currently, in Belgium 
appropriate communication between all care providers of a certain complex patient case is poor. These 
patients could benefit from treatment in expert or reference centers which are specialized in the care 
for patients with rare diseases and where integrated interdisciplinary care is developed and guided. 
Organization and financing of such integrated care is mandatory and deserves specific attention for 
policy makers on top of facilitating classical treatment innovations that are mainly pharmacological 
based or introduce new and expensive devices. In Belgium, a start of organizing the care for rare and 
complex diseases was made by the national government in 2014 (Royal Decree of 25 April 2014 
published 8 August 2014 in the Belgian Official Journal/Belgisch Staatsblad) defining the functioning of 
rare disease networks [34]. Currently, the implementation of all this is still ongoing.  
 
4. New horizons for research in the area of illness perceptions 
The results of this PhD are a stepping stone for further research in different areas concerning the topic 
of illness perceptions. In SLE and SSc, there is a need for longitudinal research to investigate the 
changes of illness perceptions and their impact on outcomes over time. In this longitudinal model all 
illness perception dimensions should be implemented together with an insertion of illness identity and 
causal attributions. In addition to research that uncovers in a prospective way the relationship 
between illness perceptions and health outcomes, also research in other areas is mandatory as 
discussed below. 
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Research in providers’ illness perceptions  
Qualitative research methods provide a complete and comprehensive understanding when little is 
known or no research has been done previously [35]. The added value of qualitative research for the 
studies conducted in this PhD project would be that certain illness perception dimensions that are 
scored totally differently between groups of physicians or in comparison with patients, can be explored 
in detail in order to understand physicians’ perceptions better. Physicians can express their experience 
in their own words without being limited by researcher-selected response categories. 
In Chapter 4, we found different illness perception profiles of physicians who are part of the 
multidisciplinary team that takes decisions concerning the therapy and long-term approach of patients 
with SLE and SSc. It could be interesting to have focus groups of physicians who belong to the same 
cluster and to explore their beliefs and the contributing factors for those specific beliefs in-depth. 
Another question that emerges is if these diverse perceptions concerning the condition of the same 
patient, can affect shared decision making in teams. It is interesting to investigate illness perceptions 
in multidisciplinary teams but also in interdisciplinary teams, between HPs from different disciplines.  
The reasons for these differences in perceptions can be explored with qualitative research asking the 
HPs why they think in a certain way. They could become aware that their education or their own 
personal models of illness contribute to the formation of illness perceptions concerning the condition 
of their patient in an appropriate or sometimes perhaps in a contra productive way.  
In Chapter 5, we described moderate to large differences between rheumatologists and GPs 
for the dimensions ‘timeline acute/chronic’ and ‘consequences’ for SLE, which needs a further 
qualitative approach in the format of for instance semi-structured interviews regarding the knowledge 
and the content of illness perceptions. 
 Studies conducted to study the link between HP-patient disparities in illness perceptions and 
their impact on outcomes would also be of great value. Within chronic diseases there are few 
publications describing the commonalities and differences in illness perceptions between patients and 
their healthcare providers. Also other researchers in the field [1,23] mention that given the large 
number of potential areas of misunderstanding and miscommunication that exist in health care, it is 
surprising that not more work has been undertaken in this area. So, our main aim within this PhD study 
was to collect data about the differences in perceptions between patients and physicians in the field 
of systemic diseases which is currently lacking; knowing this is a first step before designing the next 
phase, i.e. measuring the impact of HP-patient disparities in illness perceptions on patient outcomes 
and the impact of perceptions of healthcare professionals on patient outcomes. For instance, HP-
patient disparities in illness perceptions and their impact on outcomes can be investigated in a cross-
sectional study where first differences in HPs’ IPQ-R scores and patients’ IPQ-R scores can be 
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calculated. Thereafter, a dissimilarity index for each HP-patient dyad can be computed and correlated 
with the patient outcome. More information on the contribution of the HP’s illness conceptualizations 
to the variance in patients’ coping behaviors is needed. Also studying illness perceptions of HPs as 
possible predictors of change in patients’ health behavior is necessary. 
 
Further exploration of the psychometric properties of the IPQ-R HP 
The IPQ-R HP can be optimized for use in clinical practice after taking certain steps. First, an in-depth 
exploration of the face validity by cognitive interviewing techniques, which is also called think-aloud 
interviews, is needed. This is a technique that has been used previously in the validation process of 
illness perception measurements [36,37]. In a think-aloud study participants are asked to read each 
item and verbalize everything they were thinking regarding that item [38]. So, the purpose of this 
technique is that researchers explore if items are being understood and interpreted in the presumed 
way. Second, redundant items or items that are overlapping can be removed or revised immediately 
whereafter a second round of testing can be planned. This will improve the content validity. Also, 
dimensions with low Cronbach’s alpha coefficients can be discarded. 
Third, more insight in the factor structure of the IPQ-R HP conducting exploratory factor analysis is also 
warranted. In this way, information is gathered about items that can be discarded, where after the 
questionnaire could be modified. Also information concerning the construct validity is needed. This 
research should be conducted in large cohorts i.e. multicenter studies, not only in large groups of 
physicians but also in large groups of HPs, i.e. nurses, social workers, physiotherapists, etc. 
 
Uncovering the illness coherence dimension 
In Chapter 6, we found that the predominant direction of effects goes from health outcomes to the 
illness coherence dimension. This is applicable for both patient groups, SLE and SSc patients and 
remarkable because literature [39] states that illness coherence may play an important role in longer 
term adjustment and the response to symptoms. The reverse is true according to our work meaning 
that health outcomes predict illness coherence and not vice versa.  
Moss-Morris and colleagues (2002) [39] described for the first time in the IPQ-R the term illness 
coherence as ‘a type of meta-cognition reflecting the way in which the patient evaluates the coherence 
or usefulness of his or her illness representation’. Broadbent (2015) and coworkers [20] mentioned in 
their meta-analysis that illness coherence can be seen as a summary of how the other perceptions fit 
together to provide a coherent model rather than being an independent illness perception per se. So, 
further investigation is needed about the role of illness coherence is in the self-regulation process. Is 
it just the way a patient understands his condition or a summary of all illness perceptions? And how 
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come that depressive feelings, anxiety and perceived health status precede the formation of mostly 
illness coherence over time and predicts less the other illness perception dimensions? 
 
Exploring coping as a part of the self-regulation process in patients with SLE and SSc. 
As already mentioned in the introduction of this PhD project, which is based on Leventhal’s CSM [40], 
illness representations generate coping efforts which in turn influence health outcomes. Hagger and 
Orbell (2003) [2] stated that this relationship represent a mediational model in which coping mediates 
the link between illness representations and health outcomes. Coping as a mediator in the relationship 
between illness perceptions and outcomes has not been studied in SLE and SSc. In Chapter 6 we did 
not report coping behavior neither studied the mediating role of coping in the relation between illness 
perceptions and outcomes. Further research needs to illuminate this because maybe we can 
understand the results of Chapter 6 better, namely why only consequences and timeline acute/chronic 
predict outcomes, when we understand the coping mechanism within this relationship.   
 
In conclusion, this thesis contributes to an important aspect of future care in complex chronic diseases. 
Different aspects were explored such as modifiable correlates of illness perceptions, the preliminary 
validation of the IPQ-R HP, and an investigation of the prospective associations between illness 
perceptions and health outcomes such as depressive feelings, anxiety, perceived health status and 
disease activity. The results of this thesis guide HPs in the selection of factors to take into account 
when planning interventions for patients.  We found that not only emphasis on illness perceptions but 
on the ‘broader picture’, the physical and mental functioning is important when striving for a holistic 
care approach. Zooming into the IPQ-R HP shows that in the future, improvement of the IPQ-R HP is 
needed but also and most importantly implementing this instrument in standard care and daily 
practice. Such as for instance how to use the IPQ-R HP in practice and what it will contribute to 
outcomes. This thesis provides also evidence to what has been experienced in practice by clinicians, 
namely that physicians from the same and different medical specialties can have common or divergent 
beliefs regarding the condition of the patient. More studies are needed in the areas of precipitating 
factors of these divergent beliefs and the impact on interdisciplinary collaboration and decision 
making.   
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Illness perceptions are mental models that individuals construct when facing an illness in order to make 
sense of their symptoms and medical conditions. These illness models can be very specific to the 
individual which means that patients with the same condition can have different perceptions regarding 
their illness. Nevertheless, consistent patterns are identified in the way individuals generate illness 
perceptions. The concept of illness perceptions has been introduced in the early 1980s by Leventhal 
and colleagues in the Common-Sense Model. This model posits that internal stimuli (e.g. symptom 
experience such as pain) and external stimuli (e.g. disease-related information from family or 
healthcare professionals) generate cognitive and emotional representations which guide the selection 
of coping procedures in order to eliminate and control potential or ongoing ‘illness threats’. 
Afterwards, there is an appraisal of these coping procedures in regulating physical and emotional 
outcomes.  
Literature, which is limited, states that physicians’ perceptions about illness are possible 
correlates of patients’ illness perceptions. No clear overview is available in the literature about these 
correlates of illness perceptions or about the perceptions of physicians or healthcare professionals 
regarding the illness of the patient. Also, some of these correlates can be determinants or outcomes 
of illness perceptions. For instance, in the case of anxiety: do patients view their illness more negatively 
because they are anxious, or do they become anxious because they consider their illness so severe and 
feel they have no control over it?   
This PhD project covers studies addressing the unknowns in literature in patients with systemic 
lupus erythematosus (SLE) and systemic sclerosis (SSc). Firstly, we identified variables that are 
associated with illness perceptions. We selected the modifiable correlates of illness perceptions 
because these variables are prone to change which means that they are modifiable with clinical 
interventions. We found factors such as medication beliefs, quality of care, illness-related factors, 
psychosocial factors and information provision and satisfaction. This overview is interesting because 
healthcare professionals can take this into account in their encounter with patients during patient 
education or counseling sessions.  
Secondly, in order to gather more information regarding physicians’ perceptions about SLE and 
SSc, we set up three studies. In the first study, we performed a preliminary validation of an instrument 
aimed to measure illness perceptions in healthcare professionals. The second study was a vignette-
based study in which we investigated perceptions of physicians from different medical specialties, 
about SLE and SSc. We found diverse physician profiles based on their perceptions of SLE and SSc which 
was independent of the frequency of patient contact. In the third study, we examined perceptions of 
rheumatologists and general practitioners (GPs) about their own patients, this means patients they 
treat and care for. In the case of SSc, there were more commonalities in perceptions between 
rheumatologists and GPs and in the case of SLE more differences in illness perceptions. 
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Thirdly, in the last study we analyzed the link between illness perceptions of SLE and SSc 
patients and health outcomes such as depressive feelings, anxiety, perceived health status and disease 
activity spanning one year. We investigated whether illness perceptions are predicted by health 
outcomes or vice versa. This study was important because almost all literature in illness perceptions in 
SLE and SSc has a cross-sectional design and assumes that illness perceptions predict health outcomes. 
In other words, that the direction of the associations goes from illness perceptions to health outcomes. 
The results of the latter study were that health outcomes such as depressive feelings, anxiety, 
perceived health status determine illness perceptions one year later. For SLE, we found that illness 
perceptions are predictors of perceived health status and depressive symptomatology over time.  
 
In sum, this PhD study gave more insight in the modifiable correlates of illness perceptions, the illness 
perceptions of physicians from various medical specialties and their patients, and uncovered the links 
between illness perceptions and health outcomes in patients with SLE and SSc. Now, we have more  
evidence for planning educational interventions for healthcare professionals and for designing clinical 
interventions for patients but additional research is necessary. Future research is needed on different 
aspects such as the further investigation of the psychometric properties of the illness perception 
questionnaire for health care professionals, an evaluation of the impact of divergent illness 
perceptions of physicians on the organization of care and an investigation of the impact of physicians’ 
illness perceptions on patient outcomes. 
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Ziektepercepties zijn mentale constructies of modellen die mensen vormen wanneer ze 
geconfronteerd worden met een ziekte om zo betekenis te geven aan die ziekte of ervaren klachten. 
Deze mentale modellen kunnen zeer specifiek en individueel verschillend zijn. Dit wil zeggen dat 
patiënten met dezelfde aandoening verschillende percepties over hun ziekte kunnen hebben. 
Desondanks bestaat er een consistent patroon in het ontstaan van ziektepercepties. Leventhal en 
collega’s hebben begin jaren ‘80, voor de eerste maal het concept ‘ziekteperceptie’ geïntroduceerd en 
beschreven in het Common Sense Model. Dit model beschrijft hoe interne prikkels zoals bijvoorbeeld 
pijn en externe prikkels zoals informatie van familie of professionele hulpverleners, cognitieve en 
emotionele percepties over de ziekte doen ontstaan. De volgende stap in dit model is dat het individu 
op zoek gaat naar manieren om het hoofd te bieden aan de ziekte om zo de ziekte te elimineren of te 
controleren. Achteraf zullen deze inspanningen beoordeeld en geëvalueerd worden op vlak van 
afname van de klachten of verbetering van de ziekte.  
Op basis van beperkte literatuur weten we dat de manier waarop een arts kijkt naar de 
aandoening van de patiënt een bepalende factor is voor de ziekteperceptie van de patiënt. Op dit 
moment bestaat er geen helder overzicht in de literatuur over deze factoren die gerelateerd zijn aan 
ziektepercepties van patiënten. Ook is er geen informatie beschikbaar over wat nu precies de 
percepties zijn van artsen omtrent de ziekte van een patiënt. Daarbij komt nog dat sommige van deze 
gerelateerde factoren voorspellers of resultaten van ziektepercepties kunnen zijn. Bijvoorbeeld in het 
geval van angst, bekijken patiënten hun aandoening meer negatief omdat ze angstig zijn of zijn ze 
angstig omdat ze hun aandoening als ernstig ervaren en het gevoel hebben er geen controle over te 
hebben?   
Dit doctoraatsproject omvat studies die de leemtes opvullen in de literatuur bij patiënten met  
Systeemlupus (SLE) en Systeemsclerose (SSc). Ten eerste onderzochten we de factoren die 
geassocieerd zijn met ziektepercepties. We selecteerden de modificeerbare of ‘wijzigbare’ factoren 
die gerelateerd zijn aan ziekteperceptie omdat deze variabelen kunnen gewijzigd worden door middel 
van klinische interventies. Wij vonden factoren zoals medicatiepercepties, kwaliteit van zorg, ziekte 
gerelateerde factoren, psychosociale factoren en informatie overdracht en voldoening van de 
verkregen informatie. Dit overzicht is interessant en belangrijk omdat professionele hulpverleners 
hiermee rekening kunnen houden tijdens patiënten informatie en –educatiesessies. 
Ten tweede werden er drie studies opgesteld om meer inzicht te verkrijgen in de percepties 
van artsen omtrent SLE en SSc. De eerste studie was de ontwikkeling en voorbereidende validatie van 
een meetinstrument ontworpen om ziektepercepties van professionele hulpverleners te meten. In de 
tweede studie werden gevalsstudies van patiënten met SLE en SSc aangeboden aan artsen die 
tewerkgesteld zijn in verschillende medische disciplines met als doel deze gevalsstudies te beoordelen 
op vlak van hun percepties aangaande SLE en SSc. Wij vonden verschillende artsenprofielen terug los 
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van het aantal patiëntencontacten dat zij hadden. Hierna onderzochten we percepties van 
reumatologen en huisartsen over hun eigen patiënten, namelijk patiënten die zij zelf kennen en 
behandelen. Voor SSc vonden we dat er meer overeenkomsten tussen reumatologen en huisartsen 
waren in vergelijking met SLE. In SLE werden meer verschillen in ziektepercepties tussen reumatologen 
en huisartsen waargenomen.  
Ten derde, in de laatste studie analyseerden we de link tussen ziektepercepties van patiënten 
met SLE en SSc en gezondheidsgerelateerde resultaten van ziekteperceptie zoals depressieve 
gevoelens, angst, gepercipieerde gezondheidsstatus en ziekteactiviteit na een periode van 1 jaar. We 
waren geïnteresseerd in de vraag of ziektepercepties gezondheidsgerelateerde resultaten voorspellen 
of zelf voorspeld worden door deze gezondheidsgerelateerde factoren. Deze studie was belangrijk 
omdat veel onderzoek over ziektepercepties bij SLE en SSc, dwarsdoorsnede onderzoek is wat het 
onmogelijk maakt om de richting van de verbanden na te gaan. Wij vonden dat 
gezondheidsgerelateerde resultaten zoals depressieve gevoelens, angst, gepercipieerde 
gezondheidsstatus, ziektepercepties voorspellen een jaar later. Voor SLE vonden we ook dat 
ziektepercepties voorspellers zijn van gepercipieerde gezondheidsstatus en depressieve gevoelens 
over de tijd. 
 
Tot slot kunnen we stellen dat dit doctoraatsproject meer inzichten gaf in de modificeerbare factoren 
die gerelateerd zijn aan ziektepercepties en in ziektepercepties van artsen uit verschillende medische 
disciplines over patiënten met SLE en SSc. Ook werd de link tussen ziektepercepties en 
gezondheidsgerelateerde resultaten bij patiënten met SLE en SSc ontrafeld. De resultaten van dit 
doctoraatsproefschrift biedt op wetenschap gebaseerde gegevens om de opleiding voor professionele 
hulpverleners meer vorm te geven en om klinische interventies voor patiënten te plannen. Verder 
onderzoek is noodzakelijk op volgende gebieden: verdere exploratie van de psychometrische 
eigenschappen van de ziekteperceptie vragenlijst voor professionele hulpverleners, de impact van 
uiteenlopende ziektepercepties op de organisatie van de zorg en verder onderzoek naar de impact van 
ziektepercepties van artsen op gezondheidsgerelateerde resultaten bij patiënten.  
  
 
CURRICULUM VITAE AND PUBLICATIONS  
 
 
  
 
Curriculum Vitae| 165 
 
 
 
Seher Arat obtained her bachelor’s degree in Nursing at University College Leuven-Limburg (2000) and 
master’s degree in Medical-Social Sciences at KU Leuven (2003). Hereafter, she completed the 
Academic Teacher’s Education Program at KU Leuven (2004). From September 2004 on, she worked 
as a registered nurse at the University Hospitals Leuven in the Department of Intensive Care, 
Department of Endocrinology and Department of Rheumatology . Two years later, in September 2006, 
Seher began working as a Clinical Nurse Specialist in Systemic Diseases at the Department of 
Rheumatology. In March 2013, she got the opportunity to start a PhD project at the KU Leuven with a 
focus on illness perceptions in patients with multisystem diseases. In the meanwhile, she was also a 
guest lecturer in rheumatology nursing at the University College Leuven-Limburg and gave several 
lectures to staff nurses working at the University Hospitals Leuven about the care approach for patients 
with systemic diseases.
166 |Publications 
 
Publications in international peer-reviewed journals 
Arat S, Lenaerts J, De Langhe E, Verschueren P, Moons P, Vandenberghe J, Taelman V, Westhovens R.  
Illness representations of Systemic Lupus Erythematosus and Systemic Sclerosis: a comparison of 
patients, their rheumatologists and their general practitioners. Lupus Science & Medicine 2017 (in 
press). 
Arat S, Moons P, Vandenberghe J, Lenaerts J, De Vlam K, Westhovens R. Diverging illness perceptions 
between physicians about patients with systemic lupus erythematosus and systemic sclerosis: a 
vignette-based study. Rheumatology International 2017; 37(6): 915-22. doi: 10.1007/s00296-017-
3667-8. 
Arat S, Van den Zegel A., Van Rillaer M, Moons P, Vandenberghe J, De Langhe E, Westhovens R. 
Development and preliminary evaluation of the validity and reliability of a revised illness perception 
questionnaire for healthcare professionals. BMC Nursing 2016;15: 34. doi:10.1186/s12912-016-0156-
4. 
Arat S, Vandenberghe J, Moons P, Westhovens R. Patients’ perceptions of their rheumatic condition: 
why does it matter and how can healthcare professionals influence or deal with these perceptions? 
Musculoskeletal Care 2016; 14(3):174-9. doi: 10.1002/msc.1128.  
Van der Elst K, De Cock D, Vecoven E, Arat S, Meyfroidt S, Joly J, Moons P, Verschueren P, Westhovens 
R & CareRA study group. Are illness perception and coping style associated with the delay between 
symptom onset and the first general practitioner consultation in early rheumatoid arthritis 
management? An exploratory study within the CareRA trial. Scandinavian Journal of Rheumatology 
2016;45(3):171-8. doi: 10.3109/03009742.2015.1074278.  
Mackie S, Arat S, da Silva J, Duarte C, Halliday S, Hughes R, Morris M, Pease C, Sherman JW, Lee Simon, 
Walsh M, Westhovens R, Zakout S, Kirwan JR. Polymyalgia Rheumatic Special Interest Group  (PMR 
SIG) at OMERACT 11: Outcomes of importance for patients with PMR. Journal of Rheumatology 2014; 
41(4):1-5. DOI: 10.3899/jrheum.131254 
Westhovens R, Arat S. Evaluating systemic sclerosis patients, which measures to use? Indian Journal 
of Rheumatology 2013; 8(6): S55-S59. http://dx.doi.org/10.1016/j.injr.2013.11.012 
Vanthuyne M, Smith V, De Langhe E, Van Praet J, Arat S, Depresseux G, Westhovens R, Blockmans D, 
Badot V, Cogan E, De Keyser F, Houssiau FA. Baseline and follow-up data of the Belgian Systemic 
Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets and autoantibody 
profile. Journal of Rheumatology 2012; 39(11):1-7. doi: 10.3899/jrheum.120283 
Arat S, Verschueren P, De Langhe E, Smith V, Vanthuyne M, Diya L, Van den Heede K, Blockmans D, De 
Keyser F, Houssiau FA, Westhovens R. The association of illness perceptions with physical and mental 
health in systemic sclerosis patients: an exploratory study. Musculoskeletal Care 2012; 10: 18–28. 
doi: 10.1002/msc.223. 
Vanthuyne M, Smith V, Arat S, Westhovens R, De Keyser F, Houssiau FA, Thonnard J-L, Vandervelde L. 
Validation of a manual ability questionnaire in patients with systemic sclerosis. Arthritis & Rheumatism 
2009;61(5):695-703. doi: 10.1002/art.24426 
 
Publications| 167 
 
 
 
First-author publications in other professionally oriented journals 
Arat S, Moons P, Vandenberghe J, Lenaerts JL, de Vlam K, Westhovens R. Artsen hebben uiteenlopende 
percepties over patiënten met systeemlupus en systeemsclerose. Nederlands Tijdschrift voor 
Reumatologie. 2017; 2: 8-12. 
Arat S. Lupus Erythematodus. Niet genezen, maar stabiliseren. ‘Thuis Verplegen’, vakblad voor 
thuisverpleegkundigen. 2010; 4: 16-9. 
Westhovens R, Arat S. Aanwinsten in de reumatologie: Zorgprogramma Systeemziekten. Actua: 
tijdschrift van het centrum voor postgraduaat onderwijs in de interne geneeskunde. 2009; 78-80.   
 
Active participation at international scientific conferences  
Arat S, Lenaerts J, De Langhe E, Verschueren P, Taelman V, Vandenberghe J, Moons P, Westhovens R. 
Detecting differences in perceptions between Lupus and Systemic Sclerosis patients, their 
rheumatologists and their general practitioners: the use of the IPQ-R HP. ARPH conference, Leiden, the 
Netherlands, 2-3 February 2017 (oral presentation). 
Arat S, Moons P, Vandenberghe J, Lenaerts J, de Vlam K, Westhovens R.  Exploring physicians’ 
perceptions of illness in patients with Systemic Lupus Erythematosus and Systemic Sclerosis: a 
vignette-based study. EULAR, London, UK, 8-11 June 2016.  
Arat S, Moons P, Vandenberghe J, Lenaerts J, De Vlam K, Westhovens R. Exploring physicians' 
perceptions of illness in patients with Systemic Lupus Erythematosus and Systemic Sclerosis: a 
vignette-based study. ARPH conference 2016, Maastricht, the Netherlands, 28-29 January 2016. 
Arat S, Van den Zegel A, Moons P, Vandenberghe J, Westhovens R. Preliminary validation of an illness 
perception questionnaire for healthcare professionals. BSR conference 2015, Manchester, UK,  28-30 
April 2015. 
Arat S, De Cock D, Moons P, Vandenberghe J, Westhovens R. The determinants of illness perceptions 
in adults with acute or chronic somatic diseases: a systematic review. ARPH conference 2015, Ghent, 
Belgium, 5-6 February 2015 (oral presentation). 
Arat S, De Cock D, Moons P, Vandenberghe J, Westhovens R. The determinants of illness perceptions 
in adults with acute or chronic somatic diseases: a mixed-method review. EULAR, Paris, France, 11-14 
June 2014.  
Arat S, Verschueren P, De Langhe E, Vanthuyne M, Smith V, Van den Heede  K, Blockmans D, De Keyser 
F., Houssiau F, Westhovens, R. Illness Perceptions in Systemic Sclerosis Patients: Associations with 
Physical and Mental Health. First international Conference Rheumatology Nurses, Rotterdam, The 
Netherlands, 11-12 October 2013. 
Arat S, Verschueren P, De Langhe E, Vanthuyne M, Smith V, Van den Heede  K, Blockmans D, De Keyser 
F, Houssiau F, Westhovens, R. The influence of illness perceptions on physical and mental health in 
scleroderma. ACR/ARHP Annual Scientific Meeting. Philadelphia (USA), 20 October 2009 (oral 
presentation) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
DANKWOORD  
  
 
 
Dankwoord| 171 
 
 
 
Ongeveer 4,5 jaar geleden ben ik aan dit doctoraat begonnen. Het werd mij voorgesteld en ik mocht 
kiezen wat ik met dit voorstel deed. Aanvaarden of weigeren. In de wandelgangen van het ziekenhuis 
zag ik en hoorde ik echo’s van wat een doctoraat inhield. Een avontuur in onontgonnen gebied, een 
verkenning van je eigen grenzen maar ook hard werken, kunnen omgaan met mentale belasting en 
onzekerheid en geen garantie hebben dat je er achteraf heelhuids uitkomt.   
Ik heb uiteindelijk de beslissing genomen om te starten omdat mijn nieuwsgierigheid naar 
wetenschappelijk onderzoek binnen een academische setting veel groter was dan mijn angst voor het 
onbekende. Nu kan ik zeggen dat ondanks de vele uitdagingen waarvoor ik stond tijdens het 
doctoraatsproces, ik eigenlijk heel graag aan dit proefschrift heb gewerkt. Dit heeft voornamelijk te 
maken met de aanwezigheid en samenwerking met anderen waardoor het finaliseren van dit 
doctoraatsproject mogelijk werd gemaakt. 
Dit doctoraat was niet mogelijk geweest zonder de deelname van patiënten, huisartsen, reumatologen 
en verpleegkundigen aan de verschillende studies.  Daarom wil ik hen uit de grond van mijn hart 
bedanken om de talrijke vragenlijsten te vervolledigen en dit steeds bereidwillig en gemotiveerd te 
doen. Mijn oprechte dank daarvoor! 
Ik wil mijn promotor en copromotoren, Prof. Dr. René Westhovens, Prof. Dr. Philip Moons en Prof. Dr. 
Joris Vandenberghe bedanken voor hun begeleiding tijdens het doctoraatsproces, hun inzet, feedback, 
de talrijke vergaderingen, en nog zo veel meer. 
Prof. Westhovens, beste René: toen ik jaren geleden begon op de dienst reumatologie, geloofde jij 
reeds in mijn capaciteiten. Ik moest me niet bewijzen tegenover jou. Intuïtief voelde je vanaf dag één 
mijn kwaliteiten aan en gaf je me kansen om me verder te ontplooien. In al mijn gedrevenheid en 
vreugde dat er iemand was die in mij geloofde, heb ik me niet 100% maar 200% ingezet voor jou en 
het wetenschappelijk werk waar we samen aan gewerkt hebben. Jij hebt enorm veel tijd vrijgemaakt 
om onderzoeksdata te bekijken, revisies en manuscripten na te lezen, te herwerken en te bekritiseren, 
mij voorgesteld aan mensen in binnen-en buitenland,….jij hebt je met hart en ziel ingezet voor dit 
doctoraat, het beste van jezelf gegeven en je uiterste best gedaan om mij zo goed mogelijk te 
begeleiden en ondersteuning te voorzien indien nodig. Indien ik wou, mocht ik naar alle uithoeken van 
de wereld om mijn onderzoek te promoten. Budget was nooit een probleem.  
Ik vind dat jij een visionair bent; je hebt een toekomstvisie, je weet waarin je moet investeren en wat 
belangrijk is voor de toekomst en ontwikkelingen in de gezondheidszorg op lange termijn.  Er zouden 
meer mensen zoals jij op de wereld moeten zijn! 
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Prof. Moons, beste Philip: bedankt voor jouw enthousiasme, voor de vele inspirerende ideeën en 
methodologische inzichten, voor je kritische blik, voor de vele geweldige adviezen, om plots 
ongevraagd tijd te maken, om mij te introduceren op AccentVV, om mij in contact te brengen met de 
psycholoog onderzoekers en zo veel meer. Het was een eer om jou als copromotor te hebben.  
Prof. Vandenberghe, beste Joris: wat ben ik blij dat we destijds voor jou hebben gekozen om het 
promotorenteam te vervolledigen. Jij bent zo intelligent! Bedankt voor je interesse in het onderwerp 
over ziektepercepties, voor de vele reflecties, bedenkingen, jouw relativeringsvermogen, maar ook om 
er steeds bij te zijn tijdens de overlegmomenten ondanks je drukke agenda.  
Beste juryleden, Prof. Dobbels en Prof. Blockmans, van harte bedankt voor jullie adviezen en 
constructieve feedback tijdens de verschillende evaluatiemomenten van het doctoraatsproces. Ik heb 
daar veel aan gehad. Prof. Weinman, it is a great honor having you as a jury member of my thesis 
panel. Many thanks for accepting this task and coming to Belgium. Dr. Taal en Prof. De Keyser, hartelijk 
dank om deel uit te maken van mijn doctoraatscommissie, om mijn thesismanuscript te beoordelen 
en om hiervoor tijd te maken. Prof. Lories, bedankt voor uw toezegging om als voorzitter te fungeren 
tijdens mijn doctoraatverdediging. Bedankt voor de motiverende woorden en om al die jaren in mijn 
capaciteiten en potentieel te geloven!  
Naast mijn promotoren en leden van de examen-en begeleidingscommissie wil ik mijn collega’s 
bedanken die ongetwijfeld een belangrijke rol hebben gespeeld in het doctoraatsproces. Prof. De 
Lange, beste Ellen: meer dan 10 jaar geleden begonnen we samen aan de constructie van het 
zorgprogramma systeemziekten. Toen jij aan één van de eerste patiënten die we registreerden, uitleg 
gaf over systeemsclerose, de therapie en onderzoeken was ik verbaasd hoe je op een heldere, 
duidelijke en menselijke manier deze informatie kon communiceren. Jij staat zo dicht bij de patiënt. Ik 
heb zoveel van jou geleerd! Bedankt voor al die fijne jaren van samenwerking, voor jouw adviezen, 
voor jouw hulp, voor de motiverende woorden, voor je geloof in mijn kwaliteiten,….De snelheid en 
structuur waarmee je zowel professionele als persoonlijke zaken regelt, is bewonderenswaardig en 
inspireert mij enorm. Dr. Lenaerts, beste Jan: het was een eer om met jou te mogen samenwerken. Jij 
bent zo gedreven, consciëntieus en gestructureerd. Ik bewonder je! Bedankt voor de vele adviezen, 
voor je interesse in mijn onderzoek en om de vele vragenlijsten in te vullen wat niet altijd evident was. 
Prof. Verschueren, beste Patrick: hoewel je geen promotor of co-promotor was, heb je altijd tijd 
gemaakt voor mij en je ingezet voor mij. Ik apprecieer dat enorm! Bedankt voor de constructieve 
feedback op manuscripten maar ook presentaties waarvan ik een try-out gaf ter voorbereiding van 
congressen. Bedankt voor die vele jaren van samenwerking en om mijn vragen te beantwoorden als ik 
er had.  Prof. Luyten, bedankt om potentieel en talent in mij te zien maar ook bedankt voor uw 
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adviezen! Prof. Luyckx, beste Koen, bedankt voor je vele inzichten, om tijd te maken voor mij, om te 
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mijn mails. Ik voel me zo vereerd dat ik jou heb leren kennen. Jessica, bedankt voor alle tips, 
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Kristien, zonder jou zou het doctoreren zeer eenzaam zijn geweest. Ik ben heel blij dat jij ook -jaren 
geleden- de dienst reumatologie hebt vervolledigd en een doctoraat bent gestart. Ik vond het heel fijn 
om met jou van gedachten te wisselen over onderzoek, het dagelijkse leven maar ook de  uitdagingen 
waarvoor ik stond. Bedankt voor de gezellige babbels, voor de motiverende woorden, voor je 
relativeringsvermogen, je adviezen, begrip en luisterend oor. Ik ben heel fier op jou en wat je tot nu 
toe hebt bereikt! Diederik, ik ken niemand die zo behulpzaam is als jij en zich zo gedreven inzet voor 
de ander. Je antwoordde altijd zeer snel op mijn vragen en stond paraat om mij te helpen. Ook al had 
je zelf een drukke agenda, je maakt steeds tijd voor iedereen die hulp nodig heeft. Ik ben je daar enorm 
dankbaar voor! Veerle, bedankt voor de fijne middagpauzes waar we konden reflecteren over ons werk 
en het dagelijkse leven. Bedankt voor je vele inzichten maar ook om je hulp aan te bieden. Sofia, thank 
you for your kindness, your reflections during the PhD meetings and for offering your help. Jo, Sabien 
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